FORM 10-K
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended
December 31, 2008
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period
from to
|
Commission file
number: 0-8082
LHC GROUP, INC.
(Exact Name of Registrant as
Specified in its Charter)
|
|
|
Delaware
|
|
71-0918189
|
(State or Other Jurisdiction
of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
420 West
Pinhook Rd, Suite A
Lafayette, Louisiana 70503
(Address
of principal executive offices)
(337) 233-1307
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Exchange Act:
|
|
|
Common Stock, par value $.001
per share
|
|
NASDAQ Global Select
Market
|
(Title of each class)
|
|
(Name of each exchange on which registered)
|
Securities registered pursuant to Section 12(g) of the
Exchange Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined by Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(Section 229.405) is not contained herein, and will not be
contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by
reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated
filer o
|
|
Accelerated
filer þ
|
|
Non-accelerated
filer o
|
|
Smaller reporting
Company o
|
|
|
|
|
Do not check if a smaller reporting company)
|
|
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). Yes o No þ
As of June 30, 2008, the aggregate market value of the
registrants common stock held by non-affiliates of the
registrant was $352.9 million based on the closing sale
price as reported on the NASDAQ Global Select Market. For
purposes of this determination shares beneficially owned by
officers, directors and ten percent shareholders have been
excluded, which does not constitute a determination that such
persons are affiliates.
There were 18,323,652 shares of common stock, $.01 par
value, issued and outstanding as of March 10, 2009.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the Registrants Annual Report to stockholders
for the fiscal year ended December 31, 2008 are
incorporated by reference in Part II of this
Form 10-K.
Portions of the Registrants Proxy Statement for its 2009
Annual Meeting of Stockholders are incorporated by reference in
Part III of this annual report on
Form 10-K.
LHC
GROUP, INC.
TABLE OF
CONTENTS
2
PART I
CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report on
Form 10-K
and the information incorporated by reference herein, contain
certain statements and information that may constitute
forward-looking statements within the meaning of
Section 27A of the Securities Act of 1993 and
Section 21E of the Securities Exchange Act of 1934 (the
Exchange Act). Forward-looking statements relate to
future plans and strategies, anticipated events or trends,
future financial performance and expectations and beliefs
concerning matters that are not historical facts or that
necessarily depend upon future events. The words
may, will, should,
could, would, expect,
plan, anticipate, believe,
foresee, estimate, predict,
potential, intend and similar
expressions are intended to identify forward-looking statements.
Specifically, this report contains, among others,
forward-looking
statements about:
|
|
|
|
|
our expectations regarding financial condition or results of
operations for periods after December 31, 2008;
|
|
|
|
our critical accounting policies;
|
|
|
|
our business strategies and our ability to grow our business;
|
|
|
|
our participation in the Medicare and Medicaid programs;
|
|
|
|
the impact of the Presidents budget proposal;
|
|
|
|
the reimbursement levels of Medicare and other third-party
payors;
|
|
|
|
the prompt receipt of payments from Medicare and other
third-party payors;
|
|
|
|
our future sources of and needs for liquidity and capital
resources;
|
|
|
|
the effect of any changes in market rates on our operating and
cash flows;
|
|
|
|
our ability to obtain financing;
|
|
|
|
our ability to make payments as they become due;
|
|
|
|
the outcomes of various routine and non-routine governmental
reviews, audits and investigations;
|
|
|
|
our expansion strategy, the successful integration of recent
acquisitions and, if necessary, the ability to relocate or
restructure our current facilities;
|
|
|
|
the value of our propriety technology;
|
|
|
|
the impact of legal proceedings;
|
|
|
|
our insurance coverage;
|
|
|
|
the costs of medical supplies;
|
|
|
|
our competitors and our competitive advantages;
|
|
|
|
our ability to attract and retain valuable employees;
|
|
|
|
the price of our stock;
|
|
|
|
our compliance with environmental, health and safety laws and
regulations;
|
|
|
|
our compliance with health care laws and regulations;
|
|
|
|
our compliance with Securities and Exchange Commission laws and
regulations and Sarbanes-Oxley requirements;
|
|
|
|
the impact of federal and state government regulation on our
business; and
|
|
|
|
the impact of changes in or future interpretations of fraud,
anti-kickback or other laws.
|
3
The forward-looking statements included in this report reflect
our current views and assumptions only as of the date this
report is filed with the Securities and Exchange Commission.
Except as required by law, we assume no responsibility and do
not intend to release updates or revisions to forward-looking
statements after the date they are made, whether as a result of
new information, future events or otherwise. The occurrence of
any of the events described in Part I, Item 1A, Risk
Factors in this Annual Report on
Form 10-K
or incorporated by reference into this Annual Report on
Form 10-K,
and other events that we have not predicted or assessed could
have a material adverse effect on our earnings, financial
condition and business, and any such forward-looking statements
should not be relied on as a prediction of future events. Many
factors, beyond our ability to control or predict could cause
actual results or achievements to materially differ from any
future results or achievements expressed in or implied by our
forward-looking statements.
We qualify all of our forward-looking statements by these
cautionary statements. In addition, with respect to all of our
forward-looking statements, we claim the protection of the safe
harbor for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995.
You should read this report, the information incorporated by
reference into this report and the documents filed as exhibits
to this report completely and with the understanding that our
actual future results or achievements may be materially
different from what we expect or anticipate.
Unless otherwise indicated, LHC Group,
we, us, our and the
Company refer to LHC Group, Inc. and our consolidated
subsidiaries.
Overview
We provide post-acute health care services to patients through
our home nursing agencies, hospices, and long-term acute care
hospitals (LTACHs). Through our wholly and majority
owned subsidiaries, equity joint ventures and controlled
affiliates, we currently operate in Louisiana, Mississippi,
Arkansas, Alabama, Texas, Kentucky, Florida, Tennessee, Georgia,
Virginia, West Virginia, North Carolina, Ohio, Missouri,
Oklahoma, Maryland and Washington. As of December 31, 2008,
we owned and operated 206 home nursing agency locations, 19
hospices, two diabetes management companies, three specialty
agencies and four private duty agencies. As of December 31,
2008, we managed the operations of four home nursing agencies in
which we do not have an ownership interest. Our facility-based
services operations as of December 31, 2008, included four
long-term acute care hospitals with seven locations, an
outpatient rehabilitation clinic, a pharmacy, one medical
equipment location and a family health center. We also manage
the operations of one inpatient rehabilitation facility in which
we have no ownership interest.
We provide home-based post-acute health care services through
our home nursing agencies and hospices. Our home nursing
locations offer a wide range of services, including skilled
nursing, home health aides, medically-oriented social services
and physical, occupational and speech therapy. The nurses, home
health aides and therapists in our home nursing agencies work
closely with patients and their families to design and implement
individualized treatments in accordance with a
physician-prescribed plan of care. Our hospices provide
palliative care to patients with terminal illnesses through
interdisciplinary teams of physicians, nurses, home health
aides, counselors and volunteers. Of our 238 home-based services
locations, 134 are wholly-owned by us, 92 are majority-owned or
controlled by us through joint ventures, eight are operated
through license lease arrangements and we manage the operations
of four home nursing agencies in which we have no ownership
interest.
Our long-term acute care hospitals, six of which are located
within host hospitals, provide services primarily to patients
with complex medical conditions who have transitioned out of a
hospital intensive care unit but whose conditions remain too
severe for treatment in a non-acute setting. As of
December 31, 2008, our hospitals had 156 licensed beds. We
provide outpatient rehabilitation services through physical
therapists, occupational therapists and speech pathologists at
the outpatient rehabilitation clinic which we own. We also
provide outpatient rehabilitation services to patients on a
contractual basis. In addition, we manage the operations of one
inpatient rehabilitation facility in which we have no ownership
interest. Of our
4
12 facility-based
services locations in which we maintain an ownership interest,
six are wholly-owned by us and six are majority-owned or
controlled by us through joint ventures.
Our net service revenue by segment was as follows (amounts in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Home-Based Services
|
|
$
|
326,041
|
|
|
$
|
244,107
|
|
|
$
|
164,701
|
|
Facility-Based Services
|
|
$
|
57,255
|
|
|
$
|
53,924
|
|
|
$
|
53,834
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Net Service Revenue
|
|
$
|
383,296
|
|
|
$
|
298,031
|
|
|
$
|
218,535
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our founders began operations in September 1994 as St. Landry
Home Health, Inc. in Palmetto, Louisiana. After several years of
expansion, our founders reorganized their business and began
operating as Louisiana Healthcare Group, Inc. in June 2000. In
March 2001, Louisiana Healthcare Group, Inc. reorganized and
became a wholly owned subsidiary of The Healthcare Group, Inc.,
a Louisiana business corporation. In December 2002, The
Healthcare Group, Inc. merged into LHC Group, LLC, a Louisiana
limited liability company, with LHC Group, LLC being the
surviving entity. In January 2005, LHC Group, LLC established a
wholly owned Delaware subsidiary, LHC Group, Inc. On
February 9, 2005, LHC Group, LLC merged into LHC Group,
Inc., which is a Delaware corporation. Our principal executive
offices are located at 420 West Pinhook Road, Suite A,
Lafayette, Louisiana, 70503. Our telephone number is
(337) 233-1307
and our website is www.lhcgroup.com.
Industry
and Market Opportunity
According to the Medicare Payment Advisory Committee
(MedPAC), an independent federal body established to
advise Congress on issues affecting the Medicare program,
approximately one-third of all general acute care hospital
patients require additional care following their discharge from
the hospital. Post-acute care currently comprises approximately
15% of Medicares total spending. Some of these patients
receive less intensive care in settings such as skilled nursing
facilities, outpatient rehabilitation clinics or the home, while
others receive continuing care in more intensive care settings
such as inpatient rehabilitation facilities or long-term acute
care hospitals that are either freestanding or co-located within
general acute care facilities. According to MedPAC estimates,
Medicare spending totaled $20.2 billion in 2007 for the two
primary post-acute sectors in which we operate: home nursing
($15.7 billion) and long-term acute care hospitals
($4.5 billion).
MedPAC estimates that there were approximately 9,801
Medicare-certified home nursing agencies in the United States in
2007, the majority of which are operated by small local or
regional providers. MedPAC estimates that in 2007, 67% of
freestanding home health agencies were urban, 16% were rural and
17% were mixed. Also, 14% were not-for-profit, 79% were for
profit and 7% were government. MedPAC predicts that Medicare
spending on home nursing services will increase at an average
annual growth rate of 7.4% between 2007 and 2017. Growth is
being driven by:
|
|
|
|
|
a U.S. population that is getting older and living longer;
|
|
|
|
patient preference for less restrictive care settings;
|
|
|
|
incentives for general acute care hospitals to discharge
patients into less intensive treatment settings as quickly as
medically appropriate;
|
|
|
|
higher incidences of chronic conditions and disease; and
|
|
|
|
a continued movement of institutionalized people into home- and
community-based care.
|
Long-term acute care hospitals provide specialized medical and
rehabilitative care to patients with complex medical conditions
requiring higher intensity care and monitoring that cannot be
provided effectively in other health care settings. These
facilities typically serve as an intermediate step between the
intensive care unit of a general acute care hospital and a less
intensive treatment setting, such as a skilled nursing facility
or
5
the home. According to MedPAC estimates, Medicare spending for
services provided by long-term acute care hospitals have held
steady at $4.5 billion since 2005.
We believe our post-acute service provides valuable alternatives
to this underserved, rural patient population. According to the
National Institute of Health (NIH), rural areas have
a higher percentage of residents over the age of 65, who, in
2006, accounted for 18.0% of the total population in rural
markets compared to 15.0% in urban markets. Additionally,
according to NIH, rural areas typically do not offer the range
of post-acute health care services that are available in urban
or suburban markets. As such, patients in rural markets face
challenges in accessing health care in a convenient and
appropriate setting. For example, NIH estimates that although
20% of Americans live in rural areas, less than 9% of the
nations physicians practice in rural areas. According to
NIH, individuals in rural areas may also have difficulty
reaching health care facilities due to greater travel time or a
lack of public transportation. The economic characteristics and
population dispersion of rural markets also make these markets
less attractive to health maintenance organizations and other
managed care payors. Government studies cited by NIH have shown
rural residents also tend to have more health complications than
urban residents. Additionally, NIH has noted that residents in
rural areas are less likely to use preventive screening services
and have a higher prevalence of disabilities, heart disease,
cancer, diabetes and other chronic conditions when compared to
urban residents.
We believe we are well positioned to build and maintain
long-term relationships with local hospitals, physicians and
other health care providers and to become the highest quality
post-acute provider in our markets. In our experience, because
most rural areas have the population size to support only one or
two general acute care hospitals, the local hospital often plays
a significant role in rural market health care delivery systems.
Rural patients who require home nursing frequently receive care
from a small home care agency or an agency that, while owned and
run by the hospital, is not an area of focus for that hospital.
Similarly, patients in these markets who require services
typically offered by long-term acute care hospitals are more
likely to remain in the community hospital because it is often
the only local facility equipped to deal with severe, complex
medical conditions. By entering these markets through
affiliations with local hospitals, competition for the services
we provide is minimal.
Business
Strategy
Our objective is to become the leading provider of post-acute
services to Medicare beneficiaries in the United States. To
achieve this objective, we intend to:
Drive internal growth in existing markets. We
intend to drive internal growth in our current markets by
increasing the number of health care providers in each market
from whom we receive referrals and by expanding the breadth of
our services. We intend to achieve this growth by:
(1) continuing to educate health care providers about the
benefits of our services; (2) reinforcing the position of
our agencies and facilities as community assets;
(3) maintaining our emphasis on high-quality medical care
for our patients; and (4) providing a superior work
environment for our employees.
Achieve margin improvement through the active management of
costs. The majority of our net service revenue is
generated under Medicare prospective payment systems
(PPS) through which we are paid pre-determined rates
based upon the clinical condition and severity of the patients
in our care. Because our profitability in a fixed payment system
depends upon our ability to manage the costs of providing care,
we continue to pursue initiatives to improve our margins and net
income.
Expand into new markets. We will continue
expanding into new markets by developing de novo locations and
by acquiring existing Medicare-certified home nursing agencies
in attractive markets throughout the United States. We will
continue our unique strategy of partnering with non-profit
hospitals in home health services as these ventures provide
significant return on investment. We will also look to acquire
larger freestanding agencies that can serve as growth platforms
in markets we do not currently serve in order to support our
growth into new states.
6
Pursue strategic acquisitions. We will
continue to identify and evaluate opportunities for strategic
acquisitions in new and existing markets that will enhance our
market position, increase our referral base and expand the
breadth of services we offer.
Develop joint ventures. We endeavor to joint
venture with hospitals to provide post-acute services, such as
home health, hospice and LTACH services in communities served by
hospitals already operating Medicare- certified home health
agencies.
Services
We provide post-acute care services in the United States
providing quality cost-effective health care services to
patients within the comfort and privacy of their home or place
of residence. Our services can be broadly classified into two
principal categories: (1) home-based services offered
through our home nursing agencies and hospices; and
(2) facility-based services offered through our long-term
acute care hospitals and outpatient rehabilitation clinic and
inpatient rehabilitation facility.
Home-Based
Services
Home Nursing. Our registered and licensed
practical nurses provide a variety of medically necessary
services to homebound patients who are suffering from acute or
chronic illness, recovering from injury or surgery, or who
otherwise require care, teaching or monitoring. These services
include wound care and dressing changes, cardiac rehabilitation,
infusion therapy, pain management, pharmaceutical
administration, skilled observation and assessment and patient
education. We have also designed guidelines to treat chronic
diseases and conditions including diabetes, hypertension,
arthritis, Alzheimers disease, low vision, spinal
stenosis, Parkinsons disease, osteoporosis, complex wound
care and chronic pain. Our home health aides provide assistance
with activities of daily living such as light housekeeping,
simple meal preparation, medication management, bathing and
walking. Through our medical social workers we counsel patients
and their families with regard to financial, personal and social
concerns that arise from a patients health-related
problems. We provide skilled nursing, ventilator and tracheotomy
services, extended care specialties, medication administration
and management and patient and family assistance and education.
We also provide management services to third-party home nursing
agencies, often as an interim solution until proper state and
regulatory approvals for an acquisition can be obtained.
Our physical, occupational and speech therapists provide therapy
services to patients in their home. Our therapists coordinate
multi-disciplinary treatment plans with physicians, nurses and
social workers to restore basic mobility skills such as getting
out of bed and walking safely with crutches or a walker. As part
of the treatment and rehabilitation process, a therapist will
stretch and strengthen muscles, test balance and coordination
abilities and teach home exercise programs. Our therapists
assist patients and their families with improving and
maintaining a patients ability to perform functional
activities of daily living, such as the ability to dress, cook,
clean and manage other activities safely in the home
environment. Our speech and language therapists provide
corrective and rehabilitative treatment to patients who suffer
from physical or cognitive deficits or disorders that create
difficulty with verbal communication or swallowing.
All of our home nursing agencies offer
24-hour
personal emergency response and support services through Philips
Lifeline for qualified patients who require close medical
monitoring but who want to maintain an independent lifestyle.
These services consist principally of a communicator that
connects to the telephone line in the subscribers home and
a personal help button that is worn or carried by the individual
subscriber and that, when activated, initiates a telephone call
from the subscribers communicator to Lifelines
central monitoring facilities. Lifelines trained personnel
identify the nature and extent of the subscribers
particular need and notify the subscribers family members,
neighbors
and/or
emergency personnel, as needed. Our use of the Lifeline system
increases patient satisfaction and loyalty by providing our
patients a point of contact between scheduled nursing visits. As
a result, we provide a more complete regimen of care management
than our competitors in the markets in which we operate by
offering this service to qualified patients as part of their
home health plan of care.
7
Hospice. Our Medicare-certified hospice
operations provide a full range of hospice services designed to
meet the individual physical, spiritual and psychosocial needs
of terminally ill patients and their families. Our hospice
services are primarily provided in a patients home but can
also be provided in a nursing home, assisted living facility or
hospital. Key services provided include pain and symptom
management accompanied by palliative medication, emotional and
spiritual support, spiritual counseling and family bereavement
counseling, inpatient and respite care, homemaker services,
dietary counseling and social worker visits for up to
13 months after a patients death.
Facility-Based
Services
Long-term Acute Care Hospitals. Our long-term
acute care hospitals treat patients with severe medical
conditions who require a high-level of care, frequent monitoring
by physicians and other clinical personnel. Patients who receive
our services in a long-term acute care hospital are too
medically unstable to be treated in a non-acute setting.
Examples of these medical conditions include respiratory
failure, neuromuscular disorders, cardiac disorders, non-healing
wounds, renal disorders, cancer, head and neck injuries and
mental disorders. These impairments often are associated with
accidents, strokes, heart attacks and other serious medical
conditions. We also treat patients diagnosed with
musculoskeletal impairments that restrict their ability to
perform normal activities of daily living. As part of our
facility-based services, we operate an institutional pharmacy,
which focuses on providing a full array of institutional
pharmacy services to our long-term acute care hospitals and
inpatient rehabilitation facility.
Rehabilitation Services. We provide
rehabilitation services in multiple settings, including both
inpatient and outpatient settings. In our facilities and through
our contractual relationships, we provide physical, occupational
and speech rehabilitation services. We also provide certain
specialized services such as hand therapy or sports performance
enhancement to treat sports and work related injuries,
musculoskeletal disorders, chronic or acute pain and orthopedic
conditions. Our patients are often diagnosed with
musculoskeletal impairments that restrict their ability to
perform normal activities of daily living. These impairments are
often associated with accidents, sports injuries, strokes, heart
attacks and other medical conditions. Our rehabilitation
services are designed to help these patients minimize physical
and cognitive impairments and maximize functional ability. We
also design services to prevent short-term disabilities from
becoming chronic conditions. Our rehabilitation services are
provided by our physical, occupational and respiratory
therapists and
speech-language
pathologists. We also provide management services to one
inpatient rehabilitation facility and operate one health and
wellness center.
Operations
Financial information relating to the home- and facility- based
segments is found in the consolidated financial statements of
the Company included in this Annual Report on Form
10-K. All of
our operations are based in the United States; therefore 100% of
our revenues from external customers for the years ended
December 31, 2008, 2007 and 2006 and 100% of our long-lived
assets were attributed to the United States.
Home-Based
Services
Each of our home nursing agencies is staffed with experienced
clinical home health professionals who provide a wide range of
patient care services. Our home nursing agencies are managed by
a Director of Nursing or Branch Manager who is also a licensed
registered nurse. Our Directors of Nursing and Branch Managers
are overseen by State Directors who report to Division Vice
Presidents. The Senior Vice President of Operations is
accountable for the oversight of the Division Vice
Presidents and directly reports to the President and Chief
Operating Officer of the Company. Our patient care operating
model for our home nursing agencies is structured on a base
model that requires a Medicare patient minimum census of
50 patients. At the base model level, one registered nurse
is responsible for all aspects of the management of each
patients plan of care. A home nursing agency based on this
model is staffed with an office manager, a field-registered
nurse, a field-licensed professional nurse and a home health
aide. We also employ and/or contract with local community
therapists and other clinicians, as appropriate, to provide
additional required services. As the size
8
and patient census of a particular home nursing agency grows,
these staffing patterns are increased appropriately.
Our home nursing agencies use our Service Value Point system, a
proprietary clinical resource allocation model and cost
management system. The system is a quantitative tool that
assigns a target level of resource units to a group of patients
based upon their initial assessment and estimated skilled
nursing and therapy needs. The Service Value Point system allows
the Director of Nursing or Branch Manager to allocate adequate
resources throughout the group of patients assigned to his or
her care, rather than focusing on the profitability of an
individual patient.
Patient care is handled at the home nursing agency level.
Functions that are centralized into the home office include
payroll, accounting, financial reporting, billing, collections,
regulatory and legal compliance, risk management, pharmacy and
general clinical oversight accomplished by periodic
on-site
surveys. Each of our home nursing agencies is licensed and
certified by the state and federal governments, and 38 agencies
are accredited by the Joint Commission, a nationwide commission
that establishes standards relating to the physical plant,
administration, quality of patient care and operation of medical
staffs of hospitals. Those not yet accredited are working
towards achieving this accreditation, a process which can take
up to six months.
Facility-Based
Services
Long-Term Acute Care Hospitals. Each of our
long-term acute care hospital locations is managed by a Hospital
Administrator, while the clinical operations are directed by a
Director of Nursing who is a licensed registered nurse. The
individual Hospital Administrators are responsible for managing
the day-to-day operating activities of the hospital within
appropriate budgetary constraints. Each Hospital Administrator
reports to the Vice President of Facility-Based Services. Each
Director of Nursing reports directly to his or her respective
hospital administrator as well as indirectly to our Director of
Clinicals responsible for the oversight of the quality of
patient care services. The medical management of each patient is
overseen by a Medical Director who is responsible for ensuring
the appropriateness of admissions, as well as leading weekly
patient care conferences.
We follow a clinical approach under which each patient is
discussed in weekly, multidisciplinary team meetings. In these
meetings patient progress is assessed, compared to goals and
future goals are set. Attendees at the meetings include a
patients family member and referring physician. We believe
that this model results in higher quality care, predictable
discharge patterns and the avoidance of unnecessary delays.
All coding, medical records, human resources, case management,
utilization review and medical staff credentialing are provided
at the hospital level. Centralized functions that are provided
by the home office include payroll, accounting, financial
reporting, billing, collections, regulatory and legal
compliance, risk management, pharmacy and general clinical
oversight accomplished by periodic
on-site
surveys.
Rehabilitation Services. Our rehabilitation
services are overseen by an administrator, who is a licensed
physical therapist. Our clinic also has an
on-site
therapist responsible for addressing staffing needs and concerns
as well as managing the day-to-day operations of the outpatient
rehabilitation clinic.
As with our long-term acute care hospitals, all coding, medical
records, human resources, charge/data entry, front end
collections and marketing for our rehabilitation centers are
provided at the individual center level. Centralized functions
provided by the home office include payroll, accounting,
financial reporting, billing, collections, regulatory and legal
compliance, risk management and general clinical oversight
accomplished by periodic
on-site
surveys.
9
Joint
Ventures
As of December 31, 2008, we had 52 joint venture agreements
and four agency leasing arrangements for 107 of our agencies.
|
|
|
|
|
Type of Services
|
|
|
|
|
Home Nursing Agencies
|
|
|
91
|
|
Hospice
|
|
|
10
|
|
LTACH
|
|
|
6
|
|
|
|
|
|
|
|
|
|
107
|
|
Our joint ventures are structured either as equity joint
ventures or agency leasing arrangements, as permitted by
applicable state laws and subject to business considerations. Of
the 52 joint ventures, we have joint ventured with hospitals on
44, with physicians on four and with other parties on four. With
respect to our four joint ventures with physicians, three are
for the ownership and operation of long-term acute care
hospitals and one is for the ownership of a rural home nursing
agency.
Equity
Joint Ventures
As of December 31, 2008, we had 52 equity joint ventures
for the ownership and operation of home nursing agencies,
hospices, outpatient rehabilitation clinics and long-term acute
care hospitals. Our equity joint ventures are structured as
limited liability companies in which we own a majority equity
interest and our partners own a minority equity interest ranging
from 1% to 49%. At the time of formation, we and our partners
each contribute capital to the equity joint venture in the form
of cash or property. We believe that the amount contributed by
each party to the equity joint venture represents their pro rata
portion of the fair market value of the equity joint venture.
None of our partners are required to make or influence referrals
to our equity joint ventures. In fact, each of our hospital
joint venture partners must follow the same Medicare discharge
planning regulations, which, among other things, requires them
to offer each Medicare patient a list of available
Medicare-certified home nursing agency options and to allow the
patient to choose his or her own provider.
We serve as the manager for our equity joint ventures and
oversee their day-to-day operations. In two of our equity joint
ventures with parties other than hospitals or physicians, our
partners provide business development services and, in one case,
administrative services. From a governance perspective, our
equity joint ventures are either manager-managed or board
managed. In our manager-managed joint ventures, we are
designated as the manager, and, in our board managed joint
ventures, we generally hold a majority of the votes required to
take action. We generally possess a majority of the total votes
available to be cast by the members of the management committee.
However, in three of these joint ventures where we have
partnered with not-for-profit hospitals, the hospital controls a
majority of the total management committee votes. In such
instances we possess the right to withdraw from the equity joint
venture at any time upon notice to our partner in exchange for
the receipt of a payment in an amount calculated in accordance
with a predetermined fair market value formula. The members of
our equity joint ventures participate in profits and losses in
proportion to their equity interests. Distributions from our
equity joint ventures are made pro-rata based on percentage
ownership interests and are not based on referrals made to the
equity joint venture by any of the members.
The 52 equity joint ventures individually contribute between
0.1% and 6.8% of our total net service revenue and only two of
the equity joint ventures account for greater than 5.0% of our
total net service revenue for the 12 months ended
December 31, 2008. Louisiana Extended Care Hospital of
Lafayette, a long-term acute care hospital in which we own 87.3%
of the membership interests, with the remaining 12.7% ownership
divided among 19 individual physicians, contributed 6.59% to net
service revenue, for the year ended December 31, 2008. Any
member may withdraw from this equity joint venture upon
90 days advance written notice. Mississippi HomeCare of
Jackson II, LLC, of which we have a 66.67% ownership interest
with the remaining 33.33% ownership interest belonging to
Mississippi Baptist Medical Center Inc., contributed 6.8% to our
consolidated net service revenue. This joint venture was
converted from a license lease arrangement (discussed below) to
an equity joint venture in October 2007.
10
Several of our equity joint ventures include a buy/sell option
that grants to us and our joint venture partner(s) the right to
require the other joint venture party to either purchase all of
the exercising members membership interests or sell to the
exercising member all of the non-exercising members
membership interests, at the non-exercising members
option, within 30 days of the receipt of notice of the
exercise of the buy/sell option. In some instances, the purchase
price under these buy/sell provisions is based on a multiple of
the historical or future earnings before income taxes,
depreciation and amortization of the equity joint venture at the
time the buy/sell option is exercised. In other instances, the
buy/sell purchase price will be negotiated by the partners but
will be subject to a fair market valuation process.
License
Leasing Agreements
As of December 31, 2008, we have four agreements to lease,
through our wholly-owned subsidiaries, the right to use the home
health licenses necessary to operate five of our home nursing
agencies and three hospice agencies. These leases are entered
into in instances when state law would otherwise prohibit the
alienation and sale of home nursing agencies or when the local
hospital is reluctant to sell its home health agency due to
state-imposed limits on the number of certificates of need or
permits of approval. The leasing fees for two of these
agreements depend on net quarterly projections and are each
capped at $160,000 per year for the first three years with a
3.0% increase every three years during the initial term, which
expire in 2010. The third leasing arrangement calls for monthly
fees of $16,000 during the three years with a 5% increase every
three years of the initial terms, expiring in 2017. The fourth
leasing arrangement calls for a fixed monthly fee of $5,000 for
the initial term of the agreement, which expires in 2017. In all
four leasing arrangements, we have a right of first refusal in
the event that the lessor intends to sell the leased agency to a
third party.
Management
Services Agreements
As of December 31, 2008, we have four management services
agreements under which we manage the operations of four home
nursing agencies and one inpatient rehabilitation facility. We
currently have no ownership interest in the agencies and
facilities subject to these management services agreements. We
are responsible for the costs associated with the locations and
personnel required for the provision of services. We are
compensated based on a percentage of cash collections or are
reimbursed for operating expenses and compensated based on a
percentage of operating net income. The term of these
arrangements is typically five years, with an option to renew
for an additional five-year term. The termination dates for our
management services agreements range from August 31, 2009
to July 31, 2010.
We record management services revenue as services are provided
in accordance with the various management services agreements.
As described in the agreements we provide billing, management
and other consulting services suited to and designed for the
efficient operation of the applicable home nursing agency or
inpatient rehabilitation facility.
Competition
The home health care market is highly fragmented. According to
MedPac, there were approximately 9,801 Medicare-certified home
nursing agencies in the United States in 2007, the majority of
which are operated by small local or regional providers. MedPac
estimates that in 2007, 67% of freestanding home health agencies
were urban, 16% were rural and 17% were mixed. Although there
are a small number of public home nursing companies with
significant home nursing operations, they generally do not
compete with us in the rural markets that we currently serve. As
we expand into new markets, we may encounter public companies
that have greater resources or greater access to capital.
Competition in our markets comes primarily from small local and
regional providers, many of which are undercapitalized. These
providers include facility- and hospital-based providers,
visiting nurse associations and nurse registries. We are unaware
of any competitor offering our breadth of services and focusing
on the needs of rural markets.
Although several public and private national and regional
companies own or manage long-term acute care hospitals, they
generally do not operate in the rural markets that we serve.
Generally, the competition in our markets comes from local
health care providers. We believe our principal competitive
advantages over these
11
local providers are our diverse service offerings, our
collaborative approach to working with health care providers,
our focus on rural markets and our patient-oriented operating
model.
Compliance
and Quality Control
In March 2008, we established The LHC Group Quality Council. The
Council is responsible for formulating quality of care
indicators, identifying performance improvement priorities, and
facilitating best-practices for quality care. As part of this
council, we adopted the Plan, Do, Check, Act methodology. We
also set forth a quality platform for home care that reviews the
following:
|
|
|
|
|
external audits;
|
|
|
|
Joint Commission;
|
|
|
|
state and regulatory surveys;
|
|
|
|
home health compare; and
|
|
|
|
patient perception of care.
|
Our Compliance Committee, which was established in 1996,
oversees a comprehensive company-wide compliance program that
provides for:
|
|
|
|
|
the appointment of a compliance officer and committee;
|
|
|
|
adoption of codes of business conduct and ethics;
|
|
|
|
employee education and training;
|
|
|
|
monitoring of an internal system, including a toll-free hotline,
for reporting concerns on a confidential, anonymous basis;
|
|
|
|
ongoing internal compliance auditing and monitoring programs;
|
|
|
|
means for enforcing the compliance programs
policies; and
|
|
|
|
a system to respond to and correct detected problems.
|
We have approximately 40 Performance Improvement Personnel who
are all trained using a performance improvement specific
orientation program and mentorship.
As part of our ongoing quality control, internal auditing and
monitoring programs, we conduct internal regulatory audits and
mock surveys at each of our agencies and facilities at least
once a year. If an agency or facility does not achieve a
satisfactory rating, we require that it prepare and implement a
plan of correction. We then
follow-up to
verify that all deficiencies identified in the initial audit and
survey have been corrected.
As required under the Medicare conditions of participation, we
have a continuous quality improvement program, which involves:
|
|
|
|
|
ongoing education of staff and quarterly continuous quality
improvement meetings at each of our agencies and facilities and
at our home office;
|
|
|
|
quarterly comprehensive audits of patient charts performed by
each of our agencies and facilities;
|
|
|
|
at least annually, a comprehensive audit of patient charts
performed on each of our agencies and facilities by our home
office staff;
|
|
|
|
review of Home Health Compare scores;
|
|
|
|
assessment of patients perception of care; and
|
|
|
|
assessment of infection control practices/risk events.
|
12
If an agency or facility fails to achieve a satisfactory rating
on a patient chart audit, we require that it prepare and
implement a plan of correction. We then conduct a
follow-up
patient chart audit to verify that appropriate action has been
taken to prevent future deficiencies.
The effectiveness of our compliance program is directly related
to the legal and ethics training that we provide to our
employees. Compliance education for new hires is initiated
immediately upon employment through corporate video training and
is subsequently reinforced with a corporate orientation program
at which the Director of Corporate Compliance conducts a
comprehensive compliance training seminar. In addition, all of
our employees are required to participate in continuing
compliance education and training each year.
We continually expand and refine our compliance and quality
improvement programs. Specific written policies, procedures,
training and educational materials and programs, as well as
auditing and monitoring activities, have been prepared and
implemented to address the functional and operational aspects of
our business. Our programs also address specific problem areas
identified through regulatory interpretation and enforcement
activities. Additionally, our policies, training, standardized
documentation requirements, reviews and audits specifically
address our financial arrangements with our referral sources,
including fraud and abuse laws and physician self-referral laws.
We believe our consistent focus on compliance and continuous
quality improvement programs provide us with a competitive
advantage in the market.
Technology
and Intellectual Property
Our Service Value Point system is a proprietary information
system that assists us in, among other things, monitoring use
and other cost factors, supporting our health care management
techniques, internal benchmarking, clinical analysis, outcomes
monitoring and claims generation, revenue cycle management and
revenue reporting. We have been notified by the U.S. Patent
and Trademark Office that the patent for our Service Value
Points system will be issued during the first quarter of 2009.
This proprietary home nursing clinical resource and cost
management system is a quantitative tool that assigns a target
level of resource units to each patient based upon their initial
assessment and estimated skilled nursing and therapy needs. We
designed this system to empower our direct care employees to
make appropriate day-to-day clinical care decisions while also
allowing us to manage the quality and delivery of care across
our system and to monitor the cost of providing that care both
on a patient-specific and agency-specific basis.
In addition to our Service Value Point system, our business is
substantially dependent on other non-proprietary software. We
utilize a third-party software information system for billing
and maintaining patient claim receivables for our long-term
acute care hospitals. Our various home nursing agency databases
have been fully consolidated into an enterprise-wide system
since the first half of 2005, which has improved the accuracy,
reliability and efficiency of processing and management
reporting.
Further, we have two major patient billing systems that we use
across the enterprise: one system for our home-based services
and one for our facility-based services. In a majority of our
acquisitions we transition the patient billing to the
Companys software system; however, in certain instances
the acquired Company may not transition immediately. Both of our
systems are fully automated and contain functionality that
allows us to calculate net service revenue at both the payor and
patient level.
The software we use is based on client-server technology and is
highly scalable. We believe our software and systems are
flexible, easy-to-use and allow us to accommodate growth without
difficulty. Technology plays a key role in our
organizations ability to expand operations and maintain
effective managerial control. We believe that building and
enhancing our information and software systems provides us with
a competitive advantage that allows us to grow our business in a
more cost-efficient manner and results in better patient care.
In 2009 we intend to more closely evaluate point of care
technology (POC). We currently have 23 locations on
point of care in Maryland, Tennessee, and Virginia. Compared to
5 years ago when 30%-40% of home health agencies and 5% of
hospices utilized POC, today 65% of home health agencies and 30%
of hospices utilize POC. Five years ago POC tools did not have
predictive or disease management capabilities built in. Today
they do. Today, fifty-five percent (55%) of all Americans
already have broadband access at
13
home up from 47% in 2007, according to a July Pew
Internet & American Life Project report. The study
also found that 38% of rural Americans have broadband at home,
an increase of 23% from the previous year. $7.2 billion of
the $787 billion federal stimulus package is set aside to
expand the reach of broadband to rural areas. This supports the
increasing ability for real time transfer of information from
the field to the office and presents a more compelling quality
and efficiency return on investment.
Reimbursement
Medicare
The federal governments Medicare program, governed by the
Social Security Act of 1965, reimburses health care providers
for services furnished to Medicare beneficiaries. These
beneficiaries generally include persons age 65 and older
and those who are chronically disabled. The program is primarily
administered by the Department of Health and Human Services
(HHS) and the Centers for Medicare &
Medicaid Services (CMS). Medicare payments accounted
for 83.2%, 81.7% and 82.6% of our net service revenue for the
years ended December 31, 2008, 2007 and 2006, respectively.
Medicare reimburses us based upon the setting in which we
provide our services or the Medicare category in which those
services fall.
Home Nursing. The Medicare home nursing
benefit is available to patients who need care following
discharge from a hospital, as well as patients who suffer from
chronic conditions that require ongoing but intermittent care.
The services received need not be rehabilitative or of a finite
duration; however, patients who require full-time skilled
nursing for an extended period of time generally do not qualify
for Medicare home nursing benefits. As a condition of coverage
under Medicare, beneficiaries must: (1) be homebound in
that they are unable to leave their home without considerable
effort; (2) require intermittent skilled nursing, physical
therapy, or speech therapy services that are covered by
Medicare; and (3) receive treatment under a plan of care
that is established and periodically reviewed by a physician.
Qualifying patients also may receive reimbursement for
occupational therapy, medical social services and home health
aide services if these additional services are part of a plan of
care prescribed by a physician.
We receive a standard prospective Medicare payment for
delivering care over a base
60-day
period, referred to as an episode of care. There is no limit to
the number of episodes a beneficiary may receive as long as he
or she remains eligible. Most patients complete treatment within
one payment episode. The base episode payment, established
through federal legislation, is a flat rate that is adjusted
upward or downward based upon differences in the expected
resource needs of individual patients as indicated by clinical
severity, functional severity and service utilization. The
magnitude of the adjustment is determined by each patients
categorization into one of 153 payment groups, known as home
health resource groups and the costliness of care for patients
in each group relative to the average patient. Our payment is
adjusted for differences in local prices using the hospital wage
index. We bill and are reimbursed for services in two stages: an
initial request for advance payment when the episode commences
and a final claim when it is completed. We receive 60% of the
estimated payment for a patients initial episode up-front
(after the initial assessment is completed and upon initial
billing) and the remaining 40% upon completion of the episode
and after all final treatment orders are signed by the
physician. In the event of subsequent episodes, reimbursement
timing is 50% up-front and 50% upon completion of the episode.
Final payments may reflect one of four retroactive adjustments
to ensure the adequacy and effectiveness of the total
reimbursement: (1) an outlier payment if the patients
care was unusually costly; (2) a low utilization adjustment
if the number of visits was fewer than five; (3) a partial
payment if the patient transferred to another provider before
completing the episode; or (4) a payment adjustment based
upon the level of therapy services required in the population
base. Because the applicability of a change is dependent upon
the completion date of the episode, changes in reimbursement
rates could impact our financial results up to 60 days in
advance of the effective date and recognition of the change. We
submit all Medicare claims through five fiscal Regional Home
Health and Hospice Intermediaries for the federal government.
We verify the patients eligibility for home health
benefits at the time of admission. Through the verification
process we are able to determine the payor source and
eligibility for reimbursement of each patient. Accordingly, we
do not have any material reimbursement amounts that are pending
approval based on
14
the eligibility of a patient to receive reimbursement from the
applicable payor program. Further, we provide only limited
services to patients who are ineligible for reimbursement from a
third party payor. Therefore, we do not have any material
reimbursement from patients who are self-pay.
The base payment rate for Medicare home nursing in 2008 was
$2,270 per
60-day
episode. Since the inception of the prospective payment system
in October 2000, the base episode payment rate has varied due to
both the impact of annual market basket based increases and
Medicare-related legislation. Home health payment rates are
updated annually by either the full home health market basket
percentage, or by the home health market basket percentage as
adjusted by Congress. CMS establishes the home health market
basket index, which measures inflation in the prices of an
appropriate mix of goods and services included in home health
services.
On August 22, 2007, CMS released a final rule, updating and
significantly refining the Medicare home health prospective
payment system for 2008. The August 2007 final rule, including
any amendments thereto, was effective on January 1, 2008.
CMS instituted these changes to the home health payment system
to account for reported increases over the past several years in
the home health case-mix, which CMS believes have been caused by
changes in home health agencies (HHAs) coding
practices and documentation not by the treatment of
beneficiaries over the
60-day
episode of care, which would, in turn, improve the accuracy of
Medicare reimbursement to HHAs. To effectuate the improvements,
the new model: (1) enables more precise coding for
co-morbidities and the differing health characteristics of
longer-stay patients; (2) accounts more accurately for the
effect of rehabilitation services on resource use; and
(3) lessens the risk of overutilization of therapy services
by replacing the single threshold (10 visits per episode) with
three thresholds (at 6, 14, and 20 visits), as well as graduated
bonus system based on severity between each threshold.
To address the increases in case-mix, the August 2007 final rule
implemented a reduction in the national standardized
60-day
episode payment rate for four years. A 2.75% reduction began in
2008 and will continue for three years, with a 2.71% reduction
in the fourth year. Also, in the August 2007 final rule, CMS
finalized the market basket increase of 3%, a 0.1% increase from
the proposed rule. When the market basket update is viewed in
conjunction with (1) the 2.75% reduction in
home health payment rates for 2008; (2) the implementation
of the new case-mix adjustment system; (3) the changes in
wage index; and (4) the other changes made in the August
2007 final rule CMS predicts a 0.8% increase in
payments for urban HHAs and a 1.77% decrease in payments for
rural HHAs. Collectively, the changes in the August 2007 final
rule (not including the case-mix or wage index adjustments)
decrease the national
60-day
episode payment rate for HHAs from the 2007 level of $2,339 to
$2,270 in 2008.
On October 30, 2008, CMS finalized the market basket
increase of 2.9% for 2009. As a result of the 2.75% reduction,
as described above, and the market basket increase, the national
60-day
episode payment rate for HHAs in 2009 is $2,272.
On Thursday February 26, 2009, President Obama released his
proposed budget outline for the Federal 2010 fiscal year.
Although details have not yet been released, the proposed budget
calls for an aggregate reduction in home health industry
reimbursement of $550 million in 2010. Additionally, the
proposed budget also calls for additional significant reductions
in home health reimbursement for Medicare home health services
in 2011 and beyond. The budget is currently in proposed form and
Congress has yet to take any action on the proposal. There can
be no assurance that the budget will or will not be passed into
law. Accordingly, the Company is unable to predict what impact
the ultimate Federal budget and resulting Medicare and Medicaid
reimbursement might have on our financial condition or our
results of operations.
The Office of Inspector General (OIG) of HHS has a
responsibility to report both to the Secretary of HHS and to
Congress any program and management problems related to programs
such as Medicare. The OIGs duties are carried out through
a nationwide network of audits, investigations and inspections.
The OIG has recently undertaken a study with respect to Medicare
reimbursement for home health services. No estimate can be made
at this time regarding the impact, if any, of the OIGs
findings.
Hospice. In order for a Medicare beneficiary
to qualify for the Medicare hospice benefit, two physicians must
certify that, in the best judgment of the physician or medical
director, the beneficiary has less than six
15
months to live, assuming the beneficiarys disease runs its
normal course. In addition, the Medicare beneficiary must
affirmatively elect hospice care and waive any rights to other
Medicare benefits related to his or her terminal illness. For
each benefit period, a physician must recertify that the
Medicare beneficiarys life expectancy is six months or
less in order for the beneficiary to continue to qualify for and
to receive the Medicare hospice benefit. The first two benefit
periods are measured at
90-day
intervals and subsequent benefit periods are measured at
60-day
intervals. A Medicare beneficiary may revoke his or her election
at any time and resume receiving traditional Medicare benefits.
There is no limit on how long a Medicare beneficiary can receive
hospice benefits and services, provided that the beneficiary
continues to meet Medicare hospice eligibility criteria.
Medicare reimburses for hospice care using a prospective payment
system. Under that system, we receive one of four predetermined
daily or hourly rates based upon the level of care we furnish to
the beneficiary. These rates are subject to annual adjustments
based on inflation and geographic wage considerations. Our base
Medicare rates depend upon which of the following four levels of
care we provide:
|
|
|
|
|
Routine Care. This level of care includes care
that is not classified under any of the other levels of care,
such as the work of social workers or home health aides.
|
|
|
|
General Inpatient Care. This level of care is
available for pain control or acute or chronic symptom
management that cannot be managed in a setting other than an
inpatient Medicare certified facility, such as a hospital,
skilled nursing facility or hospice inpatient facility.
|
|
|
|
Continuous Home Care. This level of care is
provided when a patient is experiencing a medical crisis and
requires nursing services to achieve palliation and symptom
control. For services to qualify for this level of care, the
agency must provide a minimum of eight hours of care within a
24-hour
period.
|
|
|
|
Respite Care. This level of care is provided
on a short-term, inpatient basis to give temporary relief to the
person who regularly provides care to relieve the patient.
|
On August 8, 2008, CMS issued the Hospice Wage Index for
Fiscal Year 2009 Final Rule. This final rule provides for a
payment increase consisting of a 3.6% market basket increase
less a 1.1% decrease in the Budget Neutrality Adjustment Factor
(BNAF). The 3.6% increase is applied to the national
base rates from CMS Transmittal 1570 dated August 1, 2008,
and the 1.1% BNAF reduction is applied to the geographically
adjusted wage indices as indicated in the Federal Register dated
August 8, 2008.
On February 17, 2009, the Economic Stimulus Package was
enacted delaying the phase-out of the hospice programs
BNAF for one year and retroactively delaying a series of three
annual cuts (1.1%, 2.2%, 1.1%) that began on October 1,
2008.
Medicare limits the reimbursement we may receive for inpatient
care services of hospice patients. Under the so-called
80-20
rule, if the number of inpatient care days furnished by us
to Medicare beneficiaries exceeds 20% of the total days of
hospice care furnished by us to Medicare beneficiaries, Medicare
payments to us for inpatient care days exceeding the inpatient
cap will be reduced to the routine home care rate. This
determination is made annually based on the
12-month
period beginning on November 1st each year. This limit
is computed on a
program-by-program
basis. Our hospices have not exceeded the cap on inpatient care
services during 2007 or 2006. We have not received notification
that any of our hospices have exceeded the cap on inpatient care
services during 2008.
Our Medicare hospice reimbursement is also subject to a cap
amount calculated by the Medicare fiscal intermediary at the end
of the hospice cap period, which runs from
November 1st through October 31st of the
following year. We have not received notification that any of
our hospices have exceeded the cap on per beneficiary limits
during 2008.
The two caps include an inpatient cap and overall payment cap,
detailed below:
|
|
|
|
|
Inpatient Cap. This cap limits the number of
days of inpatient care (both respite and general) under a
provider number to 20% of the total number of days of hospice
care (both inpatient and in-home) furnished to all patients
served. The daily payment rate for any inpatient days of service
in excess of
|
16
|
|
|
|
|
the cap amount is calculated at the routine home care rate, with
excess amounts due back to Medicare; and
|
|
|
|
|
|
Overall Payment Cap. This cap is calculated by
the Medicare fiscal intermediary at the end of each hospice cap
period to determine the maximum allowable payments per provider
number. On a monthly and quarterly basis, we estimate our
potential cap exposure using information available for both
inpatient day limits as well as per beneficiary cap amounts. The
total cap amount for each provider is calculated by multiplying
the number of beneficiaries electing hospice care from
September 28, 2007 to September 27, 2008 by a
statutory amount that is indexed for inflation. The per
beneficiary cap amount was $22,386 for the twelve-month period
ended October 31, 2008 and $21,410 for the twelve month
period ended October 31, 2007. There will be a cap
liability if actual payments per the PS&R for the period of
November 1, 2007 to October 31, 2008 exceed the
beneficiary cap amount.
|
Long-term Acute Care Hospitals. We are
reimbursed by Medicare for services provided by our long-term
acute care hospitals under the LTACH prospective payment system
(LTACH-PPS), which was implemented on
October 1, 2002. Under the LTACH-PPS system we are paid on
the basis of the long-term care diagnosis-related groups
(LTACH-DRGs).
Under the LTACH-PPS, each patient discharged from our LTACHs is
assigned a long-term care diagnosis-related group. CMS
establishes these LTACH-DRGs by grouping diseases by diagnosis
to reflect the amount of resources needed to treat a given
disease. We are paid a pre-determined fixed amount applicable to
the particular LTACH-DRG to which that patient is assigned. This
payment is intended to reflect the average cost of treating a
Medicare patient classified in that particular LTACH-DRG. For
select patients, the amount may be further adjusted based on
length of stay and facility-specific costs, as well as in
instances where a patient is discharged and subsequently
readmitted, among other factors. Similar to other Medicare
prospective payment systems, the rate is also adjusted for
geographic wage differences.
To qualify for payment under the LTACH-PPS, a facility must be
certified as a hospital by Medicare, have an average Medicare
inpatient length of stay of greater than 25 days and meet
all of the facility criteria established by the Medicare,
Medicaid and SCHIP Extension Act of 2007 (MMSEA).
Prior to qualifying under the LTACH-PPS, facilities are
classified as short-term acute care hospitals and receive lower
payments under the acute or inpatient rehabilitation facility
prospective payment systems. New LTACHs continue to be paid
under these systems for a minimum of six months while they
establish the required average length of stay and meet certain
additional Medicare LTACH requirements. All of our LTACHs are
currently qualified to receive full payment under the LTACH-PPS.
May 2007 Final Rule. On May 1, 2007, CMS
published its annual payment rate update for the 2008 LTACH-PPS
rate year (RY 2008), affecting discharges and cost
reporting periods beginning on or after July 1, 2007 and
before July 1, 2008. The May 2007 final rule made several
changes to LTACH-PPS payment methodologies and amounts during RY
2008, although, as described below, many of these changes have
been postponed for a three year period by the MMSEA.
For cost reporting periods beginning on or after July 1,
2007, the May 2007 final rule expands the current Medicare
hospital within a hospital (HwH) admissions
threshold to apply to Medicare patients admitted from any
individual hospital. Previously, the admissions threshold was
applicable only to Medicare HwH admissions from hospitals
co-located with an LTACH or satellite of an LTACH. Under the May
2007 final rule, free-standing LTACHs and grandfathered HwHs are
subject to the Medicare admission thresholds, as well as HwHs
and satellites that admit Medicare patients from non-collocated
hospitals. To the extent that any LTACHs or LTACH
satellite facilitys discharges that are admitted from an
individual hospital (regardless of whether the referring
hospital is co-located with the LTACH or LTACH satellite) exceed
the applicable percentage threshold during a particular cost
reporting period, the payment rate for those discharges would be
subject to a downward payment adjustment. Cases admitted in
excess of the applicable threshold will be reimbursed at a rate
comparable to that under general acute care inpatient
prospective payment system (IPPS), which is
generally lower than LTACH-PPS rates. Cases that reach outlier
status in the discharging hospital would not count toward the
limit and would be paid under LTACH-PPS. CMS estimates the
impact of
17
the expansion of the Medicare admission thresholds resulted in a
reduction of 2.2% of the aggregate payments to all LTACHs in RY
2008.
The applicable percentage threshold is generally 25% after the
completion of the phase-in period described below. The
percentage threshold for LTACH discharges from a referring
hospital that is a metropolitan statistical area
(MSA) dominant hospital or a single urban hospital
is the percentage of total Medicare discharges in the MSA that
are from the referring hospital, but no less than 25% nor more
than 50%. For Medicare discharges from LTACHs or LTACH
satellites located in rural areas, as defined by the Office of
Management and Budget, the percentage threshold is 50% from any
individual referring hospital. The expanded 25% rule is being
phased in over a three year period that starts with cost
reporting periods beginning on or after July 1, 2007 and
before July 1, 2008, when the threshold is the lesser of
75% or the percentage of the LTACHs or LTACH
satellites admissions discharged from the referring
hospital during its cost reporting period beginning on or after
July 1, 2007 and before July 1, 2008, (RY
2008). For cost reporting periods beginning on or after
July 1, 2008 and before July 1, 2009, the threshold
will be the lesser of 50% or the percentage of the LTACHs
or LTACH satellites admissions from the referring
hospital, during its RY 2005 cost reporting period. For cost
reporting periods beginning on or after July 1, 2009, all
LTACHs will be subject to the 25% threshold (or applicable
threshold for rural, urban-single, or MSA dominant hospitals).
The MMSEA postpones the application of the percentage threshold
to all free-standing and grandfathered HwHs for a three-year
period commencing on an LTACHs first cost reporting period
on or after December 29, 2007. However, the MMSEA does not
postpone the application of the percentage threshold, or the
transition period stated above, to those Medicare patients
discharged from an LTACH HwH or HwH satellite that were admitted
from a non-co-located hospital. The MMSEA only postpones the
expansion of the admission threshold in the May 2007 final rule
to free-standing LTACHs and grandfathered HwHs.
The May 2007 final rule further revised the payment adjustment
for short-stay outliers (SSO) cases. Beginning with
discharges on or after July 1, 2007, for cases with a
covered length of stay less than or equal to the IPPS comparable
threshold and less than five-sixths of the geometric average
length of stay for that LTACH-DRG will be paid at an amount
comparable to the IPPS per diem. The MMSEA also postponed, for
the three year period beginning on December 29, 2007, the
SSO policy changes made in the May 2007 final rule.
The May 2007 final rule updated the standard federal rate by
0.71% for RY 2008. As a result, the federal rate for RY 2008 is
equal to $38,356.45, compared to $38,086.04 for RY 2007.
Subsequently, the MMSEA eliminated, effective April 1,
2008, the update to the standard federal rate that occurred for
RY 2008 effective April 1, 2008. This adjustment to the
standard federal rate was applied prospectively on April 1,
2008 and reduced the federal rate back to $38,086.04. In a
technical correction to the May 2007 final rule, CMS increased
the fixed-loss amount for high cost outliers in RY 2008 to
$20,738, compared to $14,887 in RY 2007. CMS projected an
estimated 0.4% decrease in LTACH payments in RY 2008 due to this
change in the fixed-loss amount, and the overall impact of the
May 2007 final rule to be a 1.2% decrease in total estimated
LTACH-PPS payments for RY 2008.
The May 2007 final rule provides that beginning with the annual
payment rate updates to the LTACH-DRG classifications and
relative weights for fiscal year 2008, affecting discharges
beginning on or after October 1, 2007 and before
September 30, 2008, annual updates to the LTACH-DRG
classification and relative weights are to have a budget neutral
impact. Under the May 2007 final rule, future LTACH-DRG
reclassifications and recalibrations, by themselves, should
neither increase nor decrease the estimated aggregated LTACH-PPS
payments.
August 2007 Final Rule. On August 1,
2007, CMS published the IPPS final rule for fiscal year 2008,
which created a new patient classification system with
categories referred to as MS-DRGs and MS-LTACH-DRGs,
respectively, for hospitals reimbursed under IPPS and LTACH-PPS,
respectively. Beginning with discharges on or after
October 1, 2007, the new classification categories take
into account the severity of the patients condition. CMS
assigned proposed relative weights to each MS-DRG and
MS-LTACH-DRG to reflect their relative use of medical care
resources.
18
The August 2007 final rule published a budget neutral update to
the MS-LTACH-DRG classification and relative weights. In the
preamble to the IPPS final rule for fiscal year 2008, CMS
restated that it intends to continue to update the LTACH-DRG
weights annually in the IPPS rulemaking and those weights would
be modified by a budget neutrality adjustment factor
(BNAF) to ensure that estimated aggregate LTACH
payments after reweighting are equal to estimated aggregate
LTACH payments before reweighting.
Medicare, Medicaid and SCHIP Extension Act of
2007. On December 29, 2007, President Bush
signed into law the MMSEA. Among other changes in the federal
health care programs, the MMSEA makes significant changes to
Medicare policy for LTACHs including a new statutory definition
of an LTACH, a report to Congress on new LTACH patient criteria,
relief from certain LTACH-PPS payment policies for three years,
a three year moratorium on the development of new LTACHs and
LTACH beds, elimination of the payment update for the last
quarter of RY 2008, and new medical necessity reviews by
Medicare contractors through at least October 1, 2010.
The MMSEA precludes the Secretary of HHS from implementing,
during the three year moratorium period, the provisions added by
the May 2007 final rule that extended the 25% rule to
free-standing LTACHs, including grandfathered LTACHs. The MMSEA
also modifies, during the moratorium, the effect of the 25% rule
for LTACHs that are co-located with other hospitals. For HwHs
and satellite facilities, the applicable percentage threshold is
set at 50% and not phased in to the 25% level. For HwHs and
satellite facilities located in rural areas and those which
receive referrals from MSA dominant hospitals or single urban
hospitals, the percentage threshold is set at no more than 75%.
These moratoria relating to LTACH admission thresholds extend
for an LTACHs three cost reporting periods beginning on or
after December 29, 2007.
The MMSEA also precludes the Secretary of HHS from implementing,
for the three year period beginning on December 29, 2007, a
one-time adjustment to the LTACH standard federal rate. This
rule, established in the original LTACH-PPS regulations, permits
CMS to restate the standard federal rate to reflect the effect
of changes in coding since the LTACH-PPS base year. In the
preamble to the May 2007 final rule, CMS discussed making a
one-time prospective adjustment to the LTACH-PPS rates for the
2009 rate year. In addition, the MMSEA reduces the Medicare
payment update for the portion of RY 2008 from April 1,
2008 to June 30, 2008 to the same base rate applied to
LTACH discharges during RY 2007. For the three years following
December 29, 2007, the Secretary of HHS must impose a
moratorium on the establishment and classification of new
LTACHs, LTACH satellite facilities, and LTACH beds in existing
LTACH or satellite facilities. This moratorium does not apply to
LTACHs that, before the date of enactment, (1) began the
qualifying period for payment under the LTACH-PPS, (2) have
a written agreement with an unrelated party for the
construction, renovation, lease or demolition for an LTACH and
have expended at least 10% of the estimated cost of the project
or $2,500,000, or (3) have obtained an approved certificate
of need.
May 6, 2008 Interim Final Rule. On
May 6, 2008, CMS published an interim final rule with
comment period, which implements portions of the MMSEA. The
interim final rule addresses: (1) the payment adjustment
for SSOs, (2) the standard federal rate for the last three
months of RY 2008, (3) adjustment of the high cost outlier
fixed-loss amount for the last three months of RY 2008, and
(4) the MMSEA in the discussion of the basis and scope of
the LTACH-PPS rules.
May 9, 2008 Final Rule. On May 9,
2008, CMS published its annual payment rate update for the 2009
LTACH-PPS rate year (RY 2009) affecting discharges
and cost reporting periods beginning on or after July 1,
2008. The final rule adopts a
15-month
rate update, from July 1, 2008 through September 30,
2009, and moves LTACH-PPS from a July-June update cycle to the
same update cycle as the general acute care hospital inpatient
rule (October September). For RY 2009, the rule
increases the Medicare base rate 2.7%, to $39,114.34 from
$38,086.04. The rule also increases the fixed-loss amount for
high cost outlier cases to $22,960, which is $2,222 higher than
the 2008 LTACH-PPS rate year. The final rule provides that CMS
may make a one-time reduction in the LTACH-PPS rates to reflect
a budget neutrality adjustment no earlier than December 29,
2010 and no later than October 1, 2012. CMS has estimated
this reduction will be approximately 3.75%.
May 22, 2008 Interim Final Rule. On
May 22, 2008, CMS published an interim final rule with
comment period, which implements portions of the MMSEA not
addressed in the May 6, 2008 interim final rule.
19
Among other things, the May 22, 2008 interim final rule
defines freestanding LTACH as a hospital that:
(1) has a Medicare provider agreement, (2) has an
average length of stay of greater than 25 days,
(3) does not occupy space in a building used by another
hospital, (4) does not occupy space in one or more separate
or entire buildings located on the same campus as buildings used
by another hospital, and (5) is not part of a hospital that
provides inpatient services in a building also used by another
hospital.
We currently have a total of seven LTACHs. Six of our hospitals
are classified as HwHs and one as freestanding. Of the six HwH
facilities, four are located in rural or non-MSAs. Two of our
six HwH facilities are located in MSA or urban areas. Of these
six locations classified as HwHs, two facilities are satellite
locations of a parent hospital located in an MSA and one is a
satellite location of a parent hospital located in a non-MSA.
Based on our discussions with CMS, we believe each of these
satellite locations will be viewed as being located in a non-MSA
regardless of the location of its parent hospital and will be
treated independently from its parent for purposes of
calculating its compliance with the admissions limitations. If
the 25% rule is extended, as planned, to
freestanding LTACHs after the three-year delay (established in
the MMSEA), our current freestanding facility would not likely
be affected because we currently do not receive more than 25% of
our Medicare admissions from any single referring hospital.
For the 12 months ended December 31, 2008, on an
individual basis, the admission of six of our LTACHs were under
the proper threshold as of September 30, 2008. Our
remaining LTACH is not an HwH; therefore, it is not subject to
these limits on host hospital referrals.
Outpatient Rehabilitation Services. Medicare
requires that outpatient therapy services be reimbursed on a fee
schedule, subject to annual limitations. Outpatient therapy
providers receive a fixed fee for each procedure performed,
adjusted by the geographical area in which the facility is
located. Medicare also imposes annual per Medicare beneficiary
caps. For 2007, these annual caps limited Medicare coverage to
$1,780 for outpatient rehabilitation services (including both
physical therapy and
speech-language
pathology services) and $1,780 for outpatient occupational
health services, including deductible and co-insurance amounts.
These caps were replaced for 2008 by an annual cap amount of
$1,810. Historically, Congress has acted to bypass the cap and
impose a moratorium on its operation. The Deficit Reduction Act
of 2005, the Tax Relief and Health Care Act of 2006 and the
MMSEA all provided for an exceptions process that
effectively prevents application of the caps.
CMS released the final rule for the 2009 Medicare physician fee
schedule on October 30, 2008. The final rule increases the
annual per beneficiary cap on outpatient therapy services for
2009 to $1,840 for combined physical therapy and speech language
pathology services and $1,840 for occupational therapy services.
The final rule also extends the existing therapy cap exceptions
process through December 31, 2009 as authorized by
Congress, updates the conversion factor, and makes adjustments
to the relative value units.
Historically, outpatient rehabilitation services have been
subject to scrutiny by the Medicare program for, among other
things, medical necessity, appropriate documentation,
supervision of therapy aides and students and billing for group
therapy. CMS has issued guidance to clarify that services
performed by a student are not reimbursable even if provided
under line of sight supervision of the therapist.
Likewise, CMS has reiterated that Medicare does not pay for
services provided by aides regardless of the level of
supervision. CMS also has issued instructions that outpatient
physical and occupational therapy services provided
simultaneously to two or more individuals by a practitioner
should be billed as group therapy services.
Inpatient Rehabilitation Facilities. Inpatient
rehabilitation facilities are paid under the inpatient
rehabilitation facility prospective payment system
(IRF-PPS). Under this system, each patient
discharged from an inpatient rehabilitation facility is assigned
to a case-mix group containing patients with similar clinical
problems that are expected to require comparable resources. An
inpatient rehabilitation facility is generally paid a
predetermined, fixed amount applicable to the assigned case-mix
group (subject to certain case- and facility-level adjustments).
The IRF-PPS for inpatient rehabilitation facilities also
includes special payment policies that adjust the payments for
some patients based on length of stay, facility costs, whether
the patient was discharged and subsequently readmitted and other
factors. MMSEA set the new compliance threshold permanently at
60%, providing relief from the so-called 75% rule,
which had restricted inpatient rehabilitation facility
admissions to certain categories of patients.
20
August 2008 Final Rule. On August 8,
2008, CMS published the final rule for the inpatient
rehabilitation facility prospective payment system
(IRF-PPS) for fiscal year 2009. The final rule
includes changes to the IRF-PPS regulations designed to
implement portions of the SCHIP Extension Act. In particular,
the patient classification criteria compliance threshold is
established at 60% (with co-morbidities counting toward this
threshold). In addition to updating the various values that
compose the IRF-PPS, the final rule updates the outlier
threshold amount to $10,250. CMS also updated the case-mix group
relative weights and average length of stay values.
Medicaid
Medicaid is a joint federal and state funded health insurance
program for certain low-income individuals. Medicaid reimburses
health care providers using a number of different systems,
including cost-based, prospective payment and negotiated rate
systems. Rates are also subject to adjustment based on statutory
and regulatory changes, administrative rulings, government
funding limitations and interpretations of policy by individual
state agencies.
Non-Governmental
Payors
A portion of our net service revenue comes from private payor
sources. These sources include insurance companies,
workers compensation programs, health maintenance
organizations, preferred provider organizations, other managed
care companies and employers, as well as patients directly.
Patients are generally not responsible for any difference
between customary charges for our services and amounts paid by
Medicare and Medicaid programs and the non-governmental payors,
but are responsible for services not covered by these programs
or plans, as well as for deductibles and co-insurance
obligations of their coverage. The amount of these deductibles
and co-insurance obligations on patients has increased in recent
years. Collection of amounts due from individuals is typically
more difficult than collection of amounts due from government or
business payors. However, the majority of our billed services
are paid in full by Medicare, Medicaid or private insurance.
Accordingly, co-payments from patients do not represent a
material portion of our billed revenue and corresponding
accounts receivable. To further reduce their health care costs,
most insurance companies, health maintenance organizations,
preferred provider organizations and other managed care
companies have negotiated discounted fee structures or fixed
amounts for services performed, rather than paying health care
providers the amounts billed.
In response to the challenges associated with collecting from
commercial payors and the unprofitable reimbursement rates paid
by many commercial payors, we terminated or sent notice of
termination to 285 commercial payors for home health services in
the fourth quarter of 2007. These 285 commercial payors had
reimbursement rates averaging 26% below cost, representing
approximately 8% of our home health revenue, 16% of our home
health admissions and 44% of our bad debt write-offs against
home health revenue in 2007. In 2008, approximately 12.2% of our
home health revenue derived from commercial payors compared to
12.8% in 2007. During 2008, we successfully negotiated higher
reimbursement rates with some of our commercial payors and we
intend to continue these efforts throughout 2009. Despite our
successful efforts in 2008, if we are unable to continue
negotiating higher reimbursement rates with commercial payors,
or if commercial payors continue to reduce health care costs
through reduction in home health reimbursement, it could have a
material adverse impact on our financial results.
Government
Regulations
General
The health care industry is highly regulated and we are required
to comply with federal, state and local laws, which
significantly affect our business. These laws and regulations
are extremely complex and, in many instances, the industry does
not have the benefit of significant regulatory or judicial
interpretation. Regulations and policies frequently change, and
we monitor these changes through trade and governmental
publications
21
and associations. The significant areas of federal and state
regulatory laws that could affect our ability to conduct our
business include the following:
|
|
|
|
|
Medicare and Medicaid participation and reimbursement;
|
|
|
|
the federal Anti-Kickback Statute and similar state laws;
|
|
|
|
the federal Stark Law and similar state laws;
|
|
|
|
false and other improper claims;
|
|
|
|
the Health Insurance Portability and Accountability Act of 1996
(HIPAA);
|
|
|
|
civil monetary penalties;
|
|
|
|
environmental health and safety laws;
|
|
|
|
licensing; and
|
|
|
|
certificates of need and permits of approval.
|
If we fail to comply with these applicable laws and regulations,
we could suffer civil or criminal penalties, including the loss
of our licenses to operate and our ability to participate in
federal and state health care programs. Although we believe we
are in material compliance with all applicable laws, these laws
are complex and a review of our practices by a court or law
enforcement or regulatory authority could result in an adverse
determination that could harm our business. Furthermore, the
laws applicable to us are subject to change, interpretation and
amendment, which could adversely affect our ability to conduct
our business.
Office
of Inspector General (OIG)
The OIG has a responsibility to report any program and
management problems related to programs such as Medicare to the
Secretary of HHS and Congress. The OIGs duties are carried
out through a nationwide network of audits, investigations and
inspections. Each year, the OIG outlines areas it intends to
study relating to a wide range of providers. In fiscal year
2008, the OIG indicated its intent to study topics relating to,
among others, home health, hospice, long-term care hospitals and
certain outpatient rehabilitation services. No estimate can be
made at this time regarding the impact, if any, of the
OIGs findings.
Medicare
Participation
During the years ended December 31, 2008, 2007 and 2006, we
received 83.2%, 81.7% and 82.6%, respectively, of our net
service revenue from Medicare. We expect to continue to receive
the majority of our net service revenue from serving Medicare
beneficiaries. Medicare is a federally funded and administered
health insurance program, primarily for individuals entitled to
social security benefits who are 65 or older or who are
disabled. To participate in the Medicare program and receive
Medicare payments, our agencies and facilities must comply with
regulations promulgated by CMS. Among other things, these
requirements, known as conditions of participation,
relate to the type of facility, its personnel and its standards
of medical care. Although we intend to continue to participate
in the Medicare reimbursement programs, we cannot guarantee that
our agencies and programs will continue to qualify for
participation.
Under Medicare rules, the designation provider-based
refers to circumstances in which a subordinate facility (e.g., a
separately-certified Medicare provider, a department of a
provider or a satellite facility) is treated as part of another
provider, called the main provider, for Medicare
payment purposes. In these cases, the services of the
subordinate facility are included in the main
providers cost report and overhead costs of the main
provider can be allocated to the subordinate facility, to the
extent that such costs are shared. We operate three long-term
acute care hospitals that are treated as provider-based
satellites of certain of our other facilities. We also provide
contract rehabilitation and management services to hospital
rehabilitation departments that may be treated as
provider-based. These facilities are required to satisfy certain
operational standards in order to retain their provider-based
status. Although we intend to continue to operate these
facilities as provider-based, we cannot guarantee that they will
continue to qualify as provider-based entities.
22
Anti-Kickback
Statute
Provisions of the Social Security Act of 1965, commonly referred
to as the Anti-Kickback Statute, prohibit the payment or receipt
of anything of value in return for the referral of patients or
arranging for the referral of patients, or in return for the
recommendation, arrangement, purchase, lease or order of items
or services that are covered by a federal health care program
such as Medicare and Medicaid. Violation of the Anti-Kickback
Statute is a felony and sanctions include imprisonment of up to
five years, criminal fines of up to $25,000, civil monetary
penalties of up to $50,000 per act plus three times the amount
claimed or three times the remuneration offered and exclusion
from federal health care programs (including the Medicare and
Medicaid programs). Many states have adopted similar
prohibitions against payments that are intended to induce
referrals of Medicaid and other third-party payor patients.
The OIG has published numerous safe harbors that
exempt some practices from enforcement action under the federal
Anti-Kickback Statute. These safe harbors exempt specified
activities, including bona-fide employment relationships,
contracts for the rental of space or equipment and personal
service arrangements and management contracts, so long as all of
the requirements of the safe harbor are met. The OIG has
recognized that the failure of an arrangement to satisfy all of
the requirements of a particular safe harbor does not
necessarily mean that the arrangement violates the Anti-Kickback
Statute. Instead, each arrangement is analyzed on a
case-by-case
basis, which is very fact specific. We cannot guarantee that our
arrangements that do not satisfy a safe harbor will ultimately
be viewed as being complaint with the Anti-Kickback Statute.
We are required under the Medicare conditions of participation
and some state licensing laws to contract with numerous health
care providers and practitioners, including physicians,
hospitals and nursing homes and to arrange for these individuals
or entities to provide services to our patients. In addition, we
have contracts with other suppliers, including pharmacies,
ambulance services and medical equipment companies. We have also
entered into various joint ventures with hospitals and
physicians for the ownership and management of home nursing
agencies and long-term acute care hospitals. Some of these
individuals or entities may refer, or be in a position to refer,
patients to us and we may refer, or be in a position to refer,
patients to these individuals or entities. We attempt to
structure these arrangements in a manner that meets the
requirements of a safe harbor. However, some of these
arrangements may not meet all of the requirements of a safe
harbor. We believe that our contracts and arrangements with
providers, practitioners and suppliers do not violate the
Anti-Kickback Statute or similar state laws. We cannot
guarantee, however, that governmental agencies and bodies will
interpret these laws in the same manner as we do.
From time to time, various federal and state agencies, such as
HHS and CMS, issue pronouncements, including fraud alerts, that
identify practices that may be subject to heightened scrutiny.
For example, the OIGs FY 2009 Work Plan describes, among
other things, the governments intention to examine
Medicare Part B payments for therapy services, accuracy of
claims coding for Medicare home health resources groups,
examining trends in utilization patterns and Medicare
reimbursement for services ordered by referring physicians, the
incidence of Medicare home health services outlier payments for
insulin injections, and analysis of HHA claims under CMS
Comprehensive Error Rate Testing Program to determine whether
payments for services and items were adequately documented,
medically necessary and coded correctly.
In June 1995, the OIG issued a special fraud alert that focused
on the home nursing industry and identified some of the illegal
practices the OIG has uncovered. In March 1998, the OIG issued a
special fraud alert titled, Fraud and Abuse in Nursing Home
Arrangements with Hospices. This special fraud alert focused
on payments received by nursing homes from hospices. We believe,
but cannot assure you, that our operations comply with the
principles expressed by the OIG in these special fraud alerts.
We endeavor to conduct our operations in compliance with federal
and state health care fraud and abuse laws, including the
Anti-Kickback Statute and similar state laws. However, our
practices may be challenged in the future and the fraud and
abuse laws may be interpreted in a way that finds us in
violation of these laws. If we are found to be in violation of
the Anti-Kickback Statute, we could be subject to civil and
criminal penalties and we could be excluded from participating
in federal health care programs such as Medicare and Medicaid.
The occurrence of any of these events could significantly harm
our business and financial condition.
23
Stark
Law
Congress passed significant prohibitions against physician
referrals of patients for certain health care services. These
prohibitions are commonly known as the Stark Law. The Stark Law
prohibits a physician from making referrals for particular
health care services (called designated health services) to
entities with which the physician, or an immediate family member
of the physician, has a financial relationship.
The term financial relationship is defined very
broadly to include most types of ownership or compensation
relationships. The Stark Law also prohibits the entity receiving
the referral from seeking payment under the Medicare and
Medicaid programs for services rendered pursuant to a prohibited
referral. If an entity is paid for services rendered pursuant to
a prohibited referral, it may incur civil penalties and could be
excluded from participating in the Medicare or Medicaid
programs. If an arrangement is covered by the Stark Law, the
requirements of a Stark Law exception must be met for the
physician to be able to make referrals to the entity for
designated health services and for the entity to be able to bill
for these services.
Designated health services under the Stark Law is
defined to include clinical laboratory services; physical
therapy services; occupational therapy services; radiology
services, including magnetic resonance imaging, computerized
axial tomography scans and ultrasound services; radiation
therapy services and supplies; durable medical equipment and
supplies; parenteral and enteral nutrients, equipment and
supplies; prosthetics, orthotics and prosthetic devices and
supplies; home health services; outpatient prescription drugs;
and inpatient and outpatient hospital services. The Stark Law
defines a financial relationship to include: (1) a
physicians ownership or investment interest in an entity
and (2) a compensation relationship between a physician and
an entity. Under the Stark Law, financial relationships include
both direct and indirect relationships.
Physicians refer patients to us for several Stark Law designated
health services, including home health services, inpatient and
outpatient hospital services and physical therapy services. We
have compensation arrangements with some of these physicians or
their professional practices in the form of medical director and
consulting agreements. We also have operations owned by joint
ventures in which physicians have an investment interest. In
addition, other physicians who refer patients to our agencies
and facilities may own our stock. As a result of these
relationships, we could be deemed to have a financial
relationship with physicians who refer patients to our
facilities and agencies for designated health services. If so,
the Stark Law would prohibit the physicians from making those
referrals and would prohibit us from billing for the services
unless a Stark Law exception applies.
The Stark Law contains exceptions for certain physician
ownership or investment interests in and certain physician
compensation arrangements with entities. If a compensation
arrangement or investment relationship between a physician, or a
physicians immediate family member, and an entity
satisfies all requirements for a Stark Law exception, the Stark
Law will not prohibit the physician from referring patients to
the entity for designated health services. The exceptions for
compensation arrangements cover employment relationships,
personal services contracts and space and equipment leases,
among others. The exceptions for a physician investment
relationship include ownership in an entire hospital and
ownership in rural providers. We believe our compensation
arrangements with referring physicians and our physician
investment relationships meet the requirements for an exception
under the Stark Law and that our operations comply with the
Stark Law.
The Stark Law also includes an exception for a physicians
ownership or investment interest in certain entities through the
ownership of stock. If a physician owns stock in an entity and
the stock is listed on a national exchange or is quoted on
NASDAQ and the ownership meets certain other requirements, the
Stark Law will not apply to prohibit the physician from
referring to the entity for designated health services. The
requirements for this Stark Law exception include a requirement
that the entity issuing the stock have at least
$75.0 million in stockholders equity at the end of
its most recent fiscal year or on average during the previous
three fiscal years. As of December 31, 2008, 2007 and 2006,
we have exceeded $75.0 million in stockholders equity.
If an entity violates the Stark Law, it could be subject to
civil penalties of up to $15,000 per prohibited claim and up to
$100,000 for knowingly entering into certain prohibited referral
schemes. The entity also may
24
be excluded from participating in federal health care programs
(including Medicare and Medicaid). There are no criminal
penalties for violations of Stark Law. If the Stark Law was
found to apply to our relationships with referring physicians
and those relationships did not meet the requirement of an
exception under the Stark Law, we would be required to
restructure these relationships or refuse to accept referrals
for designated health services from these physicians. If we were
found to have submitted claims to Medicare or Medicaid for
services provided pursuant to a referral prohibited by the Stark
Law, we would be required to repay any amounts we received from
Medicare for those services and could be subject to civil
monetary penalties. Further, we could be excluded from
participating in Medicare and Medicaid. If we were required to
repay any amounts to Medicare, subjected to fines, or excluded
from the Medicare and Medicaid Programs, our business and
financial condition would be harmed significantly.
Many states have physician relationship and referral statutes
that are similar to the Stark Law. Some of these laws generally
apply regardless of payor. We believe that our operations are
structured to comply with applicable state laws with respect to
physician relationships and referrals. However, any finding that
we are not in compliance with these state laws could require us
to change our operations or could subject us to penalties. This,
in turn, could have a negative impact on our operations.
False
and Improper Claims
The submission of claims to a federal or state health care
program for items and services that are not provided as
claimed may lead to the imposition of civil monetary
penalties, criminal fines and imprisonment
and/or
exclusion from participation in state and federally funded
health care programs, including the Medicare and Medicaid
programs. These false claims statutes include the Federal False
Claims Act. Under the Federal False Claims Act, actions against
a provider can be initiated by the federal government or by a
private party on behalf of the federal government. These private
parties are often referred to as qui tam relators, and relators
are entitled to share in any amounts recovered by the
government. Both direct enforcement activity by the government
and qui tam actions have increased significantly in recent
years. This development has increased the risk that a health
care company like us will have to defend a false claims action,
pay fines or be excluded from the Medicare and Medicaid programs
as a result of an investigation arising out of false claims
laws. Many states have enacted similar laws providing for the
imposition of civil and criminal penalties for the filing of
fraudulent claims. Because of the complexity of the government
regulations applicable to our industry, we cannot assure that we
will not be the subject of an action under the Federal False
Claims Act or similar state law.
Anti-fraud
Provisions of the HIPAA
In an effort to combat health care fraud, Congress included
several anti-fraud measures in The Health Insurance Portability
and Accountability Act (HIPAA). Among other things,
HIPAA broadened the scope of certain fraud and abuse laws,
extended criminal penalties for Medicare and Medicaid fraud to
other federal health care programs and expanded the authority of
the OIG to exclude persons and entities from participating in
the Medicare and Medicaid programs. HIPAA also extended the
Medicare and Medicaid civil monetary penalty provisions to other
federal health care programs, increased the amounts of civil
monetary penalties and established a criminal health care fraud
statute.
Federal health care offenses under HIPAA include health care
fraud and making false statements relating to health care
matters. Under HIPAA, among other things, any person or entity
that knowingly and willfully defrauds or attempts to defraud a
health care benefit program is subject to a fine, imprisonment
or both. Also under HIPAA, any person or entity that knowingly
and willfully falsifies or conceals or covers up a material fact
or makes any materially false or fraudulent statements in
connection with the delivery of or payment of health care
services by a health care benefit plan is subject to a fine,
imprisonment or both. HIPAA applies not only to governmental
plans but also to private payors.
25
Administrative
Simplification Provisions of HIPAA
HHSs final regulations governing electronic transactions
involving health information are part of the administrative
simplification provisions of HIPAA. These regulations are
commonly referred to as the Transaction Standards rule. The rule
establishes standards for eight of the most common health care
transactions by reference to technical standards promulgated by
recognized standards publishing organizations. Under the
standards, any party transmitting or receiving health
transactions electronically must send and receive data in a
single format, rather than the large number of different data
formats currently used. This rule applies to us in connection
with submitting and processing health claims. The Transaction
Standards rule also applies to many of our payors and to our
relationships with those payors. Because many of our payors
might not have been able to accept transactions in the format
required by the Transaction Standards rule by the original
compliance date, we filed a timely compliance extension plan
with HHS. We believe that our operations materially comply with
the Transaction Standards rule.
HHS also has final regulations implementing HIPAA that set forth
standards for the privacy of individually-identifiable health
information, referred to as protected health information. The
regulations cover health care providers, health care
clearinghouses and health plans. The privacy regulations require
companies covered by the regulations to use and disclose
protected health information only as allowed by the privacy
regulations. Specifically, the privacy regulations require
companies such as us to do the following, among other things:
|
|
|
|
|
obtain patient authorization prior to certain uses or
disclosures of protected health information;
|
|
|
|
provide notice of privacy practices to patients and obtain an
acknowledgement that the patient has received the notice;
|
|
|
|
respond to requests from patients for access to or to obtain a
copy of their protected health information;
|
|
|
|
respond to patient requests for amendments of their protected
health information;
|
|
|
|
provide an accounting to patients of certain disclosure of their
protected health information;
|
|
|
|
enter into agreements with the companies business
associates through which the business associates agree to use
and disclose protected health information only as permitted by
the agreement and the requirements of the privacy regulations;
|
|
|
|
train the companies workforce in privacy compliance;
|
|
|
|
designate a privacy officer;
|
|
|
|
use and disclose only the minimum necessary information to
accomplish a particular purpose; and
|
|
|
|
establish policies and procedures with respect to uses and
disclosures of protected health information.
|
These regulatory requirements impose significant administrative
and financial obligations on companies that use or disclose
individually identifiable health information relating to the
health of a patient. We have implemented policies and procedures
to maintain patient privacy and comply with HIPAAs privacy
regulations. The privacy regulations are extensive, and we may
need to change some of our practices to comply with them as they
are interpreted and as we deal with issues that arise.
In February 2003, HHS published the final security regulations
implementing HIPAA that govern the security of health
information. The compliance date for the security regulations
was April 21, 2005. The security regulations require the
implementation of policies and procedures that establish
administrative, physical and technical safeguards for electronic
protected health information. Companies covered by the security
regulations are required to ensure the confidentiality,
integrity and availability of electronic protected health
information. Specifically, among others things, companies are
required to:
|
|
|
|
|
conduct a thorough assessment of the potential risks and
vulnerabilities to confidentiality, integrity and availability
of electronic protected health information and to reduce the
risks and vulnerabilities to a reasonable and appropriate level
as required by the security regulations;
|
26
|
|
|
|
|
designate a security officer;
|
|
|
|
establish policies relating to access by the companies
workforce to electronic protected health information;
|
|
|
|
enter into agreements with the companies business
associates whereby business associates agree to establish
administrative, physical and technical safeguards for electronic
protected health information received from or on behalf of the
companies;
|
|
|
|
create a disaster and contingency plan to ensure the
availability of electronic protected health information;
|
|
|
|
train the companies workforce in security compliance;
|
|
|
|
establish physical controls for electronic devices and media
containing or transmitting electronic protected health
information;
|
|
|
|
establish policies and procedures regarding the use of
workstations with access to electronic protected health
information; and
|
|
|
|
establish technical controls for the information systems
maintaining or transmitting electronic protected health
information.
|
These regulatory requirements impose significant administrative
and financial obligations on companies like us that use or
disclose electronic health information. We have implemented
policies and procedures to comply with the security regulations.
Civil
Monetary Penalties
The Secretary of HHS may impose civil monetary penalties on any
person or entity that presents, or causes to be presented,
certain ineligible claims for medical items or services. The
amount of penalties varies depending on the offense, from $2,000
to $50,000 per violation, plus treble damages for the amount at
issue and may include exclusion from federal health care
programs (including Medicare and Medicaid).
HHS also can impose penalties on a person or entity who offers
inducements to beneficiaries for program services, who violates
rules regarding the assignment of payments or who knowingly
gives false or misleading information that could reasonably
influence the discharge of patients from a hospital. Persons who
have been excluded from a federal health care program and who
retain ownership in a participating entity and persons who
contract with excluded persons may be penalized.
HHS also can impose penalties for false or fraudulent claims and
those that include services not provided as claimed. In
addition, HHS may impose penalties on claims:
|
|
|
|
|
for physician services that the person or entity knew or should
have known were rendered by a person who was unlicensed, or
misrepresented either (1) his or her qualifications in
obtaining his or her license or (2) his or her
certification in a medical specialty;
|
|
|
|
for services furnished by a person who was, at the time the
claim was made, excluded from the program to which the claim was
made; or
|
|
|
|
that show a pattern of medically unnecessary items or services.
|
Penalties also are applicable in certain other cases, including
violations of the federal Anti-Kickback Statute, payments to
limit certain patient services and improper execution of
statements of medical necessity.
Environmental
Health and Safety Laws
We are subject to federal, state and local regulations governing
the storage, use and disposal of materials and waste products.
Although we believe that our safety procedures for storing,
handling and disposing of these hazardous materials comply with
the standards prescribed by law and regulation, we cannot
completely eliminate the risk of accidental contamination or
injury from those hazardous materials. In the event of an
27
accident, we could be held liable for any damages that result
and any liability could exceed the limits or fall outside the
coverage of our insurance. We may not be able to maintain
insurance on acceptable terms, or at all. We could incur
significant costs and the diversion of our managements
attention in order to comply with current or future
environmental laws and regulations. We do not have any
violations related to compliance with environmental, health and
safety laws through calendar year 2008.
Licensing
Our agencies and facilities are subject to state and local
licensing regulations ranging from the adequacy of medical care
to compliance with building codes and environmental protection
laws. In order to assure continued compliance with these various
regulations, governmental and other authorities periodically
inspect our agencies and facilities. Additionally, health care
professionals at our agencies and facilities are required to be
individually licensed or certified under applicable state law.
We take steps to ensure that our employees and agents possess
all necessary licenses and certifications.
The institutional pharmacy operations within our facility-based
services segment are subject to regulation by the various states
in which business is conducted as well as by the federal
government. The pharmacies are regulated under the Food, Drug
and Cosmetic Act and the Prescription Drug Marketing Act, which
are administered by the United States Food and Drug
Administration. Under the Comprehensive Drug Abuse Prevention
and Control Act of 1970, which is administered by the United
States Drug Enforcement Administration, dispensers of controlled
substances must register with the Drug Enforcement
Administration, file reports of inventories and transactions and
provide adequate security measures. Failure to comply with such
requirements could result in civil or criminal penalties. We do
not have any violations related to Comprehensive Drug Abuse
Prevention and Control Act of 1970 through fiscal year 2008.
The Joint Commission is a nationwide commission that establishes
standards relating to the physical plant, administration,
quality of patient care and operation of medical staffs of
hospitals. Currently, Joint Commission accreditation of home
nursing and hospice agencies is voluntary. However, some managed
care organizations use Joint Commission accreditation as a
credentialing standard for regional and state contracts. As of
December 31, 2008, the Joint Commission had accredited 38
of our home nursing agencies. Those not yet accredited are
working towards achieving this accreditation.
Certificate
of Need and Permit of Approval Laws
In addition to state licensing laws, some states require a
provider to obtain a certificate of need or permit of approval
prior to establishing or expanding certain health services or
facilities. States with certificate of need or permit of
approval laws place limits on both the construction and
acquisition of health care facilities and operations and the
expansion of existing facilities and services. In these states,
approvals are required for capital expenditures exceeding
certain amounts that involve certain facilities or services,
including home nursing agencies. The certificate of need or
permit of approval issued by the state determines the service
areas for the applicable agency or program. The states that
currently issue certificate of need or permits of approval are:
Alabama, Alaska, Arkansas, Georgia, Hawaii, Kentucky, Maryland,
Mississippi, Montana, New Jersey, New York, North Carolina,
South Carolina, Tennessee, Vermont, Washington, West Virginia
and the District of Columbia. In addition, the state of
Louisiana has imposed a moratorium on the issuance of new
licenses for home nursing agencies that continues to be in
effect as of the date hereof, and is expected to remain in
effect for 2009.
State certificate of need and permit of approval laws generally
provide that, prior to the addition of new capacity, the
construction of new facilities or the introduction of new
services, a designated state health planning agency must
determine that a need exists for those beds, facilities or
services. The process is intended to promote comprehensive
health care planning, assist in providing high quality health
care at the lowest possible cost and avoid unnecessary
duplication by ensuring that only those health care facilities
and operations that are needed will be built and opened.
28
Employees
As of December 31, 2008 we had 5,376 employees, of
which 3,706 were full-time and 1,670 were part-time, and
approximately 925 independent contractors. None of our employees
are subject to a collective bargaining agreement. We consider
our relationships with our employees and independent contractors
to be good.
Insurance
We are subject to claims and legal actions in the ordinary
course of our business. To cover claims that may arise, we
maintain professional malpractice liability insurance, general
liability insurance, automobile liability insurance and
workers compensation/employers liability in amounts
that we believe are appropriate and sufficient for our
operations. We maintain professional malpractice and general
liability insurance that provide primary coverage on a
claims-made basis of $1.0 million per incident and
$3.0 million in annual aggregate amounts. We maintain
workers compensation insurance that meets state statutory
requirements with a primary employer liability limit of
$1.0 million for Louisiana, Mississippi, Alabama, Arkansas,
Texas, Tennessee, Georgia, Florida, Kentucky, Missouri,
Oklahoma, Virginia, West Virginia and North Carolina. There are
no limits to employer liability in Ohio and Washington. We
maintain Automobile Liability for all owned, hired and non-owned
autos with a primary limit of $2.0 million. In addition, we
currently maintain multiple layers of umbrella coverage in the
aggregate amount of $25.0 million that provides excess
coverage for professional malpractice, general liability,
automobile liability and employers liability. We maintain
Directors and Officers liability insurance in the aggregate
amount of $25.0 million. The cost and availability of such
coverage has varied widely in recent years. While we believe
that our insurance policies and coverage are adequate for a
business enterprise of our type, we cannot guarantee that our
insurance coverage is sufficient to cover all future claims or
that it will continue to be available in adequate amounts or at
a reasonable cost.
Available
Information
Our Annual Reports on
Form 10-K,
Quarterly Reports on
Form 10-Q,
Current Reports on
Form 8-K,
proxy statements and amendments to those reports are available
free of charge on our internet website at www.lhcgroup.com as
soon as reasonably practicable after such reports are
electronically filed with or furnished to the Securities and
Exchange Commission (SEC). The SEC also maintains an
internet site at www.sec.gov that contains reports, proxy and
information statements and other information regarding issuers
that file electronically with the SEC.
The risks described below should be carefully considered
before investing in the Company. The risks and uncertainties
described below are not the only ones we face. Other
risks and uncertainties that we have not predicted or assessed
may also adversely affect us.
If any of the following risks occurs, our earnings, financial
condition or business could be materially harmed and the trading
price of our common stock could decline, resulting in the loss
of all or part of investments.
Risk
Factors Related to Reimbursement and Government
Regulation
We
derive more than 80% of our net service revenue from Medicare.
If there are changes in Medicare rates or methods governing
Medicare payments for our services, or if we are unable to
control our costs, our results of operations and cash flows
could decline materially.
For the years ended December 31, 2008, 2007 and 2006, we
received 83.2%, 81.7% and 82.6%, respectively, of our net
service revenue from Medicare. Reductions in Medicare rates or
changes in the way
29
Medicare pays for services could cause our net service revenue
and net income to decline, perhaps materially. Reductions in
Medicare reimbursement could be caused by many factors,
including:
|
|
|
|
|
administrative or legislative changes to the base rates under
the applicable prospective payment systems;
|
|
|
|
the reduction or elimination of annual rate increases;
|
|
|
|
the imposition or increase by Medicare of mechanisms, such as
co-payments, shifting more responsibility for a portion of
payment to beneficiaries;
|
|
|
|
adjustments to the relative components of the wage index used in
determining reimbursement rates;
|
|
|
|
changes to case mix or therapy thresholds;
|
|
|
|
changes in the case mix of our patients;
|
|
|
|
bundling of post-acute healthcare payments;
|
|
|
|
the reclassification of home health resource groups or long-term
care diagnosis-related groups; or
|
|
|
|
further limitations on referrals to long-term acute care
hospitals from host hospitals.
|
We generally receive fixed payments from Medicare for our
services based on the level of care provided to our patients.
Consequently, our profitability largely depends upon our ability
to manage the cost of providing these services. Medicare
currently provides for an annual adjustment of the various
payment rates, such as the base episode rate for our home
nursing services, based upon the increase or decrease of the
medical care expenditure category of the Consumer Price Index,
which may be less than actual inflation. This adjustment could
be eliminated or reduced in any given year. Our base episode
rate for home nursing services is also subject to an annual
market basket adjustment. For 2008 and 2009, the home health
market basket percentage increase was 3.0% and 2.9%,
respectively. Based on the proposed 2010 budget issued by the
Government Administration, and the report from MedPac issued in
February 2009, we believe that in 2010 there is likely to be no
market basket adjustment. Further, Medicare routinely
reclassifies home health resource groups and long-term care
diagnosis-related groups. As a result of those
reclassifications, we could receive lower reimbursement rates
depending on the case mix of the patients we service. If our
cost of providing services increases by more than the annual
Medicare price adjustment, or if these reclassifications result
in lower reimbursement rates, our results of operations, net
income and cash flows could be adversely impacted.
We are
subject to extensive government regulation. Any changes in the
laws and regulations governing our business, or the
interpretation and enforcement of those laws or regulations,
could cause us to modify our operations and could negatively
impact our operating results and cash flows.
As a provider of health care services, we are subject to
extensive regulation on the federal, state and local levels,
including with regard to:
|
|
|
|
|
licensure and certificates of need and permits of approval;
|
|
|
|
coding and billing for services;
|
|
|
|
conduct of operations, including financial relationships among
health care providers, Medicare fraud and abuse and physician
self-referral;
|
|
|
|
maintenance and protection of records, including HIPAA;
|
|
|
|
environmental protection, health and safety;
|
|
|
|
certification of additional agencies or facilities by the
Medicare program; and
|
|
|
|
payment for services.
|
The laws and regulations governing our operations, along with
the terms of participation in various government programs,
regulate how we do business, the services we offer and our
interactions with patients
30
and other providers. These laws and regulations, and their
interpretations, are subject to frequent change. Changes in
existing laws, regulations, their interpretations or the
enactment of new laws or regulations could increase our costs of
doing business and cause our net income to decline. If we fail
to comply with these applicable laws and regulations, we could
suffer civil or criminal penalties, including the loss of our
licenses to operate and our ability to participate in federal
and state reimbursement programs.
We are also subject to various routine and non-routine
governmental reviews, audits and investigations. In recent
years, federal and state civil and criminal enforcement agencies
have heightened and coordinated their oversight efforts related
to the health care industry, including with respect to referral
practices, cost reporting, billing practices, joint ventures and
other financial relationships among health care providers.
Although we have invested substantial time and effort in
implementing policies and procedures to comply with laws and
regulations, we could be subject to liabilities arising from
violations. A violation of the laws governing our operations, or
changes in the interpretation of those laws, could result in the
imposition of fines, civil or criminal penalties, the
termination of our rights to participate in federal and
state-sponsored programs or the suspension or revocation of our
licenses to operate. If we become subject to material fines or
if other sanctions or other corrective actions are imposed upon
us, we may suffer a substantial reduction in net income.
Current
economic conditions and continued decline in spending by the
Federal and State governments could harm our results of
operations and cash flows.
Worldwide economic conditions have significantly declined and
will likely remain depressed for the foreseeable future. While
our services are not typically sensitive to general declines in
the federal and state economies, the erosion in the tax base
caused by the general economic downturn has caused, and will
likely continue to cause, restrictions on the federal and state
governments ability to obtain financing and a decline in
spending. As a result, we may face reimbursement rate cuts or
reimbursement delays from Medicare and Medicaid and other
governmental payors, which could adversely impact our results or
operating and cash flows.
The
Presidents proposed budget for Federal Fiscal Year 2010
and beyond may impair our earnings, cash flow and financial
condition.
On February 26, 2009, President Obama released his proposed
budget outline for the Federal 2010 fiscal year. Although
details have not yet been released, the proposed budget calls
for an aggregate reduction in home health industry reimbursement
of $550 million in 2010. Additionally, the proposed budget
calls for additional significant reductions in home health
reimbursement for Medicare home health services in 2011 and
beyond. The budget is currently in proposed form and Congress
has yet to take any action on the proposal. We cannot predict
whether the budget will be passed into law and we are therefore
unable to determine what impact the ultimate Federal budget and
resulting Medicare and Medicaid reimbursement might have on our
financial condition or our results of operations. We may be
unable to take actions to mitigate any negative reimbursement
changes that might ultimately be enacted and the reimbursement
change ultimately enacted could have a material and adverse
effect on our liquidity, results of operations and financial
position.
If any
of our agencies or facilities fail to comply with the conditions
of participation in the Medicare program, that agency or
facility could be terminated from Medicare, which could
adversely affect our net service revenue and net
income.
Our agencies and facilities must comply with the extensive
conditions of participation in the Medicare program. These
conditions of participation vary depending on the type of agency
or facility, but in general require our agencies and facilities
to meet specified standards relating to personnel, patient
rights, patient care, patient records, administrative reporting
and legal compliance. If an agency or facility fails to meet any
of the Medicare conditions of participation, that agency or
facility may receive a notice of deficiency from the applicable
state surveyor. If that agency or facility then fails to
institute and comply with a plan of correction to correct the
deficiency within the time period provided by the state
surveyor, that agency or facility could be terminated from the
Medicare program. We respond in the ordinary course to
deficiency notices issued by state surveyors and none of our
facilities or agencies have ever been terminated from the
Medicare program
31
for failure to comply with the conditions of participation. Any
termination of one or more of our agencies or facilities from
the Medicare program for failure to satisfy the Medicare
conditions of participation could adversely affect our net
service revenue and net income.
The
inability of long-term acute care hospitals to maintain their
certification as long-term acute care hospital could have an
adverse affect on our results of operations and cash
flows.
If our long-term acute care hospitals fail to meet or maintain
the standards for Medicare certification as long-term acute care
hospitals, such as for average minimum length of patient stay,
they will receive reimbursement under the prospective payment
system applicable to general acute care hospitals rather than
the system applicable to long-term acute care hospitals.
Payments at rates applicable to general acute care hospitals
would likely result in our long-term acute care hospitals
receiving less Medicare reimbursement than they currently
receive for their patient services. Moreover, all but one of our
long-term acute care hospitals are subject to additional
Medicare criteria because they operate as separate hospitals
located in space leased from and located in, a general acute
care hospital, known as a host hospital. This is known as a
hospital within a hospital model. These additional
criteria include requirements concerning financial and
operational separateness from the host hospital. If any of our
long-term acute care hospitals were subject to payment as
general acute care hospitals or failed to comply with the
separateness requirements, our net service revenue and net
income would decline.
CMS
has adopted regulations that could materially and adversely
affect the results of operations and cash flows of our long-term
acute care hospitals.
In a final rule released on May 1, 2007, CMS expanded the
Medicare HwH admissions threshold to apply not only to long-term
acute care hospitals within hospitals and satellites but also to
freestanding LTACHs and grandfathered LTACHs. The policy also
applies to HwHs and satellites that admit Medicare patients from
non-co-located hospitals. While this policy change was supposed
to take effect for cost reporting periods beginning on or after
July 1, 2007, the MMSEA delayed the implementation of the
policy for three years with respect to freestanding LTACHs and
grandfathered LTACHs. Further, the MMSEA set the percentage
threshold at 50% for three years for HwHs and satellites located
in urban areas that would otherwise be subject to a transition
period and it established a 75% ceiling for HwHs and satellite
facilities located in rural areas and those that receive
referrals from MSA dominant hospitals or urban single hospitals.
We currently have a total of seven LTACHs. Six of our hospitals
are classified as HwHs and one as freestanding. Of the six HwH
facilities, four are located in rural or non-MSAs and are
therefore subject to a final admission percentage of 50% at the
end of the phase-in period. Two of our six HwH facilities are
located in MSA or urban areas and will be subject to a final
admission percentage of 25% at the end of the phase-in period.
Of the six locations classified as HwHs, two facilities are
satellite locations of a parent hospital located in an MSA and
one is a satellite location of a parent hospital located in a
non-MSA. Based on our discussions with CMS, we believe each of
these satellite locations will be viewed as being located in a
non-MSA regardless of the location of its parent hospital and
will be treated independently from its parent for purposes of
calculating its compliance with the admissions limitations. If
the 25 percent rule is extended, as planned, to
freestanding LTACHs after the three-year delay established in
the MMSEA, our current freestanding facility would not likely be
affected because we currently do not receive more than 25% of
our Medicare admissions from any single referring hospital.
For the 12 months ended December 31, 2008, on an
individual basis, all of our LTACH locations admitted between
50% and 75% of their patients from their host hospitals. These
hospitals came under the proper threshold as of
September 30, 2008. Our remaining LTACH is not an HwH;
therefore, it is not subject to these limits on host hospital
referrals.
Our ability to quantify the potential reduction in our
reimbursement rates resulting from the implementation of these
new regulations is contingent upon a variety of factors, such as
our ability to reduce the percentage of admissions that are
derived from our host hospitals and, if necessary, our ability
to relocate our existing long-term acute care hospitals to
freestanding locations. We may not be able to successfully
32
restructure or relocate these operations without incurring
significant expense or in a manner that avoids reimbursement
reductions. If these new regulations result in lower
reimbursement rates, our net service revenue and net income
could decline.
We are reimbursed by Medicare for services we provide in our
long-term acute care hospitals based on the long-term care
diagnosis-related group assigned to each patient. CMS
establishes these long-term care diagnosis-related groups by
grouping diseases by diagnosis to reflect the amount of
resources needed to treat a given disease. The May 2007 CMS
final rules reclassifies certain long-term care
diagnosis-related groups, which could result in a decrease in
reimbursement rates. Further, the rule kept in place the
financial penalties associated with the failure to limit the
total number of Medicare patients discharged from a host
hospital and subsequently readmitted to a long-term acute care
hospital located within the host hospital to no greater than
5.0%. If we fail to comply with these readmission rates or if
our reimbursement rates decline due to the reclassification of
certain long-term care diagnosis-related groups, our net service
revenue and net income could decline.
Legislative
initiatives could negatively impact our operations and financial
results.
In recent years, an increasing number of legislative initiatives
have been introduced or proposed in Congress and in state
legislatures that would result in major changes in the health
care system, either at the national or state level. Many of
these proposals have been introduced in an effort to reduce
costs. For example, the Medicare Modernization Act of 2003
(MMA) allocated significant additional funds to
Medicare managed care providers in order to promote greater
participation in those plans by Medicare beneficiaries. If these
increased funding levels achieve their intended result, the rate
of growth in the Medicare fee-for-service market could decline.
For the years ended December 31, 2008, 2007 and 2006, we
received 83.2%, 81.7% and 82.6%, respectively, of our net
service revenue from the Medicare fee-for-service market. Among
other proposals that have been introduced are insurance market
reforms to increase the availability of group health insurance
to small businesses, requirements that all businesses offer
health insurance coverage to their employees and the creation of
government health insurance or plans that would cover all
citizens and increase payments by beneficiaries. We cannot
predict whether any of the above proposals, or any other future
proposals, will be adopted. If adopted, we could be forced to
expend considerable resources to comply with and implement such
reforms, which may place us at a competitive disadvantage.
If the
structures or operations of our joint ventures are found to
violate the law, it could have a material adverse impact on our
financial condition and consolidated results of
operations.
As of December 31, 2008, we had 56 joint ventures with
respect to the ownership and operation of 91 home nursing agency
locations, ten hospices and six long-term acute care hospital
locations. Our joint ventures are structured either as equity
joint ventures or agency leasing arrangements, as permitted by
applicable state laws and subject to business considerations. As
of December 31, 2008, we had 52 equity joint ventures and
four agency leasing arrangements. Of these 52 joint ventures, 44
are with hospitals, four are with physicians and four are with
other parties. With respect to our four joint ventures with
physicians, three are for the ownership and operation of
long-term acute care hospitals and one is for the ownership of a
rural home nursing agency.
Our joint ventures with hospitals and physicians are governed by
the Anti-Kickback Statute and similar state laws. These
anti-kickback statutes prohibit the payment or receipt of
anything of value in return for referrals of patients or
services covered by governmental health care programs, such as
Medicare. The OIG has published numerous safe harbors that
exempt qualifying arrangements from enforcement under the
Anti-Kickback Statute. We have sought to satisfy as many safe
harbor requirements as possible in structuring our joint
ventures. For example, each of our equity joint ventures with
hospitals and physicians is structured in accordance with the
following principles:
|
|
|
|
|
the investment interest offered is not based upon actual or
expected referrals by the hospital or physician;
|
|
|
|
our joint venture partners are not required to make or influence
referrals to the joint venture;
|
33
|
|
|
|
|
at the time the joint venture is formed, each hospital or
physician joint venture partner is required to make an actual
capital contribution to the joint venture equal to the fair
market value of his or her investment interest and is at risk to
lose its investment;
|
|
|
|
neither we nor the joint venture entity lends funds to or
guarantees a loan to acquire interests in the joint venture for
a hospital or physician; and
|
|
|
|
distributions to our joint venture partners are based solely on
their equity interests and are not affected by referrals from
the hospital or physician.
|
Despite our efforts to meet the safe harbor requirements as
possible, our joint ventures may not satisfy all elements of the
safe harbor requirements.
Our four joint ventures with physicians are also governed by the
Stark Law and similar state laws, which restrict physicians from
making referrals for particular health care services to entities
with which the physicians or their families have a financial
relationship. We believe we have structured our physician joint
ventures in a way that meets applicable exceptions under the
Stark Law and similar state physician referral laws. For
example, we believe our one physician joint venture for a home
nursing agency complies with the rural provider exception to the
Stark Law and that our three physician joint ventures for
long-term acute care hospitals comply with the whole hospital
exception to the Stark Law.
If any of our joint ventures were found to be in violation of
federal or state anti-kickback or physician referral laws, we
could be required to restructure them or refuse to accept
referrals from the physicians or hospitals with which we have
entered into a joint venture. We also could be required to repay
to Medicare amounts we have received pursuant to any prohibited
referrals, and we could suffer civil or criminal penalties,
including the loss of our licenses to operate and our ability to
participate in federal and state health care programs. If any of
our joint ventures were subject to any of these penalties, our
business could be materially adversely affected. If the
structure of any of our joint ventures were found to violate
federal or state anti-kickback statutes or physician referral
laws, we may be unable to implement our growth strategy, which
could have an adverse impact on our future net income and
consolidated results of operations.
The
application of state certificate of need and permit of approval
regulations and compliance with federal and state licensing
requirements could substantially limit our ability to operate
and grow our business.
Our ability to expand operations in a state will depend on our
ability to obtain a state license to operate. States may have a
limit on the number of licenses they issue. For example, as of
December 31, 2008, we operated 51 home nursing agencies in
Louisiana. Louisiana currently has a moratorium on the issuance
of new home nursing agency licenses through 2009. We cannot
predict whether this moratorium will be extended beyond this
date or whether any other states in which we currently operate,
or may wish to operate in the future, may adopt a similar
moratorium.
We currently operate in ten states that require health care
providers to obtain prior approval, known as a certificate of
need or a permit of approval, for the purchase, construction or
expansion of health care facilities, to make certain capital
expenditures or to make changes in services or bed capacity. The
states that currently issue certificate of need or permits of
approval are: Alabama, Alaska, Arkansas, Georgia, Hawaii,
Kentucky, Maryland, Mississippi, Montana, New Jersey, New York,
North Carolina, South Carolina, Tennessee, Vermont, Washington,
West Virginia and the District of Columbia. In granting
approval, these states consider the need in the service area for
additional or expanded health care facilities or services. The
failure to obtain any requested certificate of need, permit of
approval or other license could impair our ability to operate or
expand our business.
34
Risk
Factors Related to Capital and Liquidity
The
adverse changes and uncertainty in the capital and credit
markets may negatively affect our ability to access financing.
Without such financing we may be unable to achieve our
objectives for strategic acquisitions and internal
growth.
The disruption of the global financial and credit markets and
the related instability in the global financial system may have
an effect on our long term liquidity and financial conditions.
While we have been able to achieve our current acquisition
strategy through operating cash flows and without permanently
borrowing on our Credit Facility, the need may arise to obtain
additional funding.
As of December 31, 2008, we had $3.5 million in cash.
Based on our current plan of operations, including acquisitions,
we believe this amount, when combined with our revolving line of
credit totaling $75.0 million available under our Credit
Facility, will be sufficient to fund our growth strategy and to
meet our anticipated operating expenses, capital expenditures
and debt service obligations for at least the next
12 months. If our future net service revenue or cash flow
from operations is less than we currently anticipate, we may not
have sufficient funds to implement our growth strategy. Further,
we cannot readily predict the timing, size and success of our
acquisition and internal development efforts and the associated
capital commitments. If we do not have sufficient cash
resources, our growth could be limited unless we are able to
obtain additional equity or debt financing.
We do not believe our availability of funds under our Credit
Facility is at risk; however, we continue to monitor our
lenders. If the availability of funds under our Credit Facility
decreases we may need to consider adjusting our growth strategy.
The
agreement governing our credit facility contains, and future
debt agreements may contain, various covenants that limit our
discretion in the operation of our business.
The agreement and instruments governing our outstanding Credit
Facility, and the agreements and instruments governing future
debt agreements may contain various restrictive covenants that,
among other things, require us to comply with or maintain
certain financial tests and ratios that may restrict our ability
to:
|
|
|
|
|
incur more debt;
|
|
|
|
redeem or repurchase stock, pay dividends or make other
distributions;
|
|
|
|
make certain investments;
|
|
|
|
create liens;
|
|
|
|
enter into transactions with affiliates;
|
|
|
|
make unapproved acquisitions;
|
|
|
|
merge or consolidate;
|
|
|
|
transfer or sell assets; and
|
|
|
|
make fundamental changes in our corporate existence and
principal business.
|
In addition, events beyond our control could affect our ability
to comply with and maintain these financial tests and ratios.
Any failure by us to comply with or maintain all applicable
financial tests and ratios and to comply with all applicable
covenants could result in an event of default with respect to
our credit facility or any other future debt agreements. An
event of default could lead to the acceleration of the maturity
of any outstanding loans and the termination of the commitments
to make further extensions of credit. Even if we are able to
comply with all applicable covenants, the restrictions on our
ability to operate our business at our sole discretion could
harm our business by, among other things, limiting our ability
to take advantage of financing, mergers, acquisitions and other
corporate opportunities.
35
Our
net service revenue is concentrated in a small number of states,
which makes us sensitive to regulatory and economic changes in
those states.
Our net service revenue is particularly sensitive in the
17 states in which we provide services
Louisiana, Mississippi, Kentucky, Arkansas, Alabama, Virginia,
West Virginia, Texas, Tennessee, Florida, Georgia, Ohio,
Missouri, North Carolina, Maryland, Oklahoma and Washington.
Accordingly, any changes in the current demographic, economic,
competitive, or regulatory conditions in these states could have
an adverse effect on our business, financial condition, results
of operations and cash flows. Medicaid changes in these states
could also have a material adverse effect on our results of
operations or cash flows.
Hurricanes
or other adverse weather events could negatively affect the
local economies in which we operate or disrupt our operations,
which could have an adverse effect on our business or results of
operations.
Our operations in the southern United States are particularly
susceptible to hurricanes. Such weather events can disrupt our
operations, result in damage to our properties and negatively
affect the local economies in which we operate. In late summer
2008, Hurricane Ike and Hurricane Gustav struck the Gulf Coast
region of the United States and caused extensive and
catastrophic physical damage to those areas. While we have
recovered from the effects of Hurricane Ike and Hurricane
Gustav, future hurricanes could affect our operations or the
economies in those market areas and result in damage to certain
of our facilities, the equipment located at such facilities or
equipment rented to patients in those areas. Our business or
results of operations may be adversely affected by these and
other negative effects of future hurricanes. Although we
maintain insurance coverage, we cannot guarantee that our
insurance coverage will be adequate to cover any losses or that
we will be able to maintain insurance at a reasonable cost in
the future. If our losses from business interruption or property
damage exceed the amount for which we are insured, our results
of operating and financial condition would be adversely affected.
Delays
in reimbursement may cause liquidity problems.
Our business is characterized by delays in reimbursement from
the time we request payment for our services to the time we
receive reimbursement or payment. A portion of our estimated
reimbursement (60.0% for an initial episode of care and 50.0%
for subsequent episodes of care) for each Medicare episode is
billed at the commencement of the episode and we typically
receive payment within approximately 12 days. The remaining
reimbursement is billed upon completion of the episode and is
typically paid within 14 to 17 days from the billing date.
If we have information system problems or issues arise with
Medicare or other payors, we may encounter delays in our payment
cycle, which may cause working capital shortages. As a result,
working capital management, including prompt and diligent
billing and collection, is an important factor in our
consolidated results of operations and liquidity. Significant
delays in payment or reimbursement could have an adverse impact
on our liquidity and financial condition.
Risk
Factors Related to Operations and our Growth Strategy
We
could be required to record a material non-cash charge to income
if our recorded goodwill or intangible assets are
impaired.
As of December 31, 2008, we have recorded
$112.6 million to goodwill and $30.0 million to
intangible assets, net, on our consolidated balance sheet.
Goodwill and other intangibles are assessed for impairment
annually for each of our reporting units. The assessment
includes comparing the fair value of each reporting unit to the
carrying value of the assets assigned to the reporting unit. If
the carrying value of the reporting unit were to exceed our
estimate of fair value of the reporting unit, we would be
required to estimate the fair value of the individual assets and
liabilities within the reporting unit to ascertain the fair
value of goodwill. If we determine that the fair value is less
than our book value, we could be required to record a non-cash
impairment charge to our consolidated statements of income,
which could have a material adverse effect on our earnings.
36
Our
allowance for contractual adjustments and doubtful accounts may
not be sufficient to cover uncollectible amounts.
On an ongoing basis, we estimate the amount of Medicare,
Medicaid and private insurance receivables that we will not be
able to collect. This allows us to calculate the expected loss
on our receivables for the period we are reporting. Our
allowance for contractual adjustments and doubtful accounts may
underestimate actual unpaid receivables for various reasons,
including:
|
|
|
|
|
adverse changes in our estimates as a result of changes in payor
mix and related collection rates;
|
|
|
|
inability to collect funds due to missed filing deadlines or
inability to prove that timely filings were made;
|
|
|
|
adverse changes in the economy generally exceeding our
expectations; or
|
|
|
|
unanticipated changes in reimbursement from Medicare, Medicaid
and private insurance companies.
|
If our allowance for contractual adjustments and doubtful
accounts is insufficient to cover losses on our receivables, our
business, financial position and results of operations could be
materially adversely affected.
Shortages
in qualified nurses and other health care professionals could
increase our operating costs significantly or constrain our
ability to grow.
We rely on our ability to attract and retain qualified nurses
and other health care professionals. The availability of
qualified nurses nationwide has declined in recent years and
competition for these and other health care professionals has
increased, while salary and benefit costs have risen
accordingly. Our ability to attract and retain nurses and other
health care professionals depends on several factors, including
our ability to provide desirable assignments and competitive
benefits and salaries. We may not be able to attract and retain
qualified nurses or other health care professionals in the
future. In addition, the cost of attracting and retaining these
professionals and providing them with attractive benefit
packages may be higher than anticipated which could cause our
net income to decline. Moreover, if we are unable to attract and
retain qualified professionals, the quality of services offered
to our patients may decline or our ability to grow may be
constrained.
If we
are required to either repurchase or sell a substantial portion
of the equity interests in our joint ventures, our capital
resources and financial condition could be materially adversely
impacted.
Upon the occurrence of fundamental changes to the laws and
regulations applicable to our joint ventures, or if a
substantial number of our joint venture partners were to
exercise the buy/sell provisions contained in many of our joint
venture agreements, we may be obligated to purchase or sell the
equity interests held by us or our joint venture partners. In
some instances, the purchase price under these buy/sell
provisions is based on a multiple of the historical or future
earnings before income taxes, depreciation and amortization of
the equity joint venture at the time the buy/sell option is
exercised. In other instances, the buy/sell purchase price will
be negotiated by the partners but will be subject to a fair
market valuation process. In the event the buy/sell provisions
are exercised and we lack sufficient capital to purchase the
interest of our joint venture partners, we may be obligated to
sell our equity interest in these joint ventures. If we are
forced to sell our equity interest, we will lose the benefit of
those particular joint venture operations. If these buy/sell
provisions are exercised and we choose to purchase the interest
of our joint venture partners, we may be obligated to expend
significant capital in order to complete such acquisitions. If
either of these events occurs, our net service revenue and net
income could decline or we may not have sufficient capital
necessary to implement our growth strategy.
If we
are unable to maintain relationships with existing referral
sources or establish new referral sources, our growth and net
income could be adversely affected.
Our success depends significantly on referrals from physicians,
hospitals and other health care providers in the communities in
which we deliver our services. Our referral sources are not
obligated to refer business to us and may refer business to
other health care providers. We believe many of our referral
sources refer business to us as a result of the quality of
patient care provided by our local employees in the communities
in
37
which our agencies and facilities are located. If we are unable
to retain these employees, our referral sources may refer
business to other health care providers. Our loss of, or failure
to maintain, existing relationships or our failure to develop
new relationships could affect adversely our ability to expand
our operations and operate profitably.
We
face competition, including from competitors with greater
resources, which may make it difficult for us to compete
effectively as a provider of post-acute health care
services.
We compete with local and regional home nursing and hospice
companies, hospitals and other businesses that provide
post-acute health care services, some of which are large
established companies that have significantly greater resources
than we do. Our primary competition comes from local operators
in each of our markets. We expect our competitors to develop
joint ventures with providers, referral sources and payors,
which could result in increased competition. The introduction by
our competitors of new and enhanced service offerings, in
combination with industry consolidation and the development of
competitive joint ventures, could cause a decline in net service
revenue, loss of market acceptance of our services or make our
services less attractive. Future increases in competition from
existing competitors or new entrants may limit our ability to
maintain or increase our market share. We may not be able to
compete successfully against current or future competitors and
competitive pressures may have a material, adverse impact on our
business, financial condition and consolidated results of
operations.
Future
acquisitions may be unsuccessful and could expose us to
unforeseen liabilities. Further, our acquisition and internal
development activity may impose strains on our existing
resources.
Our growth strategy involves the acquisition of home nursing
agencies throughout the United States. These acquisitions
involve significant risks and uncertainties, including
difficulties integrating acquired personnel and other corporate
cultures into our business, the potential loss of key employees
or patients of acquired agencies and the assumption of
liabilities and exposure to unforeseen liabilities of acquired
agencies. We may not be able to fully integrate the operations
of the acquired businesses with our current business structure
in an efficient and cost-effective manner. The failure to
effectively integrate any of these businesses could have a
material adverse effect on our operations.
We generally structure our acquisitions as asset purchase
transactions in which we expressly state that we are not
assuming any pre-existing liabilities of the seller and obtain
indemnification rights from the previous owners for acts or
omissions arising prior to the date of such acquisitions.
However, the allocation of liability arising from such acts or
omissions between the parties could involve the expenditure of a
significant amount of time, manpower and capital. Further, the
former owners of the agencies and facilities we acquire may not
have the financial resources necessary to satisfy our
indemnification claims relating to pre-existing liabilities. If
we were unsuccessful in a claim for indemnification from a
seller, the liability imposed could materially, adversely affect
our operations.
In addition, as we continue to expand our markets, our growth
could strain our resources, including management, information
and accounting systems, regulatory compliance, logistics and
other internal controls. Our resources may not keep pace with
our anticipated growth. If we do not manage our expected growth
effectively, our future prospects could be affected adversely.
We may
face increased competition for attractive acquisition and joint
venture candidates.
We intend to continue growing through the acquisition of
additional home nursing agencies and the formation of joint
ventures with hospitals for the operation of home nursing
agencies. We face competition for acquisition and joint venture
candidates, which may limit the number of acquisition and joint
venture opportunities available to us or lead to the payment of
higher prices for our acquisitions and joint ventures. We cannot
guarantee that we will be able to identify suitable acquisition
or joint venture opportunities in the future or that any such
opportunities, if identified, will be consummated on favorable
terms, if at all. Without successful acquisitions or joint
ventures, our future growth rate could decline. In addition, we
cannot guarantee that any future acquisitions or joint ventures,
if consummated, will result in further growth.
38
If we
are subject to substantial malpractice or other similar claims,
it could materially adversely impact our income from operations
and cash flows.
The services we offer have an inherent risk of professional
liability and related, substantial damage awards. We, and the
nurses and other health care professionals who provide services
on our behalf, may be the subject of medical malpractice claims.
These nurses and other health care professionals could be
considered our agents and, as a result, we could be held liable
for their medical negligence. We cannot predict the effect that
any claims of this nature, regardless of their ultimate outcome,
could have on our business or reputation or on our ability to
attract and retain patients and employees. We maintain
malpractice liability insurance that provides primary coverage
on a claims-made basis of $1.0 million per incident and
$3.0 million in annual aggregate amounts. In addition, we
maintain multiple layers of umbrella coverage in the aggregate
amount of $25.0 million that provide excess coverage for
professional malpractice and other liabilities. We are
responsible for deductibles and amounts in excess of the limits
of our coverage. Claims that could be made in the future in
excess of the limits of such insurance, if successful, could
materially adversely affect our ability to conduct business or
manage our assets. In addition, our insurance coverage may not
continue to be available to us at commercially reasonable rates,
in adequate amounts or on satisfactory terms.
If we
are unable to protect the proprietary nature of our software
systems and methodologies, our business and financial condition
could be harmed.
We have developed a proprietary software system, which we refer
to as our Service Value Point system that allows us to collect
assessment data, establish treatment plans, monitor patient
treatment and evaluate our clinical and financial performance.
In addition, we rely on other proprietary methodologies or
information to which others may obtain access or independently
develop. To protect our proprietary information, we require
certain of our employees, consultants, financial advisors and
strategic partners to enter into confidentiality and
non-disclosure agreements. These agreements may not ultimately
provide meaningful protection for our proprietary information in
the event of any unauthorized use, misappropriation or
disclosure. If our competitors were able to replicate our
Service Value Point system, it could allow them to improve their
operations and thereby compete more effectively in the markets
in which we operate. If we are unable to protect the proprietary
nature of our Service Value Point system or our other
proprietary information or methodologies, our business and
financial performance could be harmed.
Failure
of, or problems with, our critical software or information
systems could harm our business and operating
results.
In addition to our Service Value Point system, our business is
substantially dependent on other non-proprietary software. We
utilize a third-party software information system for billing
and maintaining patient claim receivables for our long-term
acute care hospitals. Our various home nursing agency databases
are fully consolidated into an enterprise-wide system. Problems
with, or the failure of, these systems could negatively impact
our clinical performance and our management and reporting
capabilities. Any such problems or failure could materially and
adversely affect our operations and reputation, result in
significant costs to us, cause delays in our ability to bill
Medicare or other payors for our services, or impair our ability
to provide our services in the future. The costs incurred in
correcting any errors or problems with regard to our proprietary
and non-proprietary software may be substantial and could
adversely affect our net income.
Our information systems are networked via public network
infrastructure and standards based encryption tools that meet
regulatory requirements for transmission of protected health
care information over such networks. However, threats from
computer viruses, instability of the public network on which our
data transit relies, or other instances that might render those
networks unstable or disabled would create operational
difficulties for us, including difficulties effectively
transmitting claims and maintaining efficient clinical oversight
of our patients, as well as disrupting revenue reporting and
billing and collections management, which could adversely affect
our business or operations.
39
Risk
Factors Related to our Ownership and Management
As a
holding company, we have no material assets or operations of our
own.
We are a holding company with no material assets or operations
of our own. Accordingly, our ability to service our debt and pay
dividends, if any, is dependent upon the earnings from the
business conducted by our subsidiaries. The distributions of
those earnings or advances or other distributions of funds by
these subsidiaries to us are contingent upon the
subsidiaries earnings and are subject to various business
considerations. In addition, distributions by subsidiaries could
be subject to statutory restrictions, including state laws
requiring that the subsidiary be solvent, or contractual
restrictions. If our subsidiaries are unable to make sufficient
distributions or advances to us, we may not have the cash
resources necessary to service our debt or pay dividends.
The
loss of certain senior management could have a material adverse
effect on our operations and financial
performance.
Our success depends upon the continued employment of certain
members of our senior management, including our co-founder,
Chief Executive Officer and Chairman, Keith G. Myers, our Senior
Vice President, Chief Financial Officer, Peter J. Roman, and our
President, Chief Operating Officer, Secretary and Director, John
L. Indest. We have entered into an employment agreement with
each of these officers in an effort to further secure their
employment. The loss of service of any of these officers could
have a material adverse effect on our operations if we were
unable to find a suitable replacement.
Certain
provisions of our charter, bylaws, Delaware law and our
stockholders rights plan may delay or prevent a change in
control of the Company.
Delaware law and our corporate documents contain provisions that
may enable our board of directors to resist a change in control
of the Company. These provisions include:
|
|
|
|
|
a staggered board of directors;
|
|
|
|
limitations on persons authorized to call a special meeting of
stockholders;
|
|
|
|
the authorization of undesignated preferred stock, the terms of
which may be established and shares of which may be issued
without stockholder approval;
|
|
|
|
advance notice procedures required for stockholders to nominate
candidates for election as directors or to bring matters before
an annual meeting of stockholders; and
|
|
|
|
a stockholders rights plan that includes a 20% threshold
for triggering events, a three-year term for directors, an
independent director evaluation provision (commonly known as a
TIDE provision) and a stockholder redemption feature
allowing stockholders to vote at a special meeting that would be
called to consider qualified takeover offers.
|
These anti-takeover defenses could discourage, delay or prevent
a transaction involving a change in control of the Company.
These provisions could also discourage proxy contests and make
it more difficult for stockholders to elect directors or cause
us to take other corporate actions.
Our
stock price is thinly traded, which may cause volatility in our
common stock, including a decline in value.
We have a relatively low volume of daily trades in our common
stock on the Nasdaq Global Select Market. For example, the
average daily trading volume of our common stock on NASDAQ over
the three-month trading period ending March 3, 2009 was
approximately 414,000 shares per day. Because our common
stock is traded infrequently, the price per share of our common
stock can fluctuate more significantly from day-to-day than a
widely held stock that is actively traded on a daily basis. For
example, trading of a large volume of our common stock may have
a significant impact on our trading price. In addition, future
issuances of our common stock, including the exercise of any
options or the vesting of any restricted stock that we may
40
grant to directors, executive officers and other employees in
the future and the issuance of common stock in connection with
acquisitions, could have an adverse effect on the market price
of our common stock.
If we
identify deficiencies in our internal control over financial
reporting, our business and our stock price could be adversely
affected.
Beginning with our annual report for the year ending
December 31, 2006, we are required to report on the
effectiveness of our internal control over financial reporting
as required by Section 404 of Sarbanes-Oxley. Under
Section 404, we are required to assess the effectiveness of
our internal control over financial reporting and report our
conclusion in our annual report. Our auditor is also required to
report its conclusion regarding the effectiveness of our
internal control over financial reporting. The existence of one
or more material weaknesses would require us and our auditor to
conclude that our internal control over financial reporting is
not effective. If there are identified deficiencies in our
internal control over financial reporting, we could be subject
to regulatory scrutiny and a loss of public confidence in our
financial reporting, which could have an adverse effect on our
business and our stock price.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
We have no unresolved written comments from the staff of the SEC
regarding our periodic or current reports filed under the
Exchange Act.
As of December 31, 2008, we owned, leased or managed the
following locations:
|
|
|
|
|
Louisiana
|
|
|
62
|
|
Mississippi
|
|
|
28
|
|
Tennessee
|
|
|
28
|
|
Kentucky
|
|
|
25
|
|
Arkansas
|
|
|
19
|
|
West Virginia
|
|
|
16
|
|
Alabama
|
|
|
14
|
|
Texas
|
|
|
12
|
|
Washington
|
|
|
12
|
|
Maryland
|
|
|
11
|
|
Florida
|
|
|
6
|
|
Georgia
|
|
|
5
|
|
Missouri
|
|
|
5
|
|
North Carolina
|
|
|
2
|
|
Ohio
|
|
|
2
|
|
Virginia
|
|
|
2
|
|
Oklahoma
|
|
|
1
|
|
|
|
|
|
|
|
|
|
250
|
|
|
|
|
|
|
Our home office is located in Lafayette, Louisiana in
19,159 square feet of leased office space under a lease
that commenced on March 1, 2004 and expires
February 28, 2014. Our 206 owned home nursing agencies are
located in leased facilities. Generally, the leases for our home
nursing agencies have initial terms of one year, but range from
one to five years. Most of the leases either contain multiple
options to extend the lease period in one-year increments or
convert to a month-to-month lease upon the expiration of the
initial term. Six of our long-term acute care hospital locations
are hospitals within a hospital, meaning we have a lease or
sublease for space with the host hospital, which are also our
joint venture partners. Generally, our leases or subleases for
long-term acute care hospitals have initial terms of five years,
but range from three to
41
ten years. Most of our leases and subleases for our long-term
acute care hospitals contain multiple options to extend the term
in one-year increments.
|
|
Item 3.
|
Legal
Proceedings.
|
We are involved in litigation and proceedings in the ordinary
course of our business. We do not believe that the outcome of
any of the matters in which we are currently involved,
individually or in the aggregate, will have a material adverse
effect upon our business, financial condition or results of
operations.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders.
|
No matters were submitted to a vote of the Companys
stockholders during the fourth quarter of 2008.
PART II
|
|
Item 5.
|
Market
for Registrants Common Equity, Related Stockholder Matters
and Issuer Purchases of Equity Securities.
|
Sales of
Unregistered Common Stock
Effective May 10, 2008, we acquired an additional ownership
interest in one of our majority owned long-term acute care
hospitals for $1.0 million. The $1.0 million purchase
price was paid by us through the issuance of 51,736 shares
of unregistered common stock. We believe issuance was exempt
from registration under Rule 504 of the Securities Act of
1933, as amended (the Act). All recipients of the
common stock represented that they were Accredited
Investors as that term is defined in Rule 501 of the
Act and the aggregate offering price of the issued securities
did not exceed $1.0 million.
Market
Information and Holders
The Companys common stock trades on the NASDAQ Global
Select Market under the symbol LHCG. As of
March 10, 2009, there were approximately 197 registered
holders of record of the Companys common stock and the
Company believes there are approximately 21,400 beneficial
holders.
Dividend
Policy
The Company has not paid any dividends on its common stock since
its initial public offering in 2005 and does not anticipate
paying dividends in the foreseeable future. We currently intend
to retain future earnings, if any, to support the development
and growth of our business. Payment of future dividends, if any,
will be at the discretion of our board of directors and subject
to any requirements under our Credit Facility or any future
credit facility.
Price
Range of Common Stock
The following table provides the high and low prices of the
Companys Common Stock during 2008 and 2007 as quoted by
NASDAQ Global Select Market.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
2008
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
36.83
|
|
|
$
|
22.46
|
|
Third Quarter
|
|
|
31.42
|
|
|
|
21.50
|
|
Second Quarter
|
|
|
23.64
|
|
|
|
13.55
|
|
First Quarter
|
|
|
25.48
|
|
|
|
15.04
|
|
42
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
2007
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
26.17
|
|
|
$
|
20.28
|
|
Third Quarter
|
|
|
27.06
|
|
|
|
18.58
|
|
Second Quarter
|
|
|
33.14
|
|
|
|
24.52
|
|
First Quarter
|
|
|
33.00
|
|
|
|
24.15
|
|
The closing price of our common stock as reported by NASDAQ on
March 10, 2009 was $18.22
Performance
Graph
This item is incorporated by reference from our annual report to
stockholders for the fiscal year ended December 31, 2008.
|
|
Item 6.
|
Selected
Financial Data.
|
The selected consolidated financial data presented below is
derived from our audited consolidated financial statements
included in this Annual Report on
Form 10-K
as of and for each of the years ended December 31, 2008,
2007 and 2006. The selected consolidated financial data
presented below as of and for each of the years ended
December 31, 2004 and 2005 is derived from our audited
consolidated financial statements not included in this Annual
Report on
Form 10-K.
The financial data as of and for the years ended
December 31, 2008, 2007 and 2006 should be read together
with our Consolidated Financial Statements and related notes
included in Part II,
Item 8-Financial
Statements and Supplementary Data and Item 7.
Managements Discussion and Analysis of Financial Condition
and Consolidated Results of Operations included herein.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands except share and per share data)
|
|
|
Consolidated Statements of Income Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
383,296
|
|
|
$
|
298,031
|
|
|
$
|
218,535
|
|
|
$
|
155,687
|
|
|
$
|
116,090
|
|
Gross margin
|
|
|
196,447
|
|
|
|
147,272
|
|
|
|
107,741
|
|
|
|
71,247
|
|
|
|
57,357
|
|
Operating income
|
|
|
60,286
|
|
|
|
38,659
|
|
|
|
35,325
|
|
|
|
23,760
|
|
|
|
22,523
|
|
Income from continuing operations
|
|
|
30,730
|
|
|
|
21,225
|
|
|
|
21,421
|
|
|
|
11,226
|
|
|
|
9,852
|
|
Net income
|
|
|
30,202
|
|
|
|
19,589
|
|
|
|
20,594
|
|
|
|
10,102
|
|
|
|
9,313
|
|
Change in the redemption value of redeemable minority interests
|
|
|
31
|
|
|
|
193
|
|
|
|
1,163
|
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common stockholders
|
|
$
|
30,233
|
|
|
$
|
19,782
|
|
|
$
|
21,757
|
|
|
$
|
8,626
|
|
|
$
|
9,313
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per basic share(1):
|
|
$
|
1.69
|
|
|
$
|
1.11
|
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per diluted share(1)
|
|
$
|
1.69
|
|
|
$
|
1.11
|
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
17,855,634
|
|
|
|
17,760,432
|
|
|
|
17,090,583
|
|
|
|
14,628,737
|
|
|
|
12,085,154
|
|
Diluted
|
|
|
17,899,087
|
|
|
|
17,827,444
|
|
|
|
17,104,660
|
|
|
|
14,684,639
|
|
|
|
12,145,150
|
|
Cash dividends declared per common share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
.009
|
|
|
|
.039
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
|
(In thousands)
|
|
|
Consolidated Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
3,511
|
|
|
$
|
1,155
|
|
|
$
|
26,877
|
|
|
$
|
17,398
|
|
|
$
|
2,911
|
|
Total assets
|
|
$
|
243,400
|
|
|
|
174,985
|
|
|
|
152,694
|
|
|
|
104,418
|
|
|
|
47,519
|
|
Total debt
|
|
$
|
5,116
|
|
|
|
3,431
|
|
|
|
3,837
|
|
|
|
5,427
|
|
|
|
18,275
|
|
Total stockholders equity
|
|
$
|
176,821
|
|
|
|
143,371
|
|
|
|
121,889
|
|
|
|
78,444
|
|
|
|
16,351
|
|
|
|
|
(1) |
|
All references to shares and per share amounts have been
retroactively restated to reflect our incorporation in the State
of Delaware in 2005 and to give effect to a three-for-two stock
split with respect to our common stock as if such events
occurred as of the beginning of the earliest period presented. |
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations.
|
The following discussion and analysis contains
forward-looking statements about our future revenues, operating
results, plans and expectations. Forward-looking statements are
based on a number of assumptions and estimates that are
inherently subject to significant risks and uncertainties and
our results could differ materially from the results anticipated
by our forward-looking statements as a result of many known or
unknown factors, including, but not limited to, those factors
discussed in Part I, Item 1A , Risk
Factors. Also, please read the Cautionary Statements
Regarding Forward-Looking Statements set forth at the
beginning of this Annual Report on
Form 10-K.
Please read the following discussion in conjunction with
Part 1 of this
Form 10-K
as well as our Consolidated Financial Statements and the related
notes contained elsewhere in this Annual Report on
Form 10-K.
Overview
We provide post-acute health care services primarily to Medicare
beneficiaries throughout the United States, through our
home nursing agencies, hospices and long-term acute care
hospitals. Our net service revenue increased $85.3 million
from $298.0 million for the period ending December 31,
2007 to $383.3 million for the period ending
December 31, 2008. During 2008, we acquired
24 companies with a total of 63 home nursing agencies and
entered into six additional states. We also initiated the
operations of 19 home health agencies and one hospice. Since our
founders began operations in 1994 with one home nursing agency
in Palmetto, Louisiana, we have grown to 250 locations in the
following 17 states: Louisiana, Mississippi, Arkansas,
Alabama, Texas, Kentucky, Florida, Tennessee, Georgia,
North Carolina, Virginia, West Virginia, Ohio, Missouri,
Oklahoma, Maryland and Washington.
Segments
We operate in two segments for financial reporting purposes:
home-based services and facility-based services. We derived
85.1%, 81.9% and 75.4% of our net service revenue during the
year ended December 31, 2008, 2007 and 2006, respectively,
from our home-based services segment and derived the balance of
our net service revenue from our facility-based services segment.
44
Through our home-based services segment we offer a wide range of
services, including skilled nursing, private duty nursing,
physical, occupational and speech therapy, medically-oriented
social services and hospice care. As of December 31, 2008,
the home-based services segment was comprised of the following:
|
|
|
|
|
Type of Service
|
|
|
|
|
Home Health
|
|
|
206
|
|
Hospice
|
|
|
19
|
|
Diabetes Management Company
|
|
|
2
|
|
Private Duty
|
|
|
4
|
|
Specialty Services
|
|
|
3
|
|
Management Companies
|
|
|
4
|
|
|
|
|
|
|
|
|
|
238
|
|
Of our 238 home-based services locations, 134 are wholly-owned
by us, 92 are majority-owned or controlled by us through joint
ventures, eight are controlled by us through license lease
arrangements and the remaining four are management companies in
which we have no ownership interest. We intend to increase the
number of home nursing agencies that we operate through
continued acquisitions and development as we implement our
growth strategy. As we acquire and develop home nursing
agencies, we anticipate the percentage of our net service
revenue and operating income derived from our home-based
services segment will continue to increase.
We provide facility-based services principally through our
long-term acute care hospitals and outpatient rehabilitation
clinics. As of December 31, 2008, we owned and operated
four long-term acute care hospitals with seven locations, of
which all but one are located within host hospitals. We also
owned and operated an outpatient rehabilitation clinic, a
pharmacy, one medical equipment location and a health and
fitness center. Of these 11 facility-based services locations,
six are wholly-owned by us and six are majority-owned or
controlled by us through joint ventures. We also manage the
operations of one inpatient rehabilitation facility in which we
have no ownership interest.
Development
Activities
The following table is a summary of our acquisitions,
divestitures and internal development activities from
January 1, 2006 through December 31, 2008. This table
does not include the five management services agreements under
which we manage the operations of four home nursing agencies and
one inpatient rehabilitation facility.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Facility-Based Services
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Acute Care
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialty
|
|
|
Hospitals, Critical
|
|
|
Specialty and
|
|
|
|
Home-Based Services
|
|
|
and
|
|
|
Access Hospitals
|
|
|
Outpatient
|
|
|
|
Home Nursing
|
|
|
Hospice
|
|
|
Private
|
|
|
and Inpatient
|
|
|
Rehabilitation
|
|
Year
|
|
Agencies
|
|
|
Agencies
|
|
|
Duty
|
|
|
Rehabilitation Facilities
|
|
|
Clinics
|
|
|
Total at January 1, 2006
|
|
|
69
|
|
|
|
4
|
|
|
|
2
|
|
|
|
9
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Developed
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired
|
|
|
27
|
|
|
|
2
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
Divested/Closed
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at January 1, 2007
|
|
|
100
|
|
|
|
6
|
|
|
|
3
|
|
|
|
8
|
|
|
|
4
|
|
Developed
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired
|
|
|
20
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Divested/Closed
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2007
|
|
|
137
|
|
|
|
9
|
|
|
|
3
|
|
|
|
7
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Developed
|
|
|
19
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired
|
|
|
50
|
|
|
|
9
|
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2008
|
|
|
206
|
|
|
|
19
|
|
|
|
9
|
|
|
|
7
|
|
|
|
4
|
|
45
Recent
Developments
Home-Based
Services
Home Nursing. The base payment rate for
Medicare home nursing in 2008 was $2,270 per
60-day
episode. Since the inception of the prospective payment system
in October 2000, the base episode rate payment has varied due to
both the impact of annual market basket based increases and
Medicare-related legislation. Home health payment rates are
updated annually by either the full home health market basket
percentage, or by the home health market basket percentage as
adjusted by Congress. CMS establishes the home health market
basket index, which measures inflation in the prices of an
appropriate mix of goods and services included in home health
services.
Beginning January 1, 2008, we implemented the requirements
of CMS final rule released on August 22, 2007, which
updated and made major refinement to the Medicare home health
prospective payment system for 2008. To address the increases in
case-mix, the August 2007 final rule reduced the national
standardized
60-day
episode payment rate for four years. A 2.75% reduction was
effective in 2008 and will continue through 2010, with a 2.71%
reduction rate going into effect in 2011. Also, in the August
2007 final rule, CMS finalized the market basket increase of
3.0%, a 0.1% increase from the proposed rule. When the market
basket update is viewed in conjunction with
(1) the 2.75% reduction in home health payment rates for
2008; (2) the implementation of the new case-mix adjustment
system; (3) the changes in wage index; and (4) the
other changes made in the August 2007 final rule CMS
predicts a 0.8% increase in payments for Urban HHAs and a 1.77%
decrease in payments for rural HHAs. Collectively, the changes
in the August 2007 final rule (not including the case-mix or
wage index adjustments) decrease the national
60-day
episode payment rate for HHAs from the 2007 level of $2,339 to
$2,270 in 2008.
On October 30, 2008, CMS finalized the market basket
increase of 2.9% for 2009. As a result of the 2.75% reduction,
as described above, and the market basket increase, the national
60-day
episode payment rate for HHAs in 2009 is $2,272.
Hospice. On August 8, 2008, CMS issued
the Hospice Wage Index for Fiscal Year 2009 Final Rule. This
final rule provides for a payment increase consisting of a 3.6%
market basket increase less a 1.1% decrease in the Budget
Neutrality Adjustment Factor (BNAF). The 3.6% increase is
applied to the national base rates from CMS Transmittal 1570
dated August 1, 2008, and the 1.1% BNAF reduction is
applied to the geographically adjusted wage indices as indicated
in the Federal Register dated August 8, 2008.
On February 17, 2009, the Economic Stimulus Package was
enacted, delaying the phase-out of the hospice programs
budget BNAF for one year and retroactively delaying a series of
three annual cuts (1.1%, 2.2%, 1.1%) that began on
October 1, 2008.
Facility-Based
Services
LTACHs. On May 6, 2008, CMS published an
interim final rule with comment period, which implements
portions of the MMSEA. The interim final rule addresses:
(1) the payment adjustment for very short-stay outliers,
(2) the standard federal rate for the last three months of
RY 2008, (3) adjustment of the high cost outlier fixed-loss
amount for the last three months of RY 2008, and (4) the
basis and scope of the LTACH-PPS rules in reference to the MMSEA.
On May 9, 2008, CMS published its annual payment rate
update for the 2009 LTACH-PPS rate year, or RY 2009
(affecting discharges and cost reporting periods beginning on or
after July 1, 2008). The final rule adopts a
15-month
rate update, from July 1, 2008 through September 30,
2009 and moves LTACH-PPS from a July-June update cycle to the
same update cycle as the general acute care hospital inpatient
rule (October September). For RY 2009, the rule
increases the Medicare base rate 2.7%, to $39,114.34 from
$38,086.04. The rule also increases the fixed-loss amount for
high cost outlier cases to $22,960, which is $2,222 higher than
the 2008 LTACH-PPS rate year. The final rule provides that CMS
may make a one-time reduction in the LTACH-PPS rates to reflect
a budget neutrality adjustment no earlier than December 29,
2010 and no later than October 1, 2012. CMS estimates this
reduction will be approximately 3.75%.
46
On May 22, 2008, CMS published an interim final rule with
comment period, which implements portions of the MMSEA not
addressed in the May 6, 2008 interim final rule. Among
other things, the second May 22, 2008 interim final rule
defines a freestanding LTACH as a hospital that:
(1) has a Medicare provider agreement, (2) has an
average length of stay of greater than 25 days,
(3) does not occupy space in a building used by another
hospital, (4) does not occupy space in one or more separate
or entire buildings located on the same campus as buildings used
by another hospital, and (5) is not part of a hospital that
provides inpatient services in a building also used by another
hospital.
2008 and
2007 Operational Data
The following table sets forth, for the period indicated, data
regarding admissions and Medicare admissions to our home-based
segment and patient days for our facility-based segment. Certain
historical data has been included in order to present a more
comparative analysis of the statistical data.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Year Ended
|
|
|
|
March 31, 2008
|
|
|
June 30, 2008
|
|
|
September 30, 2008
|
|
|
December 31, 2008
|
|
|
December 31, 2008
|
|
|
Home-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average census
|
|
|
18,958
|
|
|
|
20,469
|
|
|
|
21,733
|
|
|
|
24,675
|
|
|
|
21,519
|
|
Average Medicare census
|
|
|
14,876
|
|
|
|
16,544
|
|
|
|
17,810
|
|
|
|
19,987
|
|
|
|
17,355
|
|
Admissions
|
|
|
13,367
|
|
|
|
13,688
|
|
|
|
14,113
|
|
|
|
15,462
|
|
|
|
56,630
|
|
Medicare admissions
|
|
|
9,774
|
|
|
|
10,053
|
|
|
|
10,482
|
|
|
|
11,402
|
|
|
|
41,711
|
|
Facility-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days
|
|
|
12,034
|
|
|
|
11,298
|
|
|
|
10,930
|
|
|
|
11,928
|
|
|
|
46,190
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Year Ended
|
|
|
|
March 31, 2007
|
|
|
June 30, 2007
|
|
|
September 30, 2007
|
|
|
December 31, 2007
|
|
|
December 31, 2007
|
|
|
Home-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average census
|
|
|
15,712
|
|
|
|
16,283
|
|
|
|
16,862
|
|
|
|
17,914
|
|
|
|
16,635
|
|
Average Medicare census
|
|
|
11,642
|
|
|
|
12,222
|
|
|
|
12,767
|
|
|
|
13,734
|
|
|
|
12,560
|
|
Admissions
|
|
|
10,615
|
|
|
|
10,825
|
|
|
|
11,216
|
|
|
|
11,080
|
|
|
|
43,736
|
|
Medicare admissions
|
|
|
7,333
|
|
|
|
7,500
|
|
|
|
7,819
|
|
|
|
8,099
|
|
|
|
30,751
|
|
Facility-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days
|
|
|
11,674
|
|
|
|
11,453
|
|
|
|
11,202
|
|
|
|
11,489
|
|
|
|
45,818
|
|
47
Consolidated
Results of Operations
The following table sets forth, for the periods indicated, net
service revenue, cost of service revenue, general and
administrative expenses, and operating income by segment. The
table also includes data regarding total admissions and total
Medicare admissions for our home-based services segment and
patient days for our facility-based services segment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Home-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
326,041
|
|
|
$
|
244,107
|
|
|
$
|
164,701
|
|
Cost of service revenue
|
|
|
154,376
|
|
|
|
116,962
|
|
|
|
78,089
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
171,665
|
|
|
|
127,145
|
|
|
|
86,612
|
|
Provision for bad debts
|
|
|
10,208
|
|
|
|
9,426
|
|
|
|
3,051
|
|
General and administrative expenses
|
|
|
109,917
|
|
|
|
80,595
|
|
|
|
53,630
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
51,540
|
|
|
$
|
37,124
|
|
|
$
|
29,931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average census
|
|
|
21,519
|
|
|
|
16,635
|
|
|
|
12,982
|
|
Average Medicare census
|
|
|
17,355
|
|
|
|
12,560
|
|
|
|
9,573
|
|
Total admissions
|
|
|
56,630
|
|
|
|
43,736
|
|
|
|
26,972
|
|
Total Medicare admissions
|
|
|
41,711
|
|
|
|
30,751
|
|
|
|
19,138
|
|
Facility-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
57,255
|
|
|
$
|
53,924
|
|
|
$
|
53,834
|
|
Cost of service revenue
|
|
|
32,473
|
|
|
|
33,797
|
|
|
|
32,705
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
24,782
|
|
|
|
20,127
|
|
|
|
21,129
|
|
Provision for bad debts
|
|
|
1,563
|
|
|
|
2,822
|
|
|
|
1,054
|
|
General and administrative expenses
|
|
|
14,473
|
|
|
|
15,770
|
|
|
|
14,681
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
8,746
|
|
|
$
|
1,535
|
|
|
$
|
5,394
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days
|
|
|
46,190
|
|
|
|
45,818
|
|
|
|
45,461
|
|
The growth in home-based services in 2008 primarily relates to
our acquisitions and de-novo locations during 2008. The
relationship between the Companys expenses and net service
revenue provides a more comparative analysis of the financial
information. The following table sets forth, for the periods
indicated, certain items included in our consolidated statement
of income as a percentage of our net service revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Net service revenue
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Cost of service revenue
|
|
|
48.7
|
|
|
|
50.6
|
|
|
|
50.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
51.3
|
|
|
|
49.4
|
|
|
|
49.3
|
|
Provision for bad debts
|
|
|
3.1
|
|
|
|
4.1
|
|
|
|
1.9
|
|
General and administrative expenses
|
|
|
32.5
|
|
|
|
32.3
|
|
|
|
31.3
|
|
Operating income
|
|
|
15.7
|
|
|
|
13.0
|
|
|
|
16.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense
|
|
|
(0.1
|
)
|
|
|
(0.1
|
)
|
|
|
(0.1
|
)
|
Non-operating income, including gain on sales of assets
|
|
|
0.4
|
|
|
|
0.4
|
|
|
|
0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
4.9
|
|
|
|
4.1
|
|
|
|
4.9
|
|
Minority interest expense
|
|
|
3.1
|
|
|
|
2.0
|
|
|
|
2.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
8.0
|
%
|
|
|
7.1
|
%
|
|
|
9.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48
Year
Ended December 31, 2008 Compared to Year Ended
December 31, 2007
Net
Service Revenue
Consolidated net service revenue for the year ended
December 31, 2008 was $383.3 million, an increase of
28.6% or $85.3 million from $298.0 million for the
same period ending December 31, 2007. The growth in the
home- based services net service revenue contributed
$81.9 million of the increase in consolidated net service
revenue between 2008 and 2007. Net service revenue was comprised
of the following for the periods ending December 31:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Home-based services
|
|
|
85.1
|
%
|
|
|
81.9
|
%
|
Facility-based services
|
|
|
14.9
|
|
|
|
18.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
Revenue derived from Medicare represented 83.2% and 81.7% of
consolidated net service revenue for the years ended
December 31, 2008 and 2007, respectively.
Home-Based Services. Net service revenue from
home-based services for the year ended December 31, 2008
was $326.0 million, an increase of $81.9 million, or
33.6%, from $244.1 million for the year ended
December 31, 2007. Total admissions increased 29.5% to
56,630 during the period, versus 43,736 for the same period in
2007. Average home-based patient census for the year ended
December 31, 2008 increased 29.4% to 21,519 patients
as compared with 16,635 patients for the year ended
December 31, 2007.
As detailed in the table below, the increase in revenue in 2008
resulted from organic growth and the growth from our
acquisitions during the year ended December 31, 2008.
Organic growth includes growth in same store
locations, or those locations owned for greater than
12 months, and growth from de novo locations.
We calculate organic growth by dividing organic growth generated
in a period by total revenue generated in the same period of the
prior year. Revenue from acquired agencies contributes to
organic growth beginning with the thirteenth month after
acquisition.
The following table details the home-based services revenue
growth and percentages for organic and total growth:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Same
|
|
|
|
|
|
|
|
|
Organic
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
Store(1)
|
|
|
De Novo(2)
|
|
|
Organic(3)
|
|
|
Growth %
|
|
|
Acquired(4)
|
|
|
Total
|
|
|
Growth %
|
|
|
Revenue
|
|
$
|
286,342
|
|
|
$
|
2,879
|
|
|
$
|
289,221
|
|
|
|
18.5
|
%
|
|
$
|
36,820
|
|
|
$
|
326,041
|
|
|
|
33.6
|
%
|
Revenue Medicare
|
|
$
|
239,627
|
|
|
$
|
2,431
|
|
|
$
|
242,058
|
|
|
|
21.9
|
%
|
|
$
|
31,375
|
|
|
$
|
273,433
|
|
|
|
37.7
|
%
|
Average Census
|
|
|
17,228
|
|
|
|
341
|
|
|
|
17,569
|
|
|
|
5.6
|
%
|
|
|
3,950
|
|
|
|
21,519
|
|
|
|
29.4
|
%
|
Average Medicare Census
|
|
|
14,099
|
|
|
|
277
|
|
|
|
14,376
|
|
|
|
14.5
|
%
|
|
|
2,979
|
|
|
|
17,355
|
|
|
|
38.2
|
%
|
Episodes
|
|
|
105,712
|
|
|
|
1,323
|
|
|
|
107,035
|
|
|
|
34.4
|
%
|
|
|
10,412
|
|
|
|
117,447
|
|
|
|
47.4
|
%
|
|
|
|
(1) |
|
Same store location that has been in service with
the Company for greater than 12 months. |
|
(2) |
|
De Novo internally developed location that has been
in service with the Company for 12 months or less. |
|
(3) |
|
Organic combination of same store and de novo. |
|
(4) |
|
Acquired purchased location that has been in service
with the Company for 12 months or less. |
Facility-Based Services. Net service revenue
from the facility-based services for the year ended
December 31, 2008 was $57.3 million, an increase of
$3.4 million, or 6.3%, compared with $53.9 million for
the year ended December 31, 2007. Organic growth made up
the total growth in this service sector during the period. The
increase in net service revenue primarily relates to an increase
in patient acuity throughout the year. Patient days increased to
46,190 in the year ended December 31, 2008, from 45,818 in
the year ended December 31, 2007.
49
Cost
of Service Revenue
Our cost of service revenue consists of expenses incurred by our
clinical and clerical personnel in our agencies and facilities.
Cost of service revenue for the year ended December 31,
2008 was $186.8 million, an increase of $36.0 million,
or 23.9%, from $150.8 million for the year ended
December 31, 2007. Cost of service revenue represented
approximately 48.7% and 50.6% of our net service revenue for the
years ended December 31, 2008 and 2007, respectively.
Home-Based Services. Cost of service revenue
from home-based services for the year ended December 31,
2008 was $154.4 million, an increase of $37.4 million,
or 32.0%, from $117.0 million for the year ended
December 31, 2007. The following table summarizes cost of
service revenue (amounts in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Salaries, wages and benefits
|
|
|
131,452
|
|
|
|
40.3
|
%(1)
|
|
|
99,446
|
|
|
|
40.7
|
%(1)
|
Transportation, primarily mileage reimbursement
|
|
|
11,803
|
|
|
|
3.6
|
|
|
|
8,589
|
|
|
|
3.5
|
|
Supplies and services
|
|
|
11,121
|
|
|
|
3.4
|
|
|
|
8,927
|
|
|
|
3.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
154,376
|
|
|
|
47.3
|
%
|
|
$
|
116,962
|
|
|
|
47.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Percentage of Home-Based net service revenue |
The decrease in cost of home-based service revenue as a
percentage of home-based net service revenue for the year ended
December 31, 2008 relates primarily to the decrease in
salaries, wages and benefits and supplies and services as a
percentage of net service revenue. Salaries, wages and benefits
decreased as a percentage of net service revenue due to improved
controls over these costs particularly in agencies acquired in
2007 and 2008. Supplies and services benefited from renegotiated
contracts with major suppliers.
Facility-Based Services. Cost of service
revenue from facility-based services for the year ended
December 31, 2008 was $32.5 million, a decrease of
$1.3 million, or 3.8%, from $33.8 million for the year
ended December 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Salaries, wages and benefits
|
|
|
20,717
|
|
|
|
36.2
|
%(1)
|
|
|
20,969
|
|
|
|
38.9
|
%(1)
|
Transportation
|
|
|
262
|
|
|
|
0.4
|
|
|
|
327
|
|
|
|
0.6
|
|
Supplies and services
|
|
|
11,494
|
|
|
|
20.1
|
|
|
|
12,501
|
|
|
|
23.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
32,473
|
|
|
|
56.7
|
%
|
|
$
|
33,797
|
|
|
|
62.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Percentage of Facility-Based net service revenue |
The decrease in cost of facility-based service revenue as a
percentage of facility based net service revenue for the year
ended December 31, 2008 relates primarily to a decrease in
salary, wages and benefits as a percentage of net service
revenue. The decrease is the result of cost management at the
facilities and increased acuity of the patients receiving
treatment, resulting in higher net service revenue but not
increased patient days. Additionally during 2008, management
renegotiated several contracts with its major suppliers. As a
result of the renegotiations, the Company experienced reductions
in the dollar amount of cost of supplies and as a percentage of
net service revenue, throughout the year.
Provision
for Bad Debts
Provision for bad debts for the year ended December 31,
2008 was $11.8 million compared to $12.2 million for
the year ended December 31, 2007. For the years ended
December 31, 2008 and 2007, the provision for bad debts was
approximately 3.1% and 4.1% of net service revenue,
respectively. In the fourth quarter of 2007, we increased bad
debt expense $3.9 million to reflect collection
difficulties, primarily with commercial claims. Prior to that
increase, we had been recording bad debt expense of
approximately 2.9% of
50
net service revenue. During 2008, we have increased collection
efforts, including those related to commercial claims, increased
cash collections and reduced overall receivables and days sales
outstanding at year end, which resulted in lower bad debt
expense as a percentage of net service revenue.
General
and Administrative Expenses
General and administrative expenses consist primarily of the
following expenses incurred by our home office and
administrative field personnel:
|
|
|
|
|
salaries and related benefits;
|
|
|
|
insurance;
|
|
|
|
costs associated with advertising and other marketing
activities; and
|
|
|
|
rent and utilities;
|
|
|
|
|
|
accounting, legal and other professional services; and
|
|
|
|
office supplies;
|
|
|
|
|
|
Depreciation; and
|
|
|
|
Other:
|
|
|
|
|
|
advertising and marketing expenses;
|
|
|
|
recruitment;
|
|
|
|
operating locations rent; and
|
|
|
|
taxes.
|
General and administrative expenses for the year ended
December 31, 2008 were $124.4 million, an increase of
$28.0 million, or 29.1%, from $96.4 million for the
year ended December 31, 2007. General and administrative
expenses represented approximately 32.5% and 32.3% of our net
service revenue for the years ended December 31, 2008 and
2007, respectively.
Home-Based Services. General and
administrative expenses from the home-based services for the
year ended December 31, 2008 were $109.9 million, an
increase from $80.6 million for the year ended
December 31, 2007. General and administrative expenses were
33.7% of our net service revenue compared to 33.0% during the
year ended December 31, 2008 and 2007, respectively. This
increase as a percentage of net service revenue was in part
caused by higher general and administrative expenses in agencies
acquired in 2008, approximately 35.8% of net service revenue,
and denovo locations, approximately 41.0% of net service
revenue. In addition, investment in our billing and collections
department, which have improved collections and reduced
receivables, and growth and development in other departments
which support the Companys growth, increased these costs
throughout 2008.
Facility-Based Services. General and
administrative expenses from facility-based services for the
year ended December 31, 2008 were $14.5 million, a
decrease of $1.3 million, or 8.2%, from $15.8 million
for the year ended December 31, 2007.
General and administrative expenses in facility-based segment
for the year ended December 31, 2008 represented 25.3% of
our net service revenue compared to 29.2% during the year ended
December 31, 2007.
51
Non-operating
income
Non-operating income for the year ended December 31, 2008
was $1.4 million compared to $1.1 million for the year
ended December 31, 2007. During 2008, the Company recorded
a gain of $624,000 for the exchange of a minority ownership in
two of the Companys entities, for a majority ownership in
an acquired entity. Also during 2008, the Company recognized a
gain of $315,000 related to the sale of the Companys
aircraft.
Income
Tax Expense
The effective tax rates for the years ended December 31,
2008 and 2007 were 37.9% and 36.4%, respectively. The increase
is related to the effect of higher state tax rates and the
related mix of taxable income in those states and a lower credit
in 2008 related to the Gulf Opportunity Act.
Minority
Interest
The minority interest expense for the year ended
December 31, 2008 was $11.8 million, 3.1% of net
service revenue, an increase of $5.8 million, compared to
$6.0 million. 2.0% of net service revenue for the year
ended December 31, 2007. Between June 30, 2007 and
December 31, 2007, the Company entered into seven joint
venture agreements. These joint ventures contributed to minority
interest expense for a 12 month period ending
December 31, 2008 versus only a few months of the preceding
year. Further, during 2008, the Company entered into 13
additional joint venture agreements. These new joint venture
acquisitions contributed $3.7 million to the increase in
minority interest for the year ending December 31, 2008.
The remaining increase relates to the increase in income from
operations related to all of our joint ventures.
Discontinued
Operations
Revenue from discontinued operations for the years ended
December 31, 2008 and 2007 was $51,000 and
$3.0 million, respectively. Costs, expenses and minority
interest were $689,000 and $4.9 million, respectively, for
the years ended December 31, 2008 and 2007. For the year
ended December 31, 2008, the loss from discontinued
operations was $528,000, as compared to a loss from discontinued
operations of $1.7 million for the same period in 2007. In
2007, we placed a home health pharmacy and a critical access
hospital into discontinued operations and recorded a valuation
allowance of $505,000 on the deferred tax asset generated by the
tax net operating loss carry forward of the pharmacy. The
valuation allowance as of December 31, 2008 was $643,000.
The home health pharmacy was closed on September 30, 2007,
and the sale of the hospital was completed on July 1, 2007.
Year
Ended December 31, 2007 Compared to Year Ended
December 31, 2006
Net
Service Revenue
Net service revenue for the year ended December 31, 2007
was $298.0 million, an increase of 36.4% from
$218.5 million for the same period ending December 31,
2006.
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
Home-based services
|
|
|
81.9
|
%
|
|
|
75.4
|
%
|
Facility-based services
|
|
|
18.1
|
|
|
|
24.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
Revenue derived from Medicare represented 81.7% and 82.6% of
consolidated net service revenue for the years ended
December 31, 2007 and 2006, respectively.
Home-Based Services. Net service revenue from
home-based services for the year ended December 31, 2007
was $244.1 million, an increase of $79.4 million, or
48.2%, from $164.7 million for the year ended
December 31, 2006. Total admissions increased 62.2% to
43,736 during the period, versus 26,972 for the same
52
period in 2006. Average home-based patient census for the year
ended December 31, 2007, increased 28.1% to
16,635 patients as compared with 12,982 patients for
the year ended December 31, 2006.
As detailed in the table below, the increase in revenue in 2007
is explained by organic growth, our internal acquisition growth
and the growth from our acquisitions during the year ended
December 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Same
|
|
|
|
|
|
|
|
|
Organic
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
Store(1)
|
|
|
De Novo(2)
|
|
|
Organic(3)
|
|
|
Growth %
|
|
|
Acquired(4)
|
|
|
Total
|
|
|
Growth %
|
|
|
Revenue
|
|
$
|
221,154
|
|
|
$
|
2,674
|
|
|
$
|
223,828
|
|
|
|
35.9
|
%
|
|
$
|
20,279
|
|
|
$
|
244,107
|
|
|
|
48.2
|
%
|
Revenue Medicare
|
|
$
|
178,795
|
|
|
$
|
2,213
|
|
|
$
|
181,008
|
|
|
|
36.0
|
%
|
|
$
|
17,595
|
|
|
$
|
198,603
|
|
|
|
49.2
|
%
|
Average Census
|
|
|
14,285
|
|
|
|
297
|
|
|
|
14,582
|
|
|
|
12.3
|
%
|
|
|
2,053
|
|
|
|
16,635
|
|
|
|
28.1
|
%
|
Average Medicare Census
|
|
|
10,645
|
|
|
|
224
|
|
|
|
10,869
|
|
|
|
13.5
|
%
|
|
|
1,691
|
|
|
|
12,560
|
|
|
|
31.2
|
%
|
Episodes
|
|
|
75,305
|
|
|
|
485
|
|
|
|
75,790
|
|
|
|
43.5
|
%
|
|
|
3,872
|
|
|
|
79,662
|
|
|
|
50.8
|
%
|
|
|
|
(1) |
|
Same store location that has been in service with
the Company for greater than 12 months. |
|
(2) |
|
De Novo internally developed location that has been
in service with the Company for 12 months or less. |
|
(3) |
|
Organic combination of same store and de novo. |
|
(4) |
|
Acquired purchased location that has been in service
with the Company for 12 months or less. |
Facility-Based Services. Net service revenue
from facility-based services for the year ended
December 31, 2007 increased $100,000, or 0.2%, to
$53.9 million compared with $53.8 million for the year
ended December 31, 2006. Organic growth made up the total
growth in this service sector during the period. The increase in
net service revenue was due in part to an increase in patient
days of 0.8% to 45,818 in the year ended December 31, 2007,
from 45,461 in the year ended December 31, 2006.
Cost
of Service Revenue
Cost of service revenue for the year ended December 31,
2007 was $150.8 million, an increase of $40.0 million,
or 36.1%, from $110.8 million for the year ended
December 31, 2006. Cost of service revenue represented
approximately 50.6% and 50.7% of our net service revenue for the
years ended December 31, 2007 and 2006, respectively.
Home-Based Services. Cost of service revenue
from home-based services for the year ended December 31,
2007 was $117.0 million, an increase of $38.9 million,
or 49.8%, from $78.1 million for the year ended
December 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
Salaries, wages and benefits
|
|
|
99,446
|
|
|
|
40.7
|
%(1)
|
|
|
66,419
|
|
|
|
40.0
|
%(1)
|
Transportation, primarily mileage reimbursement
|
|
|
8,589
|
|
|
|
3.5
|
|
|
|
5,548
|
|
|
|
3.4
|
|
Supplies and services
|
|
|
8,927
|
|
|
|
3.7
|
|
|
|
6,122
|
|
|
|
3.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
116,962
|
|
|
|
47.9
|
%
|
|
$
|
78,089
|
|
|
|
47.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Percentage of Home-Based net service revenue |
Approximately $33.5 million of this increase resulted from
an increase in salaries, wages and benefits, of which
$26.9 million was incurred as a result of acquisition and
development activity that occurred during 2006 and
$13.2 million was incurred as a result of acquisition and
development activity during 2007. The growth in salaries, wages
and benefits expense due to acquisitions and developments is
offset by a decrease in the salaries, wages and benefits expense
in the same store locations by approximately
$6.6 million. The remaining increase in cost of service
revenue was attributable to increases in supplies and services
expense and transportation expense. Supplies and service expense
increased approximately $2.8 million in 2007 as compared to
2006. Supplies and services expense increased $2.0 million
related to acquisitions and
53
developments that occurred in 2006 and $1.3 million related
to acquisitions and developments that occurred in 2007. The
growth in supplies and services expense due to acquisitions and
developments is offset by a decrease in the supplies and
services expense in the same store locations by
approximately $495,000. Transportation expense increased
approximately $3.0 million in 2007 as compared to 2006.
Transportation expense increased $2.4 million related to
acquisitions and developments that occurred in 2006 and
$1.1 million related to acquisitions and developments that
occurred in 2007. The growth in transportation expense due to
acquisitions and developments is offset by a decrease in the
transportation expense in the same store locations
by approximately $531,000.
Facility-Based Services. Cost of service
revenue from facility-based services for the year ended
December 31, 2007 was $33.8 million, an increase of
$1.1 million, or 3.4%, from $32.7 million for the year
ended December 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
December 31,
|
|
|
|
2007
|
|
|
|
|
|
2006
|
|
|
|
|
|
Salaries, wages and benefits
|
|
|
20,969
|
|
|
|
38.9
|
%(1)
|
|
|
20,949
|
|
|
|
38.9
|
%(1)
|
Transportation
|
|
|
327
|
|
|
|
0.6
|
|
|
|
254
|
|
|
|
0.5
|
|
Supplies and services
|
|
|
12,501
|
|
|
|
23.2
|
|
|
|
11,502
|
|
|
|
21.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
33,797
|
|
|
|
62.7
|
%
|
|
$
|
32,705
|
|
|
|
60.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Percentage of Facility-Based net service revenue |
The entire increase in cost of service revenue from
facility-based services is due primarily to an increase in
supplies and services resulting from an increase in patient days.
General
and Administrative Expenses
General and administrative expenses for the year ended
December 31, 2007 were $96.4 million, an increase of
$28.1 million, or 41.1%, from $68.3 million for the
year ended December 31, 2006. General and administrative
expenses represented approximately 32.3% and 31.3% of our net
service revenue for the years ended December 31, 2007 and
2006, respectively.
Home-Based Services. General and
administrative expenses from home-based services for the year
ended December 31, 2007 were $80.6 million, an
increase of $27.0 million, or 50.4%, from
$53.6 million for the year ended December 31, 2006.
Approximately $20.2 million of the increase in general and
administrative expenses was due to acquisitions that occurred in
2006, and approximately $9.6 million of the increase in
general and administrative expenses was due to acquisitions that
occurred in 2007. General and administrative expenses in the
same store locations decreased by $2.4 million
and were offset by an increase in the provision for bad debts of
$6.4 million in 2007 as compared to 2006.
General and administrative expenses in the home-based segment
for the year ended December 31, 2007 represented 33.0% of
our net service revenue, compared to 32.6% during the year ended
December 31, 2006.
Facility-Based Services. General and
administrative expenses the facility-based services for the year
ended December 31, 2007 were $15.8 million, an
increase of $1.1 million, or 7.5%, from $14.7 million
for the year ended December 31, 2006.
General and administrative expenses in the facility-based
segment for the year ended December 31, 2007 represented
29.2% of our net service revenue compared to 27.3% during the
year ended December 31, 2006.
Non-operating
income
Non-operating income for the year ended December 31, 2007
was $1.1 million, a decrease of approximately $900,000 from
$2.0 million for the year ended December 31, 2006.
Non-operating income in 2006 includes $1.0 million in
proceeds received from the life insurance policy on our former
chief financial officer who passed away in a plane crash after
retiring from the Company.
54
Income
Tax Expense
The effective tax rates for the years ended December 31,
2007 and 2006 were 36.4% and 33.6%, respectively. The effective
tax rate for the year ended December 31, 2007 is higher due
to a lower credit related to the Gulf Opportunity Act in 2007
than in 2006 and the effect of income from insurance proceeds in
2006, which are not taxable.
Minority
Interest
Minority interest expense for the year ended December 31,
2007 was $6.0 million, an increase of $1.2 million,
compared to $4.8 million for the year ended
December 31, 2006. Minority interest expense varies
depending on the operations of each joint venture.
Discontinued
Operations
Revenue from discontinued operations for the years ended
December 31, 2007 and 2006 was $3.0 million and
$5.3 million, respectively. Costs, expenses and minority
interest were $4.9 million and $7.6 million,
respectively, for the years ended December 31, 2007 and
2006. For the year ended December 31, 2007, the loss from
discontinued operations was $1.7 million as compared to a
loss from discontinued operations of $1.5 million for the
same period in 2006. In 2007, we placed a home health pharmacy
and a critical access hospital into discontinued operations and
recorded a valuation allowance of $505,000 in the deferred tax
asset generated by the tax net operating loss carry forward of
the pharmacy. The home health pharmacy was closed on
September 30, 2007, and the sale of the hospital was
completed on July 1, 2007.
Liquidity
and Capital Resources
Liquidity
Our principal source of liquidity for our operating activities
is the collection of our accounts receivable, most of which are
collected from governmental and third-party commercial payors.
Our reported cash flows from operating activities are impacted
by various external and internal factors, including the
following:
|
|
|
|
|
Operating Results Our net income has a
significant impact on our operating cash flows. Any significant
increase or decrease in our net income could have a material
impact on our operating cash flows.
|
|
|
|
Timing of Acquisitions We use our operating
cash flows to purchase home health and hospice agencies. When
the acquisitions occur at or near the end of a period, our cash
outflows significantly increase.
|
|
|
|
Start-Up
Costs Following the completion of an
acquisition, we suspend billing Medicare and Medicaid claims
until we receive the change of ownership and electronic funds
transfer approvals. We also generally incur substantial
start-up
costs in order to implement our business strategy. There is
generally a delay between our expenditure
start-up
costs and the increase in net service revenue and subsequent
cash collections, which adversely affects our cash flows from
operating activities.
|
|
|
|
Timing of Payroll Our employees are paid
bi-weekly on Fridays; therefore, operating cash flows decline in
reporting periods that end on a Friday. Conversely, for those
reporting periods ending on a day other than Friday, our cash
flows are higher because we have not yet paid our payroll.
|
|
|
|
Medical Insurance Plan Funding We are
self-funded for medical insurance purposes. Any significant
changes in the amount of insurance claims submitted could have a
direct impact on our operating cash flows.
|
|
|
|
Medical Supplies A significant expense
associated with our business is the cost of medical supplies.
Any increase in the cost of medical supplies, or in the use of
medical supplies by our patients, could have a material impact
on our operating cash flows.
|
55
Cash used in investing activities is primarily for acquisitions
of home nursing and hospice agencies, while cash used by
financing activities relates to payments on outstanding debt
agreements and payments to our minority interest partners.
The following table summarizes changes in cash flows (amounts in
thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
Cash provided by operating activities
|
|
$
|
85,504
|
|
|
$
|
12,014
|
|
Cash used in investing activities
|
|
|
(75,876
|
)
|
|
|
(32,281
|
)
|
Cash used in financing activities
|
|
|
(7,272
|
)
|
|
|
(5,455
|
)
|
|
|
|
|
|
|
|
|
|
Change in cash
|
|
|
2,356
|
|
|
|
(25,722
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
1,155
|
|
|
|
26,877
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
3,511
|
|
|
$
|
1,155
|
|
|
|
|
|
|
|
|
|
|
Operating activities during the year ended December 31,
2008 provided $85.5 million in cash compared to
$12.0 million for year ended December 31, 2007. Net
income provided $30.2 million of operating cash flow in
2008. Non-cash items such as depreciation and amortization,
provision for bad debts, restricted stock expense, minority
interest in earnings of subsidiaries, deferred income taxes and
gain on sale of assets totaled $29.3 million. Operating
cash flows also increased due to the change in working capital.
At December 31, 2008, working capital was
$32.1 million compared to $61.0 million at
December 31, 2007, a decrease of $28.9 million. The
decrease relates to increased accounts payable and accrued
expenses. This increase primarily relates to income taxes
payable and salaries, wages and benefits payable.
Days sales outstanding (DSO) for the year ended
December 31, 2008 was 51 days compared to 73 days
for the same period in 2007. DSO, when adjusted for acquisitions
and unbilled accounts receivables, was 50 days. The
adjustment takes into account $576,000 of unbilled receivables
that the Company is delayed in billing due to the lag time in
receiving the change of ownership after acquiring companies. For
the comparable period in 2007, adjusted DSO was 63 days,
taking into account $8.8 million in unbilled accounts
receivable.
Investing activities used $75.9 million and
$32.3 million in cash for the years ended December 31,
2008 and 2007, respectively. In 2008, acquisitions accounted for
$69.9 million of the cash used in investing activities
compared to $28.9 million in 2007. Additionally,
$2.0 million of the increase in cash used in investing
activities relates to the net effect of acquiring the
Companys current aircraft for $5.1 million offset by
proceeds from selling the previous aircraft of $3.1 million.
Financing activities used $7.3 million and
$5.5 million in cash in the years ended December 31,
2008 and 2007, respectively. The increase primarily relates to
the financing arrangements on the purchase of the Companys
aircraft in 2008. In February 2008, the Company entered into a
new loan agreement with Capital One, National Association
(Capital One) for $5.1 million and paid off our
December 31, 2007 outstanding loan with a balance of
$2.9 million.
Indebtedness
Our total long-term indebtedness was $5.1 million at
December 31, 2008 and $3.4 million at
December 31, 2007, including the current portions of
$583,000 and $521,000, respectively.
On February 20, 2008, the Company entered into a new credit
facility agreement (New Credit Facility) with
Capital One, which was amended on March 6, 2008 to include
an additional lender, First Tennessee Bank, N.A., to increase
the line of credit from $25.0 million to $37.5 million
and to amend the Eurodollar Margin for each Eurodollar Loan (as
those terms are defined in the New Credit Facility) issued under
the New Credit Facility. The credit agreement for the New Credit
Facility was amended and restated on June 12, 2008 to add
Branch Banking and Trust Company as a Lender and to
increase the maximum aggregate principal amount of the line of
credit from $37.5 million to $75.0 million. The New
Credit Facility is unsecured, has a
56
term of two years and a letter of credit sublimit of
$2.5 million. The annual facility fee is 0.125% of the
total availability. No amounts were outstanding on the New
Credit Facility as of December 31, 2008.
The interest rate for borrowings under the New Credit Agreement
is a function of the prime rate (Base Rate) or the Eurodollar
rate (Eurodollar), as elected by the Company, plus the
applicable margin as set forth below:
|
|
|
|
|
|
|
|
|
|
|
Eurodollar
|
|
|
Base Rate
|
|
Leverage Ratio
|
|
Margin
|
|
|
Margin
|
|
|
< 1.00:1.00
|
|
|
1.75
|
%
|
|
|
(0.25
|
)%
|
³
1.00:1.00 < 1.50:100
|
|
|
2.00
|
%
|
|
|
0
|
%
|
³
1.50:1.00 < 2.00:1.00
|
|
|
2.25
|
%
|
|
|
0
|
%
|
³2.00:1.00
|
|
|
2.50
|
%
|
|
|
0
|
%
|
The New Credit Facility contains customary affirmative, negative
and financial covenants. For example, we are restricted in
incurring additional debt, disposing of assets, making
investments, allowing fundamental changes to our business or
organization and making certain payments in respect to stock or
other ownership interests, such as dividends and stock
repurchases. Under the New Credit Facility we are also required
to meet certain financial covenants with respect to fixed charge
coverage, leverage, working capital and liabilities to tangible
net worth ratios. We were in compliance with all covenants under
the New Credit Facility as of December 31, 2008. The
covenants were negotiated with our lenders and were designed to
support the companys acquisition strategy and growth. A
single acquisition which was large and required a significant
portion of the line of credit to be drawn in order to fund the
acquisition could result in the Company being unable to meet the
tangible net worth covenant after the acquisition. However, we
discuss all acquisitions with our lenders and collectively
evaluate them. So in the event such a target was identified, we
would work with the lenders to restructure the covenant prior to
completing the acquisition. We expect to be in compliance with
our covenants throughout 2009.
The New Credit Facility also contains customary events of
default, including bankruptcy and other insolvency events,
cross-defaults to other debt agreements, a change in control
involving the Company or any subsidiary guarantor and the
failure to comply with certain covenants.
On February 20, 2008, the Company terminated its credit
facility agreement (the Former Credit Facility) with
C.F. Blackburn, LLC, successor by assignment to Residential
Funding Company, LLC, f/k/a Residential Funding Corporation. At
December 31, 2007, the borrowing limit under the Former
Credit Facility was $22.5 million and no amounts were
outstanding. The Former Credit Facility was due to expire on
April 15, 2010.
On February 28, 2008, the Company paid its promissory note
with Bancorp Equipment Finance, Inc. in full. The note was
collateralized by the Companys previous aircraft, which
was sold in February 2008 for $3.1 million. The sale
resulted in a gain of $315,000.
In February 2008, the Company entered into a loan agreement with
Capital One for a term note in the amount of $5.1 million
for the purchase of a 1999 Cessna 560 aircraft. The aircraft is
collateral for the term note, which is payable in
83 monthly installments of principal plus interest
commencing on March 6, 2008 followed by one balloon
installment on February 6, 2015 of $2.7 million. The
term note bears interest at the LIBOR rate (adjusted monthly)
plus the Applicable Margin (as defined in the term note) of
1.9%, 3.8% at December 31, 2008.
57
Commitments
The following table discloses aggregate information about our
contractual obligations and the periods in which payments are
due as of December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment due by period
|
|
|
|
|
|
|
Less Than
|
|
|
|
|
|
|
|
|
More Than
|
|
Contractual Cash Obligation
|
|
Total
|
|
|
1 Year
|
|
|
1-3 Years
|
|
|
3-5 Years
|
|
|
5 Years
|
|
|
|
(In thousands)
|
|
|
Long-term debt
|
|
$
|
4,991
|
|
|
$
|
508
|
|
|
$
|
1,061
|
|
|
$
|
1,010
|
|
|
$
|
2,412
|
|
Capital lease obligations
|
|
|
125
|
|
|
|
75
|
|
|
|
50
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
|
19,049
|
|
|
|
7,699
|
|
|
|
9,103
|
|
|
|
2,180
|
|
|
|
67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual cash obligations
|
|
$
|
24,165
|
|
|
$
|
8,282
|
|
|
$
|
10,214
|
|
|
$
|
3,190
|
|
|
$
|
2,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Off-Balance
Sheet Arrangements
We do not currently have any off-balance sheet arrangements with
unconsolidated entities, financial partnerships or entities
often referred to as structured finance or special purpose
entities, which would have been established for the purpose of
facilitating off-balance sheet arrangements or other
contractually narrow or limited purposes. In addition, we do not
engage in trading activities involving non-exchange traded
contracts. As such, we are not materially exposed to any
financing, liquidity, market or credit risk that could arise if
we had engaged in these relationships.
The following discussions describe our critical accounting
policies, which we believe require the most significant
judgments and estimates used in the preparation of our
consolidated financial statements.
Critical
Accounting Policies
The preparation of financial statements in conformity with
U.S. generally accepted accounting principles requires
management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported revenue and expenses during the
reported period. Actual results could differ from those
estimates. Changes in the accounting estimates are reasonably
likely to occur from period to period. Accordingly, actual
results could differ materially from our estimates. To the
extent that there are material differences between these
estimates and actual results, our financial condition or results
of operations will be affected. We base our estimates on past
experience and other assumptions that we believe are reasonable
under the circumstances and we evaluate these estimates on an
ongoing basis. We refer to accounting estimates of this type as
critical accounting policies and estimates, which we discuss
further below.
Principles
of Consolidation
The consolidated financial statements include all subsidiaries
and entities controlled by the Company. Control is defined by
the Company as ownership of a majority of the voting interest of
an entity. The consolidated financial statements include
entities in which the Company absorbs a majority of the
entities expected losses, receives a majority of the
entities expected residual returns, or both, as a result
of ownership, contractual or other financial interests in the
entities.
58
The following table summarizes the percentage of net service
revenue earned by type of ownership or relationship the Company
had with the operating entity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Wholly owned subsidiaries
|
|
|
46.6
|
%
|
|
|
46.4
|
%
|
|
|
41.7
|
%
|
Equity joint ventures
|
|
|
49.6
|
|
|
|
43.7
|
|
|
|
46.3
|
|
License leasing arrangements
|
|
|
2.1
|
|
|
|
7.8
|
|
|
|
9.5
|
|
Management services
|
|
|
1.7
|
|
|
|
2.1
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The change in the percentage of revenue earned by license
leasing arrangements and the equity joint ventures relates to
the conversion of one of the Companys license leasing
arrangements to a joint venture on October 1, 2007.
All significant inter-company accounts and transactions have
been eliminated in consolidation. Business combinations
accounted for as purchases have been included in the
consolidated financial statements from the respective dates of
acquisition.
The following describes the Companys consolidation policy
with respect to its various ventures excluding wholly owned
subsidiaries:
Equity
Joint Ventures
The Companys joint ventures are structured as limited
liability companies in which the Company typically owns a
majority equity interest ranging from 51% to 99%. Each member of
all but one of the Companys equity joint ventures
participates in profits and losses in proportion to their equity
interests. The Company has one joint venture partner whose
participation in losses is limited. The Company consolidates
these entities as the Company absorbs a majority of the
entities expected losses, receives a majority of the
entities expected residual returns and generally has
voting control over the entity.
License
Leasing Arrangements
The Company, through wholly owned subsidiaries, leases home
health licenses necessary to operate certain of its home nursing
agencies. As with wholly owned subsidiaries, the Company owns
100% of the equity of these entities and consolidates them based
on such ownership as well as the Companys right to receive
a majority of the entities expected residual returns and
the Companys obligation to absorb a majority of the
entities expected losses.
Management
Services
The Company has various management services agreements under
which the Company manages certain operations of agencies and
facilities. The Company does not consolidate these agencies or
facilities, as the Company does not have an ownership interest
and does not have a right to receive a majority of the
agencies or facilities expected residual returns or
an obligation to absorb a majority of the agencies or
facilities expected losses.
Revenue
Recognition
The Company reports net service revenue at the estimated net
realizable amount due from Medicare, Medicaid, commercial
insurance, managed care payors, patients and others for services
rendered. All payors contribute to both the home-based services
and facility-based services.
59
The following table sets forth the percentage of net service
revenue earned by category of payor for the years ending
December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Payor:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
83.2
|
%
|
|
|
81.7
|
%
|
|
|
82.6
|
%
|
Medicaid
|
|
|
4.6
|
|
|
|
5.5
|
|
|
|
5.7
|
|
Other
|
|
|
12.2
|
|
|
|
12.8
|
|
|
|
11.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The percentage of net service revenue contributed from each
reporting segment was as follows for the years ending December
31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Home-based services
|
|
|
85.1
|
%
|
|
|
81.9
|
%
|
|
|
75.4
|
%
|
Facility-based services
|
|
|
14.9
|
|
|
|
18.1
|
|
|
|
24.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
Home-Based
Services
Home Nursing Services. The Companys home
nursing Medicare patients are classified into one of 153 home
health resource groups prior to receiving services. Based on
this home health resource group, the Company is entitled to
receive a standard prospective Medicare payment for delivering
care over a
60-day
period referred to as an episode. The Company recognizes revenue
based on the number of days elapsed during an episode of care
within the reporting period.
Final payments from Medicare may reflect one of four retroactive
adjustments to ensure the adequacy and effectiveness of the
total reimbursement: (a) an outlier payment if the
patients care was unusually costly; (b) a low
utilization adjustment if the number of visits was fewer than
five; (c) a partial payment if the patient transferred to
another provider before completing the episode; or (d) a
payment adjustment based upon the level of therapy services
required in the population base. Management estimates the impact
of these payment adjustments based on historical experience and
records this estimate during the period the services are
rendered. The Companys payment is also adjusted for
differences in local prices using the hospital wage index. In
calculating the Companys reported net service revenue from
home nursing services, the Company adjusts the prospective
Medicare payments by an estimate of the adjustments. The
adjustments are calculated using a historical average of prior
adjustments. The Company performs payment variance analyses to
verify that the models utilized in projecting total net service
revenue are accurately reflecting the payments to be received.
Hospice Services. The Company is paid by
Medicare under a per diem payment system. The Company receives
one of four predetermined daily or hourly rates based upon the
level of care the Company furnished. The Company records net
service revenue from hospice services based on the daily or
hourly rate and recognizes revenue as hospice services are
provided.
Hospice payments are also subject to two caps. One relates to
individual programs receiving more than 20% of its total
Medicare reimbursement from inpatient care services and the
second relates to individual programs receiving reimbursements
in excess of a cap amount calculated by multiplying
the number of beneficiaries during the period by a statutory
amount indexed for inflation. The determination for each cap is
made annually based on the
12-month
period ending on October 31 of each year. This limit is computed
on a
program-by-program
basis. We have not received notification that any of our
hospices have exceeded the cap on inpatient care services during
2008. None of the Companys hospices exceeded either cap
during the years ended December 31, 2007, or 2006.
60
Facility-Based
Services
Long-Term Acute Care Services. The Company is
reimbursed by Medicare for services provided under the LTACH
prospective payment system, which was implemented on
October 1, 2002. Each patient is assigned a long-term care
diagnosis-related group. The Company is paid a predetermined
fixed amount applicable to that particular group. This payment
is intended to reflect the average cost of treating a Medicare
patient classified in that particular long-term care
diagnosis-related group. For selected patients, the amount may
be further adjusted based on length of stay and
facility-specific costs, as well as in instances where a patient
is discharged and subsequently readmitted, among other factors.
Similar to other Medicare prospective payment systems, the rate
is also adjusted for geographic wage differences. The Company
calculates the adjustment based on a historical average of these
types of adjustments for claims paid. Revenue is recognized as
services are provided for the Companys LTACHs.
Outpatient Rehabilitation Services. Outpatient
therapy services are reimbursed on a fee schedule, subject to
annual limitations. Outpatient therapy providers receive a fixed
fee for each procedure performed, adjusted by the geographical
area in which the facility is located. The Company recognizes
revenue as the services are provided. There are also annual per
Medicare beneficiary caps that limit Medicare coverage for
outpatient rehabilitation services.
Medicaid,
managed care and other payors
The Companys Medicaid reimbursement is based on a
predetermined fee schedule applied to each service provided.
Therefore, revenue is recognized for Medicaid services as
services are provided based on this fee schedule. The
Companys managed care payors reimburse the Company in a
manner similar to either Medicare or Medicaid. Accordingly, the
Company recognizes revenue from managed care payors in the same
manner as the Company recognizes revenue from Medicare or
Medicaid.
Management
Services
The Company records management services revenue as services are
provided in accordance with the various management services
agreements to which the Company is a party. As described in the
agreements, the Company provides billing, management and other
consulting services suited to and designed for the efficient
operation of the applicable home nursing agency or inpatient
rehabilitation facility. The Company is responsible for the
costs associated with the locations and personnel required for
the provision of services. The Company is compensated based on a
percentage of cash collections or is reimbursed for operating
expenses and compensated based on a percentage of operating net
income.
Accounts
Receivable and Allowances for Uncollectible
Accounts
The Company reports accounts receivable net of estimated
allowances for uncollectible accounts and adjustments. Accounts
receivable are uncollateralized and primarily consist of amounts
due from third-party payors and patients. To provide for
accounts receivable that could become uncollectible in the
future, the Company establishes an allowance for uncollectible
accounts to reduce the carrying amount of such receivables to
their estimated net realizable value. The credit risk for other
concentrations of receivables is limited due to the significance
of Medicare as the primary payor. The Company does not believe
that there are any other significant concentrations of
receivables from any particular payor that would subject it to
any significant credit risk in the collection of accounts
receivable.
The amount of the provision for bad debts is based upon the
Companys assessment of historical and expected net
collections, business and economic conditions, trends in
government reimbursement and other collection indicators.
Uncollectible accounts are written off when the Company has
determined the account will not be collected.
A portion of the estimated Medicare prospective payment system
reimbursement from each submitted home nursing episode is
received in the form of a request for accelerated payment
(RAP). The Company submits a RAP for 60% of the
estimated reimbursement for the initial episode at the start of
care. The full
61
amount of the episode is billed after the episode has been
completed. The RAP received for that particular episode is
deducted from the final payment. If a final bill is not
submitted within the greater of 120 days from the start of
the episode, or 60 days from the date the RAP was paid, any
RAPs received for that episode will be recouped by Medicare from
any other Medicare claims in process for that particular
provider. The RAP and final claim must then be resubmitted. For
subsequent episodes of care contiguous with the first episode
for a particular patient, the Company submits a RAP for 50%
instead of 60% of the estimated reimbursement. The remaining 50%
reimbursement is requested upon completion of the episode. The
Company has earned net service revenue in excess of billings
rendered to Medicare.
Our Medicare population is paid at a prospectively set amount
that can be determined at the time services are rendered. Our
Medicaid reimbursement is based on a predetermined fee schedule
applied to each individual service we provide. Our managed care
contracts are structured similar to either the Medicare or
Medicaid payment methodologies. Because of our payor mix, we are
able to calculate our actual amount due at the patient level and
adjust the gross charges down to the actual amount at the time
of billing. This negates the need for an estimated contractual
allowance to be booked at the time we report net service revenue
for each reporting period.
At December 31, 2008, our allowance for uncollectible
accounts, as a percentage of patient accounts receivable, was
approximately 14.0%, or $10.0 million, compared to 11.3% at
December 31, 2007.
The following table sets forth as of December 31, 2008, the
aging of accounts receivable (based on the billing date) and the
total allowance for uncollectible accounts expressed as a
percentage of the related aged accounts receivable:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payor
|
|
0-30
|
|
|
31-60
|
|
|
61-90
|
|
|
91-120
|
|
|
121-150
|
|
|
151-180
|
|
|
181-240
|
|
|
241+
|
|
|
Total
|
|
|
|
(Amounts in thousands)
|
|
|
|
|
|
Medicare
|
|
$
|
30,704
|
|
|
$
|
7,113
|
|
|
$
|
3,955
|
|
|
$
|
2,688
|
|
|
$
|
2,207
|
|
|
$
|
1,911
|
|
|
$
|
711
|
|
|
$
|
3,272
|
|
|
$
|
52,561
|
|
Medicaid
|
|
|
1,556
|
|
|
|
837
|
|
|
|
414
|
|
|
|
301
|
|
|
|
281
|
|
|
|
499
|
|
|
|
327
|
|
|
|
1,727
|
|
|
|
5,942
|
|
Other
|
|
|
2,126
|
|
|
|
4,060
|
|
|
|
1,470
|
|
|
|
1,160
|
|
|
|
1,106
|
|
|
|
973
|
|
|
|
406
|
|
|
|
1,696
|
|
|
|
12,997
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
34,386
|
|
|
$
|
12,010
|
|
|
$
|
5,839
|
|
|
$
|
4,149
|
|
|
$
|
3,594
|
|
|
$
|
3,383
|
|
|
$
|
1,444
|
|
|
$
|
6,995
|
|
|
$
|
71,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance as a
percentage of
|
|
|
6.1%
|
|
|
|
8.0%
|
|
|
|
9.3%
|
|
|
|
10.3%
|
|
|
|
10.9%
|
|
|
|
27.6%
|
|
|
|
41.8%
|
|
|
|
59.8%
|
|
|
|
14.0%
|
|
receivables
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For home-based services, we calculate the allowance for
uncollectible accounts as a percentage of total patient
receivables. The percentage changes depending on the payor and
increases as the patient receivables age. For facility-based
services, we calculate the allowance for uncollectible accounts
based on a claim by claim review. As a result, the allowance
percentages presented in the table above vary between the aging
categories because of the mix of claims in each category.
The following table sets forth as of December 31, 2007, the
aging of accounts receivable (based on the billing date) and the
total allowance for uncollectible accounts expressed as a
percentage of the related aged accounts receivable:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payor
|
|
0-30
|
|
|
31-60
|
|
|
61-90
|
|
|
91-120
|
|
|
121-150
|
|
|
151-180
|
|
|
181-240
|
|
|
241+
|
|
|
Total
|
|
|
|
(Amounts in thousands)
|
|
|
|
|
|
Medicare
|
|
$
|
20,326
|
|
|
$
|
4,904
|
|
|
$
|
4,678
|
|
|
$
|
3,751
|
|
|
$
|
2,915
|
|
|
$
|
3,722
|
|
|
$
|
861
|
|
|
$
|
3,629
|
|
|
$
|
44,786
|
|
Medicaid
|
|
|
7,292
|
|
|
|
1,111
|
|
|
|
938
|
|
|
|
840
|
|
|
|
958
|
|
|
|
1,040
|
|
|
|
309
|
|
|
|
3,083
|
|
|
|
15,571
|
|
Other
|
|
|
3,228
|
|
|
|
2,799
|
|
|
|
2,321
|
|
|
|
1,012
|
|
|
|
1,151
|
|
|
|
1,113
|
|
|
|
1,051
|
|
|
|
5,954
|
|
|
|
18,269
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
30,846
|
|
|
$
|
8,814
|
|
|
$
|
7,937
|
|
|
$
|
5,603
|
|
|
$
|
5,024
|
|
|
$
|
5,875
|
|
|
$
|
2,221
|
|
|
|
12,666
|
|
|
$
|
78,986
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance as a percentage of receivables
|
|
|
4.6
|
%
|
|
|
5.1
|
%
|
|
|
5.4
|
%
|
|
|
4.7
|
%
|
|
|
6.2
|
%
|
|
|
11.7
|
%
|
|
|
23.9
|
%
|
|
|
38.3
|
%
|
|
|
11.3
|
%
|
62
The following table summarizes the activity and ending balances
in the allowance for uncollectible accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning
|
|
|
|
|
|
|
|
|
End of
|
|
|
|
of Year
|
|
|
Additions and
|
|
|
|
|
|
Year
|
|
|
|
Balance
|
|
|
Expenses
|
|
|
Deductions
|
|
|
Balance
|
|
|
|
(In thousands)
|
|
|
Year ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
$
|
8,953
|
|
|
$
|
12,463
|
|
|
$
|
11,440
|
|
|
$
|
9,976
|
|
2007
|
|
|
5,769
|
|
|
|
13,817
|
|
|
|
10,633
|
|
|
|
8,953
|
|
2006
|
|
|
2,544
|
|
|
|
4,778
|
|
|
|
1,553
|
|
|
|
5,769
|
|
Goodwill
and Intangible Assets
Goodwill and other intangible assets with indefinite lives are
reviewed annually for impairment or more frequently if
circumstances indicate impairment may have occurred. If the
carrying value of goodwill or an indefinite-lived intangible
asset exceeds its fair value, an impairment loss is recognized.
The evaluation of impairment involves comparing the current fair
value of each of the Companys reporting units to their
recorded value, including goodwill. Components of the
Companys home nursing operating segment are generally
represented by individual subsidiaries or joint ventures with
individual licenses to conduct specific operations within
geographic markets as limited by the terms of each license.
Components of the Companys facility-based services are
represented by individual operating entities. Management
aggregates the components of these two segments into two
reporting units for purposes of evaluating impairment.
The Company performs its annual impairment review as of
September 30th,
by estimating the fair value of its identified reporting units
using the discounted cash flow method and the market multiple
analysis method. These valuations require management to make
estimates and assumptions regarding industry economic factors
and the profitability of future business strategies. Management
considers historical experience and all available information at
the time the fair values of its reporting units are estimated.
For each of the reporting units, the estimated fair value is
determined based on a formula that considers 75% of the
estimated value based on a multiple of earnings before interest,
taxes, depreciation and amortization plus 25% of the estimated
value using recent sales of comparable facilities. A change in
the weight assigned to each methodology would not have changed
the conclusion that no impairment charge is necessary during the
year ending December 31, 2008. The Company has not
recognized goodwill impairment charges in 2008, 2007 or 2006.
Included in intangible assets, net are definite-lived assets
subject to amortization such as software licenses and
non-compete agreements. Amortization of the definite-lived
intangible assets is calculated on a straight-line basis over
the estimated useful lives of the related assets. Software
licenses are amortized over a three year period and non-compete
agreements are amortized over the life of the agreement, usually
ranging from three to five years.
The Company also has indefinite-lived assets that are not
subject to amortization expense such as trade names and
certificates of need. The Company has concluded that trade names
and certificates of need have indefinite lives, as management
has determined that there are no legal, regulatory, contractual,
economic or other factors that would limit the useful life of
these intangible assets and the Company intends to renew and
operate the licenses and use these trade names indefinitely. The
Company performs an annual impairment test on the trade names
using the relief-from royalty method. Under this method, the
fair value of the intangible asset is determined by calculating
the present value of the after-tax cost savings associated with
owning the trade names and therefore not having to pay royalties
for its use for the remainder of its estimated useful lives. The
certificates of need are tested annually for impairment using
the cost approach. Under this method, assumptions are made about
the cost to replace the certificates of need.
Adoption
of New Accounting Standards
In September 2006, the Financial Accounting Standards Board
(FASB) issued SFAS No. 157, Fair Value
Measurements (SFAS 157), which defines fair
value, establishes a framework for measuring fair value in U.S.
generally accepted accounting principles and expands disclosures
about fair value measurements.
63
SFAS 157 does not require any new fair value measurements
but rather eliminates inconsistencies in guidance found in
various prior accounting pronouncements. In February 2008, the
FASB issued FASB Staff Position
No. 157-2,
which deferred the effective date for all nonfinancial assets
and nonfinancial liabilities, except those that are recognized
or disclosed at fair value in the financial statements on a
recurring basis, until fiscal years beginning after
November 15, 2008 and interim periods within those fiscal
years. These nonfinancial items include assets and liabilities
such as reporting units measured at fair value in goodwill
impairment tests and nonfinancial assets acquired and
liabilities assumed in a business combination. The Company
adopted SFAS 157 for financial assets and liabilities
recognized at fair value on recurring bases effective
January 1, 2008. The partial adoption of SFAS 157 for
financial assets and liabilities did not have a material effect
on the Companys consolidated financial position, results
of operations or cash flows.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option for Financial Assets and Financial Liabilities
(SFAS 159). Under SFAS 159, companies
may elect to measure certain financial instruments and certain
other items at fair value. The standard requires that unrealized
gains and losses on items for which the fair value option has
been elected be reported in operations. SFAS 159 was
effective for the Company beginning in the first quarter of
2008. The Company has not elected to fair value any eligible
items throughout 2008. Therefore, the adoption of SFAS 159
did not affect the Companys consolidated financial
position, results of operations or cash flows.
Recently
Issued Accounting Pronouncements
In December 2007, the FASB issued Statement of Financial
Accounting Standards No. 141 (Revised 2007), Business
Combinations (SFAS 141R). SFAS 141R
changes the accounting treatment and disclosure for certain
specific items in a business combination. Under SFAS 141R,
an acquiring entity will be required to recognize all the assets
acquired and liabilities assumed in a transaction at the
acquisition-date fair value with limited exceptions. This
includes the fair values of the non-controlling interest
(minority interest) acquired. Under current guidance, the
non-controlling interest is recorded at the parent level at the
minority owners historical balance. This also includes
contingent payments on acquisitions. Contingent payments under
SFAS 141 are recorded when settled, however under
SFAS 141R contingent payments will be recorded at the
acquisition-date fair value. The change in the fair value of the
contingent payment and the settlement amount will be recognized
through the statement of income. Other changes include the
treatment of acquisition-related costs, which, with the
exception of debt or equity issuance costs, are to be recognized
as an expense in the period that the costs are incurred and the
services are received. Currently, these costs are included as
part of the purchase price and allocated to the assets and
liabilities acquired. Further, any adjustments during the
measurement period to the provisional amounts recognized as part
of the purchase price allocation are treated retrospectively as
of the acquisition date. SFAS 141R applies prospectively to
business combinations for which the acquisition date is on or
after the beginning of the first annual reporting period
beginning on or after December 15, 2008. Early adoption is
prohibited. The Company expects SFAS 141R will have an
effect on accounting for business combinations as well as an
effect on the Companys consolidated balance sheet. The
effect, however, is dependent upon acquisitions subsequent to
adoption.
In December 2007, the FASB issued SFAS No. 160,
Non-controlling Interests in Consolidated Financial
Statements an Amendment of ARB No. 51
(SFAS 160). SFAS 160 establishes new
accounting and reporting standards for the non-controlling
interest, currently known as minority interest. Non-controlling
ownership interest in consolidated subsidiaries will be
presented in the consolidated balance sheet within
stockholders equity as a separate component from the
parents equity. Consolidated net income will include
earnings attributable to both the parent and the non-controlling
interest. The adoption of SFAS 160 will not affect earnings
per share. Earnings per share will continue to be based on
earnings attributable only to the parent company. SFAS 160
also provides guidance on accounting for changes in the
parents ownership interest in a subsidiary, including
transactions where control is retained and where control is
relinquished. SFAS 160 requires additional disclosure
information related to amounts attributable to the parent for
income from continuing operations, discontinued operations and
extraordinary items and reconciliations of the parent and
non-controlling interests equity in subsidiaries.
SFAS 160 is effective for fiscal years beginning on or
after December 15, 2008. The Company will adopt SFAS
prospectively during the first quarter of 2009. While
64
the adoption is prospective, disclosure requirements will be
applied retrospectively for periods presented in the
Companys filings subsequent to adoption.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures about Market Risk.
|
As of December 31, 2008, we had $3.5 million in cash.
Cash in excess of requirements are deposited in highly liquid
money market instruments with maturities less than 90 days.
Because of the short maturities of these instruments, we would
not expect our operating results or cash flows to be materially
affected by the effect of a sudden change in market interest
rates on our portfolio. At times, the Companys cash in
banks exceeds the Federal Insurance Deposit Corporation
(FDIC) insurance limit. The Company has not
experienced any loss as a result of those deposits and does not
expect any in the future.
Our exposure to market risk relates to changes in interest rates
for borrowings under the New Credit Facility we entered into in
February 2008. A hypothetical 100 basis point increase in
interest rates on the average daily amounts outstanding under
the New Credit Facility would have increased interest expense
$2,000 for the year ended December 31, 2008. At
December 31, 2007, we had no amounts outstanding under our
Former Credit Facility and therefore had more limited exposure
to changes in interest rates.
|
|
Item 8.
|
Financial
Statements and Supplementary Data.
|
The consolidated financial statements and financial statement
schedules in Part IV, Item 15 of this Annual Report on
Form 10-K
are incorporated by reference into this Item 8.
|
|
Item 9.
|
Changes
In and Disagreements with Accountants on Accounting and
Financial Disclosure.
|
On August 20, 2008, the Audit Committee of the
Companys Board of Directors dismissed Ernst &
Young LLP (Ernst & Young) as our
independent registered public accounting firm. The reports of
Ernst & Young on the financial statements of the
Company for the past two fiscal years contained no adverse
opinion or disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope or accounting principles.
During our two most recent fiscal years and subsequent interim
period through August 20, 2008, there were no disagreements
with Ernst & Young on any matter of accounting
principles or practices, financial statement disclosure, or
auditing scope or procedure, which disagreements if not resolved
to the satisfaction of Ernst & Young would have caused
it to make reference to the subject matter of such disagreements
in their reports on the financial statements for such years.
In Ernst & Youngs report on our consolidated
financial statements as of and for the fiscal year ended
December 31, 2007, Ernst & Young identified a
material weakness in our internal control over financial
reporting related to our process of estimating the allowance for
uncollectible accounts. Such material weakness caused
Ernst & Young to opine that we had not maintained
effective internal control over financial reporting as of
December 31, 2007, based on criteria established in
Internal Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway
Commission. The material weakness is more fully described in
Controls and Procedures Managements
Report on Internal Control Over Financial Reporting in the
Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2007, which the
Company filed with the SEC.
As previously reported in our Quarterly Report on
Form 10-Q
for the period ended June 30, 2008, we enhanced the
controls and processes for calculating the allowance for
uncollectible accounts and had substantially completed
remediation efforts with respect to the above mentioned material
weakness as of June 30, 2008. As discussed below under
Item 9A. Controls and Procedures
Managements Report on Internal Control Over Financial
Reporting and the Report of Independent Registered Public
Accounting Firm Internal Control Over Financial
Reporting contained in this Annual Report on
Form 10-K,
management and the Companys independent registered public
accounting firm have concluded that, as of December 31,
2008, the material weakness was remediated during 2008, and the
Company maintained effective internal controls over financial
reporting as of December 31, 2008.
65
|
|
Item 9A.
|
Controls
and Procedures.
|
Evaluation
of Disclosure Control and Procedures
Under the supervision and with the participation of the
Companys Chief Executive Officer and Chief Financial
Officer, management evaluated the effectiveness of the
Companys disclosure controls and procedures (as such term
is defined under
Rule 13a-15(e)
promulgated under the Securities Exchange Act of 1934, as
amended) as of December 31, 2008. Based on that evaluation,
the Companys Chief Executive Officer and its Chief
Financial Officer concluded that the Companys disclosure
controls and procedures are effective in ensuring that
information required to be disclosed by the Company in the
reports that it files or submits under the Securities Exchange
Act is recorded, processed, summarized and reported within the
time periods specified in the SECs rules and forms and
that such information is accumulated and communicated to the
Companys management, including its principal executive and
principal financial officers, as appropriate to allow timely
decisions regarding required disclosure.
Managements
Report on Internal Control Over Financial Reporting
The Companys management is responsible for establishing
and maintaining adequate internal control over financial
reporting, as that term is defined in Exchange Act
Rule 13a-15(f).
Under the supervision and with the participation of the
Companys Chief Executive Officer and Chief Financial
Officer, management conducted an evaluation of the
Companys internal control over financial reporting based
on the framework in Internal Control Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Because of its
inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to
the risk that controls may become inadequate because of changes
in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.
Based on managements testing and evaluation under the
framework in Internal Control-Integrated Framework,
management concluded that the Companys internal control
over financial reporting, as defined in Exchange Act Rule
13a-15(f),
was effective as of December 31, 2008.
The attestation report of KPMG, the Companys independent
registered public accounting firm, appears below.
Changes
in Internal Control Over Financial Reporting
There have not been any changes in the Companys internal
control over financial reporting, as such term is defined in
Rule 13a-15(f)
under the Exchange Act, during the Companys fiscal year
ended December 31, 2008 that have materially affected, or
are reasonably likely to materially affect, the Companys
internal control over financial reporting.
66
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
THE BOARD OF DIRECTORS AND STOCKHOLDERS
LHC GROUP INC.
We have audited LHC Group Inc.s internal control over
financial reporting as of December 31, 2008, based on
criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO). LHC Group
Inc.s (the Company) management is responsible for
maintaining effective internal control over financial reporting
and for its assessment of the effectiveness of internal control
over financial reporting, included in the accompanying
Managements Report on Internal Control over Financial
Reporting. Our responsibility is to express an opinion on the
Companys internal control over financial reporting based
on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, and testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk. Our audit also included performing such other
procedures as we considered necessary in the circumstances. We
believe that our audit provides a reasonable basis for our
opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
U.S. generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with U.S. generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, LHC Group Inc. maintained, in all material
respects, effective internal control over financial reporting as
of December 31, 2008, based on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheet of LHC Group, Inc. and subsidiaries
as of December 31, 2008, and the related consolidated statements
of income, changes in stockholders equity, and cash flows
for the year then ended, and our report dated March 16,
2009, expressed an unqualified opinion on those consolidated
financial statements.
Baton Rouge, Louisiana
March 16, 2009
67
|
|
Item 9B.
|
Other
Information.
|
None.
PART III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance.
|
The information required by this Item with respect to directors
and executive officers is incorporated by reference from the
information contained in our definitive Proxy Statement relating
to the Companys 2009 Annual Meeting of Stockholders.
The information required by this Item regarding compliance with
Section 16(a) of he Exchange Act is incorporated by
reference from the section entitled Directors and
Executive Officers in the definitive Proxy Statement
relating to the Companys 2009 Annual Meeting of
Stockholders.
The information required by this Item with respect to corporate
governance is incorporated by reference from the information
contained under the heading The Board of Directors and
Corporate Governance in the definitive Proxy Statement for
the Companys 2009 Annual Meeting of Stockholders.
Code of
Conduct and Ethics
We have adopted a code of ethics that applies to all of our
directors, officers and employees. This code is publicly
available in the investor relations area of our website at
www.lhcgroup.com. This code of ethics is not incorporated in
this report by reference. Copies of our code of ethics may also
be requested in print by writing to Investor Relations at LHC
Group, Inc., 420 West Pinhook Road, Suite A,
Lafayette, Louisiana, 70503.
|
|
Item 11.
|
Executive
Compensation.
|
The information required by this Item is incorporated by
reference from the section entitled Executive
Compensation in the definitive Proxy Statement relating to
the Companys 2009 Annual Meeting of Stockholders.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters.
|
With the exception of the equity plan information table set
forth below, the information required by this Item is
incorporated by reference to the sections entitled
Security Ownership of Certain Beneficial Owners and
Management in the definitive Proxy Statement relating to
the Companys 2008 Annual Meeting of Stockholders.
Equity
Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|
|
Number of Shares to
|
|
|
|
|
|
Remaining Available
|
|
|
|
be Issued Upon
|
|
|
Weighted-Average
|
|
|
for Future Issuance
|
|
|
|
Exercise of
|
|
|
Exercise Price of
|
|
|
Under Equity
|
|
|
|
Outstanding
|
|
|
Outstanding Price
|
|
|
Compensation Plans
|
|
|
|
Options, Warrants,
|
|
|
of Outstanding
|
|
|
(Excluding Securities
|
|
Plan Category
|
|
and Rights
|
|
|
Rights
|
|
|
Reflected in Column(a))
|
|
|
Equity compensation plans approved by Stockholders:
|
|
|
19,000
|
|
|
$
|
17.20
|
|
|
|
767,627
|
(1)
|
Equity compensation plans not approved by Stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
19,000
|
|
|
$
|
17.20
|
|
|
|
767,627
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
68
|
|
|
(1) |
|
564,604 of these shares are reserved under the LHC Group, Inc.
2005 Long-Term Incentive Plan and are available for issuance
pursuant to the exercise or grant of stock options, stock
appreciation rights, restricted stock, restricted stock units,
performance shares or unrestricted stock. 203,023 of these
shares are reserved and available for issuance under the 2006
LHC Group, Inc. Employee Stock Purchase Plan. |
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence.
|
The information required by this Item is incorporated by
reference from the section entitled Certain Relationships
and Related Transactions in the definitive Proxy Statement
relating to the Companys 2009 Annual Meeting of
Stockholders.
|
|
Item 14.
|
Principal
Accounting Fees and Services.
|
The information required by this Item is incorporated by
reference from the section entitled Principal Accounting
Fees and Services in the definitive Proxy Statement
relating to the Companys 2009 Annual Meeting of
Stockholders.
69
PART IV
|
|
Item 15.
|
Exhibits,
Financial Statement Schedules.
|
(a) Documents to be filed with
Form 10-K:
(1) Financial Statements
|
|
|
|
|
|
|
|
F-1
|
|
|
|
|
F-3
|
|
For each of the three years in the period ended December 31,
2008, 2007 and 2006
|
|
|
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
|
|
|
F-7
|
|
(2) Financial Statement Schedules
There are no financial statement schedules included in this
report.
(3) Exhibits
The Exhibits are listed in the Index of Exhibits Required
by Item 601 of
Regulation S-K
included herewith, which is incorporated by reference.
70
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
LHC Group, Inc.:
We have audited the accompanying consolidated balance sheet of
LHC Group, Inc. and subsidiaries (the Company) as of
December 31, 2008, and the related consolidated statements
of income, changes in stockholders equity, and cash flows
for the year then ended. These consolidated financial statements
are the responsibility of the Companys management. Our
responsibility is to express an opinion on these consolidated
financial statements based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audit provides a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial
position of LHC Group, Inc. and subsidiaries as of
December 31, 2008, and the results of their operations and
their cash flows for the year ended December 31, 2008, in
conformity with U.S. generally accepted accounting
principles.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), LHC
Group, Inc.s internal control over financial reporting as
of December 31, 2008, based on criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO), and our report March 16, 2009 expressed
an unqualified opinion on the effectiveness of the LHC Group,
Inc.s internal control over financial reporting.
Baton Rouge, Louisiana
March 16, 2009
F-1
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders of LHC Group, Inc.
We have audited the accompanying consolidated balance sheet of
LHC Group Inc. and subsidiaries as of December 31, 2007,
and the related consolidated statements of income,
shareholders equity, and cash flows for each of the two
years in the period ended December 31, 2007. These
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the consolidated
financial position of LHC Group, Inc. and subsidiaries at
December 31, 2007, and the consolidated results of their
operations and their cash flows for each of the two years in the
period ended December 31, 2007, in conformity with
U.S. generally accepted accounting principles.
As discussed in Note 2 to the consolidated financial
statements, effective January 1, 2007 the Company adopted
FASB Interpretation No. 48, Accounting for Uncertainty
in Income Taxes an Interpretation of FASB Statement
No. 109, and effective January 1, 2006 the Company
adopted Statement of Financial Accounting Standards No. 123
(revised 2004), Share-Based Payment.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), LHC
Group, Inc. and subsidiaries internal control over
financial reporting as of December 31, 2007, based on
criteria established in Internal Control-Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission and our report dated
March 14, 2008 expressed an adverse opinion thereon.
/s/ Ernst & Young
New Orleans, Louisiana
March 14, 2008
F-2
LHC
GROUP, INC. AND SUBSIDIARIES
(Amounts
in thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
3,511
|
|
|
$
|
1,155
|
|
Receivables:
|
|
|
|
|
|
|
|
|
Patient accounts receivable, less allowance for uncollectible
accounts of $9,976 and $8,953, respectively
|
|
|
61,524
|
|
|
|
70,033
|
|
Other receivables
|
|
|
2,317
|
|
|
|
1,748
|
|
Amounts due from governmental entities
|
|
|
2,434
|
|
|
|
1,459
|
|
|
|
|
|
|
|
|
|
|
Total receivables, net
|
|
|
66,275
|
|
|
|
73,240
|
|
Deferred income taxes
|
|
|
4,959
|
|
|
|
2,946
|
|
Prepaid expenses and other current assets
|
|
|
6,464
|
|
|
|
5,656
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
81,209
|
|
|
|
82,997
|
|
Property, building and equipment, net
|
|
|
16,348
|
|
|
|
12,523
|
|
Goodwill
|
|
|
112,572
|
|
|
|
62,227
|
|
Intangible assets, net
|
|
|
29,975
|
|
|
|
14,055
|
|
Other assets
|
|
|
3,296
|
|
|
|
3,183
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
243,400
|
|
|
$
|
174,985
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable and other accrued liabilities
|
|
$
|
15,422
|
|
|
$
|
6,103
|
|
Salaries, wages and benefits payable
|
|
|
16,400
|
|
|
|
11,303
|
|
Amounts due to governmental entities
|
|
|
6,023
|
|
|
|
3,162
|
|
Income taxes payable
|
|
|
10,682
|
|
|
|
863
|
|
Current portion of capital lease obligations
|
|
|
75
|
|
|
|
88
|
|
Current portion of long-term debt
|
|
|
508
|
|
|
|
433
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
49,110
|
|
|
|
21,952
|
|
Deferred income taxes
|
|
|
5,718
|
|
|
|
3,243
|
|
Capital lease obligations, less current portion
|
|
|
50
|
|
|
|
63
|
|
Long-term debt, less current portion
|
|
|
4,483
|
|
|
|
2,847
|
|
Minority interests subject to exchange contracts and/or put
options
|
|
|
95
|
|
|
|
121
|
|
Other minority interests
|
|
|
7,123
|
|
|
|
3,388
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock $0.01 par value:
40,000,000 shares authorized; 20,853,463 and
20,725,713 shares issued and 17,895,832 and
17,775,284 shares outstanding, respectively
|
|
|
179
|
|
|
|
177
|
|
Treasury stock 2,957,631 and 2,950,429 shares
at cost, respectively
|
|
|
(3,072
|
)
|
|
|
(2,866
|
)
|
Additional paid-in capital
|
|
|
85,404
|
|
|
|
81,983
|
|
Retained earnings
|
|
|
94,310
|
|
|
|
64,077
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
176,821
|
|
|
|
143,371
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
243,400
|
|
|
$
|
174,985
|
|
|
|
|
|
|
|
|
|
|
See accompanying Notes to the Consolidated Financial Statements
F-3
LHC
GROUP, INC. AND SUBSIDIARIES
(Amounts
in thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Net service revenue
|
|
$
|
383,296
|
|
|
$
|
298,031
|
|
|
$
|
218,535
|
|
Cost of service revenue
|
|
|
186,849
|
|
|
|
150,759
|
|
|
|
110,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
196,447
|
|
|
|
147,272
|
|
|
|
107,741
|
|
Provision for bad debts
|
|
|
11,771
|
|
|
|
12,248
|
|
|
|
4,105
|
|
General and administrative expenses
|
|
|
124,390
|
|
|
|
96,365
|
|
|
|
68,311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
60,286
|
|
|
|
38,659
|
|
|
|
35,325
|
|
Interest expense
|
|
|
(469
|
)
|
|
|
(376
|
)
|
|
|
(325
|
)
|
Gain (loss) on the sale of assets and entities
|
|
|
967
|
|
|
|
(108
|
)
|
|
|
(20
|
)
|
Non-operating income
|
|
|
473
|
|
|
|
1,181
|
|
|
|
2,053
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
minority interest
|
|
|
61,257
|
|
|
|
39,356
|
|
|
|
37,033
|
|
Income tax expense
|
|
|
18,728
|
|
|
|
12,147
|
|
|
|
10,817
|
|
Minority interest
|
|
|
11,799
|
|
|
|
5,984
|
|
|
|
4,795
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
30,730
|
|
|
|
21,225
|
|
|
|
21,421
|
|
Loss from discontinued operations (net of income tax benefit of
$110, $239 and $897, respectively)
|
|
|
(528
|
)
|
|
|
(1,667
|
)
|
|
|
(1,464
|
)
|
Gain on sale of discontinued operations (net of income taxes of
$20 and $390, respectively)
|
|
|
|
|
|
|
31
|
|
|
|
637
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
30,202
|
|
|
|
19,589
|
|
|
|
20,594
|
|
Change in the redemption value of redeemable minority interests
|
|
|
31
|
|
|
|
193
|
|
|
|
1,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common stockholders
|
|
$
|
30,233
|
|
|
$
|
19,782
|
|
|
$
|
21,757
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share basic and diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
1.72
|
|
|
|
1.19
|
|
|
|
1.25
|
|
Loss from discontinued operations, net
|
|
|
(0.03
|
)
|
|
|
(0.09
|
)
|
|
|
(0.09
|
)
|
Gain on sale of discontinued operations, net
|
|
|
|
|
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1.69
|
|
|
|
1.10
|
|
|
|
1.20
|
|
Change in the redemption value of redeemable minority interests
|
|
|
|
|
|
|
0.01
|
|
|
|
0.07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
1.69
|
|
|
$
|
1.11
|
|
|
$
|
1.27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
17,855,634
|
|
|
|
17,760,432
|
|
|
|
17,090,583
|
|
Diluted
|
|
|
17,899,087
|
|
|
|
17,827,444
|
|
|
|
17,104,660
|
|
See accompanying Notes to the Consolidated Financial Statements
F-4
LHC
GROUP, INC. AND SUBSIDIARIES
(Amounts
in thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
Issued
|
|
|
Treasury
|
|
|
Paid-In
|
|
|
Retained
|
|
|
|
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Capital
|
|
|
Earnings
|
|
|
Total
|
|
|
Balances at December 31, 2005
|
|
$
|
166
|
|
|
|
19,507,887
|
|
|
$
|
(2,856
|
)
|
|
|
2,950,059
|
|
|
$
|
58,596
|
|
|
$
|
22,538
|
|
|
$
|
78,444
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,594
|
|
|
|
20,594
|
|
Sale of 1,150,000 shares of common stock at $19.25 per
share, net of underwriting discount and offering costs of $1,403
|
|
|
11
|
|
|
|
1,150,000
|
|
|
|
|
|
|
|
|
|
|
|
20,711
|
|
|
|
|
|
|
|
20,722
|
|
Stock option compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
128
|
|
|
|
|
|
|
|
128
|
|
Exercise of stock options
|
|
|
|
|
|
|
8,000
|
|
|
|
|
|
|
|
|
|
|
|
165
|
|
|
|
|
|
|
|
165
|
|
Nonvested stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
484
|
|
|
|
|
|
|
|
484
|
|
Issuance of 1,167 shares of vested stock
|
|
|
|
|
|
|
1,167
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
23
|
|
Issuance of vested stock
|
|
|
|
|
|
|
8,167
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
|
|
|
|
7,096
|
|
|
|
|
|
|
|
|
|
|
|
166
|
|
|
|
|
|
|
|
166
|
|
Change in redemption value of redeemable minority interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,163
|
|
|
|
1,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2006
|
|
|
177
|
|
|
|
20,682,317
|
|
|
|
(2,856
|
)
|
|
|
2,950,059
|
|
|
|
80,273
|
|
|
|
44,295
|
|
|
|
121,889
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,589
|
|
|
|
19,589
|
|
Exercise of stock options
|
|
|
|
|
|
|
527
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,125
|
|
|
|
|
|
|
|
1,125
|
|
Issuance of vested stock
|
|
|
|
|
|
|
25,976
|
|
|
|
|
|
|
|
|
|
|
|
62
|
|
|
|
|
|
|
|
62
|
|
Treasury shares redeemed to pay income tax
|
|
|
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
370
|
|
|
|
|
|
|
|
|
|
|
|
(10
|
)
|
Excess tax benefit vesting of nonvested stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
104
|
|
|
|
|
|
|
|
104
|
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
|
|
|
|
16,893
|
|
|
|
|
|
|
|
|
|
|
|
419
|
|
|
|
|
|
|
|
419
|
|
Change in redemption value of redeemable minority interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193
|
|
|
|
193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2007
|
|
|
177
|
|
|
|
20,725,713
|
|
|
|
(2,866
|
)
|
|
|
2,950,429
|
|
|
|
81,983
|
|
|
|
64,077
|
|
|
|
143,371
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,202
|
|
|
|
30,202
|
|
Issuance of common stock to joint venture partners in exchange
for a portion of their minority ownership
|
|
|
1
|
|
|
|
51,736
|
|
|
|
|
|
|
|
|
|
|
|
1,033
|
|
|
|
|
|
|
|
1,034
|
|
Nonvested stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,935
|
|
|
|
|
|
|
|
1,935
|
|
Issuance of vested stock
|
|
|
|
|
|
|
53,026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasury shares redeemed to pay income tax
|
|
|
|
|
|
|
|
|
|
|
(206
|
)
|
|
|
7,202
|
|
|
|
|
|
|
|
|
|
|
|
(206
|
)
|
Tax short-fall vesting of nonvested stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(39
|
)
|
|
|
|
|
|
|
(39
|
)
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
1
|
|
|
|
22,988
|
|
|
|
|
|
|
|
|
|
|
|
492
|
|
|
|
|
|
|
|
493
|
|
Change in redemption value of redeemable minority interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31
|
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2008
|
|
$
|
179
|
|
|
|
20,853,463
|
|
|
$
|
(3,072
|
)
|
|
|
2,957,631
|
|
|
$
|
85,404
|
|
|
$
|
94,310
|
|
|
$
|
176,821
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying Notes to the Consolidated Financial Statements
F-5
LHC
GROUP, INC. AND SUBSIDIARIES
(Amounts
in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
30,202
|
|
|
$
|
19,589
|
|
|
$
|
20,594
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
3,740
|
|
|
|
3,026
|
|
|
|
2,427
|
|
Provision for bad debts
|
|
|
12,463
|
|
|
|
13,817
|
|
|
|
4,778
|
|
Stock based compensation expense
|
|
|
1,935
|
|
|
|
1,187
|
|
|
|
635
|
|
Minority interest in earnings of subsidiaries
|
|
|
11,676
|
|
|
|
5,312
|
|
|
|
4,471
|
|
Deferred income taxes
|
|
|
462
|
|
|
|
129
|
|
|
|
(1,253
|
)
|
Gain on sale of assets and partial sale of entity
|
|
|
(967
|
)
|
|
|
|
|
|
|
(979
|
)
|
Changes in operating assets and liabilities, net of acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(597
|
)
|
|
|
(31,109
|
)
|
|
|
(15,625
|
)
|
Prepaid expenses, other assets
|
|
|
4,155
|
|
|
|
(1,446
|
)
|
|
|
(1,466
|
)
|
Accounts payable and accrued expenses
|
|
|
20,549
|
|
|
|
1,570
|
|
|
|
6,036
|
|
Net amounts due from/to governmental entities
|
|
|
1,886
|
|
|
|
(61
|
)
|
|
|
2,144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
85,504
|
|
|
|
12,014
|
|
|
|
21,762
|
|
Investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, building and equipment
|
|
|
(8,550
|
)
|
|
|
(3,346
|
)
|
|
|
(3,938
|
)
|
Proceeds from sale of property and equipment
|
|
|
3,094
|
|
|
|
|
|
|
|
7
|
|
Purchase of certificate of deposit
|
|
|
(522
|
)
|
|
|
|
|
|
|
|
|
Proceeds from sale of entities
|
|
|
|
|
|
|
|
|
|
|
1,440
|
|
Acquisitions, net of cash acquired
|
|
|
(69,898
|
)
|
|
|
(28,935
|
)
|
|
|
(25,009
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(75,876
|
)
|
|
|
(32,281
|
)
|
|
|
(27,500
|
)
|
Financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from line of credit
|
|
|
32,850
|
|
|
|
|
|
|
|
|
|
Payments on line of credit
|
|
|
(32,850
|
)
|
|
|
|
|
|
|
|
|
Proceeds from debt issuance
|
|
|
5,050
|
|
|
|
|
|
|
|
|
|
Principal payments on debt
|
|
|
(3,339
|
)
|
|
|
(199
|
)
|
|
|
(1,201
|
)
|
Payment of deferred financing fees
|
|
|
(75
|
)
|
|
|
|
|
|
|
|
|
Payments on capital leases
|
|
|
(101
|
)
|
|
|
(207
|
)
|
|
|
(389
|
)
|
Excess tax benefits from vesting of restricted stock
|
|
|
91
|
|
|
|
104
|
|
|
|
|
|
Offering costs incurred
|
|
|
|
|
|
|
|
|
|
|
(311
|
)
|
Proceeds from exercise of stock options
|
|
|
|
|
|
|
|
|
|
|
135
|
|
Proceeds from issuance of common stock under ESPP
|
|
|
493
|
|
|
|
419
|
|
|
|
140
|
|
Minority interest distributions, net of contributions
|
|
|
(9,391
|
)
|
|
|
(5,572
|
)
|
|
|
(4,190
|
)
|
Issuance of common stock, net of underwriting discounts of $1,104
|
|
|
|
|
|
|
|
|
|
|
21,033
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
(7,272
|
)
|
|
|
(5,455
|
)
|
|
|
15,217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash
|
|
|
2,356
|
|
|
|
(25,722
|
)
|
|
|
9,479
|
|
Cash at beginning of period
|
|
|
1,155
|
|
|
|
26,877
|
|
|
|
17,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash at end of period
|
|
$
|
3,511
|
|
|
$
|
1,155
|
|
|
$
|
26,877
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
456
|
|
|
$
|
376
|
|
|
$
|
342
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
$
|
8,937
|
|
|
$
|
12,052
|
|
|
$
|
9,370
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental
disclosure of non-cash transactions:
During the year ended December 31, 2008, the Company issued
common stock valued at $1.0 million to several joint
venture partners upon the acquisition of a portion of their
minority interest. Also, in October 2008, the Company sold a
minority ownership interest in two of its entities as
consideration to purchase a majority ownership in an entity. The
Company recognized a gain of $624,000 on the partial acquisition.
During the year ended December 31, 2006, the Company sold a
clinic for promissory notes totaling $946,000 and recognized a
loss on the sale of $28,000.
See accompanying Notes to the Consolidated Financial Statements
F-6
LHC
GROUP, INC. AND SUBSIDIARIES
LHC Group, Inc. (Company) is a health care provider specializing
in the post-acute continuum of care primarily for Medicare
beneficiaries. The Company provides home-based services,
primarily through home nursing agencies and hospices and
facility-based services, primarily through long-term acute care
hospitals and outpatient rehabilitation clinics. The Company,
through its wholly and majority-owned subsidiaries, equity joint
ventures and controlled affiliates, currently operates in
Louisiana, Mississippi, Arkansas, Alabama, Texas, Kentucky,
Florida, Tennessee, Georgia, Virginia, West Virginia, Ohio,
Missouri, Maryland, Washington, Oklahoma and North Carolina.
|
|
2.
|
Summary
of Significant Accounting Policies
|
Use of
Estimates
The preparation of financial statements in conformity with
U.S. generally accepted accounting principles (US
GAAP) requires management to make estimates and
assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported revenue
and expenses during the reported period. Actual results could
differ from those estimates.
Reclassifications
Certain reclassifications have been made to the 2007 and 2006
financial information to conform to the 2008 presentation. These
reclassifications include $677,000 to other current assets from
other receivables related to estimated amounts that will be
billed to Medicare on the 2009 cost reports. The Company also
reclassified $1.8 million and $1.3 million from cost
of service revenue to general and administrative expense related
to payroll taxes for home office employees and local
administrative employees at the agencies for the years ending
December 31, 2007 and 2006, respectively. Excess tax
benefits from the vesting of restricted stock is included in the
financing activities in the Consolidated Statement of Cash Flows
for all periods presented. Previously it had been reported in
operating activities on the Consolidated Statement of Cash Flows
for the years ending December 31, 2007 and 2006.
Principles
of Consolidation
The consolidated financial statements include all subsidiaries
and entities controlled by the Company. Control is defined by
the Company as ownership of a majority of the voting interest of
an entity. The consolidated financial statements include
entities in which the Company absorbs a majority of the
entities expected losses, receives a majority of the
entities expected residual returns, or both, as a result
of ownership, contractual or other financial interests in the
entities.
The following table summarizes the percentage of net service
revenue earned by type of ownership or relationship the Company
had with the operating entity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Wholly owned subsidiaries
|
|
|
46.6
|
%
|
|
|
46.4
|
%
|
|
|
41.7
|
%
|
Equity joint ventures
|
|
|
49.6
|
|
|
|
43.7
|
|
|
|
46.3
|
|
License leasing arrangements
|
|
|
2.1
|
|
|
|
7.8
|
|
|
|
9.5
|
|
Management services
|
|
|
1.7
|
|
|
|
2.1
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-7
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The changes in the percentages of revenue earned by license
leasing arrangements and by the equity joint ventures relate to
the conversion of one of the Companys license leasing
arrangements to a joint venture on October 1, 2007.
All significant inter-company accounts and transactions have
been eliminated in consolidation. Business combinations
accounted for as purchases have been included in the
consolidated financial statements from the respective dates of
acquisition.
The following describes the Companys consolidation policy
with respect to its various ventures excluding wholly owned
subsidiaries:
Equity
Joint Ventures
The Companys joint ventures are structured as limited
liability companies in which the Company typically owns a
majority equity interest ranging from 51% to 99%. The members of
the Companys equity joint ventures participate in profits
and losses in proportion to their equity interests. The Company
consolidates these entities as the Company absorbs a majority of
the entities expected losses, receives a majority of the
entities expected residual returns and generally has
voting control over the entity.
License
Leasing Arrangements
The Company, through wholly owned subsidiaries, leases home
health licenses necessary to operate certain of its home nursing
agencies. As with wholly owned subsidiaries, the Company owns
100% of the equity of these entities and consolidates them based
on such ownership as well as the Companys right to receive
a majority of the entities expected residual returns and
the Companys obligation to absorb a majority of the
entities expected losses.
Management
Services
The Company has various management services agreements under
which the Company manages certain operations of agencies and
facilities for a fee. The Company does not consolidate these
agencies or facilities, as the Company does not have an
ownership interest and does not have a right to receive a
majority of the agencies or facilities expected
residual returns or an obligation to absorb a majority of the
agencies or facilities expected losses.
Revenue
Recognition
The Company reports net service revenue at the estimated net
realizable amount due from Medicare, Medicaid, commercial
insurance, managed care payors, patients and others for services
rendered. All payors contribute to both the home-based services
and facility-based services.
The following table sets forth the percentage of net service
revenue earned by category of payor for the years ending
December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Payor:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
83.2
|
%
|
|
|
81.7
|
%
|
|
|
82.6
|
%
|
Medicaid
|
|
|
4.6
|
|
|
|
5.5
|
|
|
|
5.7
|
|
Other
|
|
|
12.2
|
|
|
|
12.8
|
|
|
|
11.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-8
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The percentage of net service revenue contributed from each
reporting segment was as follows for the years ending December
31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Home-based services
|
|
|
85.1
|
%
|
|
|
81.9
|
%
|
|
|
75.4
|
%
|
Facility-based services
|
|
|
14.9
|
|
|
|
18.1
|
|
|
|
24.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
Home-Based
Services
Home Nursing Services. The Companys home
nursing Medicare patients are classified into one of 153 home
health resource groups prior to receiving services. Based on
this home health resource group, the Company is entitled to
receive a standard prospective Medicare payment for delivering
care over a
60-day
period referred to as an episode. The Company recognizes revenue
based on the number of days elapsed during an episode of care
within the reporting period.
Final payments from Medicare may reflect one of four retroactive
adjustments to ensure the adequacy and effectiveness of the
total reimbursement: (a) an outlier payment if the
patients care was unusually costly; (b) a low
utilization adjustment if the number of visits was fewer than
five; (c) a partial payment if the patient transferred to
another provider before completing the episode; or (d) a
payment adjustment based upon the level of therapy services
required in the population base. Management estimates the impact
of these payment adjustments based on historical experience and
records this estimate during the period the services are
rendered. The Companys payment is also adjusted for
differences in local prices using the hospital wage index. In
calculating the Companys reported net service revenue from
home nursing services, the Company adjusts the prospective
Medicare payments by an estimate of the adjustments. The
adjustments are calculated using a historical average of prior
adjustments. The Company performs payment variance analyses to
verify that the models utilized in projecting total net service
revenue are accurately reflecting the payments to be received.
Hospice Services. The Company is paid by
Medicare under a per diem payment system. The Company receives
one of four predetermined daily or hourly rates based upon the
level of care the Company furnished. The Company records net
service revenue from hospice services based on the daily or
hourly rate and recognizes revenue as hospice services are
provided.
Hospice payments are also subject to two caps. One relates to
individual programs receiving more than 20% of its total
Medicare reimbursement from inpatient care services and the
second relates to individual programs receiving reimbursements
in excess of a cap amount, calculated by multiplying
the number of beneficiaries during the period by a statutory
amount that is indexed for inflation. The determination for each
cap is made annually based on the
12-month
period ending on October 31 of each year. This limit is computed
on a
program-by-program
basis. We have not received notification that any of our
hospices have exceeded the cap on inpatient care services during
2008. None of the Companys hospices exceeded either cap
during the years ended December 31, 2007, or 2006.
Facility-Based
Services
Long-Term Acute Care Services
(LTACHs). The Company is reimbursed
by Medicare for services provided under LTACH prospective
payment system, which was implemented on October 1, 2002.
Each patient is assigned a long-term care diagnosis-related
group. The Company is paid a predetermined fixed amount
applicable to that particular group. This payment is intended to
reflect the average cost of treating a Medicare patient
classified in that particular long-term care diagnosis-related
group. For selected patients, the
F-9
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
amount may be further adjusted based on length of stay and
facility-specific costs, as well as in instances where a patient
is discharged and subsequently readmitted, among other factors.
Similar to other Medicare prospective payment systems, the rate
is also adjusted for geographic wage differences. The Company
calculates the adjustment based on a historical average of these
types of adjustments for claims paid. Revenue is recognized as
services are provided for the Companys LTACHs.
Outpatient Rehabilitation Services. Outpatient
therapy services are reimbursed on a fee schedule, subject to
annual limitations. Outpatient therapy providers receive a fixed
fee for each procedure performed, adjusted by the geographical
area in which the facility is located. The Company recognizes
revenue as the services are provided. There are also annual per
Medicare beneficiary caps that limit Medicare coverage for
outpatient rehabilitation services.
Medicaid,
managed care and other payors
The Companys Medicaid reimbursement is based on a
predetermined fee schedule applied to each service provided.
Therefore, revenue is recognized for Medicaid services as
services are provided based on this fee schedule. The
Companys managed care payors reimburse the Company in a
manner similar to either Medicare or Medicaid. Accordingly, the
Company recognizes revenue from managed care payors in the same
manner as the Company recognizes revenue from Medicare or
Medicaid.
Management
Services
The Company records management services revenue as services are
provided in accordance with the various management services
agreements to which the Company is a party. As described in the
agreements, the Company provides billing, management and other
consulting services suited to and designed for the efficient
operation of the applicable home nursing agency or inpatient
rehabilitation facility. The Company is responsible for the
costs associated with the locations and personnel required for
the provision of services. The Company is compensated based on a
percentage of cash collections or is reimbursed for operating
expenses and compensated based on a percentage of operating net
income.
Accounts
Receivable and Allowances for Uncollectible
Accounts
The Company reports accounts receivable net of estimated
allowances for uncollectible accounts and adjustments. Accounts
receivable are uncollateralized and primarily consist of amounts
due from third-party payors and patients. To provide for
accounts receivable that could become uncollectible in the
future, the Company establishes an allowance for uncollectible
accounts to reduce the carrying amount of such receivables to
their estimated net realizable value. The credit risk for other
concentrations of receivables is limited due to the significance
of Medicare as the primary payor. The Company does not believe
that there are any other significant concentrations of
receivables from any particular payor that would subject it to
any significant credit risk in the collection of accounts
receivable.
The amount of the provision for bad debts is based upon the
Companys assessment of historical and expected net
collections, business and economic conditions and trends in
government reimbursement. Uncollectible accounts are written off
when the Company has determined the account will not be
collected.
A portion of the estimated Medicare prospective payment system
reimbursement from each submitted home nursing episode is
received in the form of a request for accelerated payment
(RAP). The Company submits a RAP for 60% of the
estimated reimbursement for the initial episode at the start of
care. The full amount of the episode is billed after the episode
has been completed. The RAP received for that particular episode
is deducted from the final payment. If a final bill is not
submitted within the greater of 120 days from the start of
the episode, or 60 days from the date the RAP was paid, any
RAPs received for that episode will be recouped by Medicare from
any other Medicare claims in process for that particular
provider. The RAP and
F-10
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
final claim must then be resubmitted. For subsequent episodes of
care contiguous with the first episode for a particular patient,
the Company submits a RAP for 50% instead of 60% of the
estimated reimbursement. The remaining 50% reimbursement is
requested upon completion of the episode. The Company has earned
net service revenue in excess of billings rendered to Medicare.
Our Medicare population is paid at a prospectively set amount
that can be determined at the time services are rendered. Our
Medicaid reimbursement is based on a predetermined fee schedule
applied to each individual service we provide. Our managed care
contracts are structured similar to either the Medicare or
Medicaid payment methodologies. Because of our payor mix, we are
able to calculate our actual amount due at the patient level and
adjust the gross charges down to the actual amount at the time
of billing. This negates the need for an estimated contractual
allowance to be booked at the time we report net service revenue
for each reporting period.
Goodwill
and Intangible Assets
Goodwill and other intangible assets with indefinite lives are
reviewed annually for impairment or more frequently if
circumstances indicate impairment may have occurred. An
impairment loss is recognized if the carrying value of goodwill
or an indefinite-lived intangible asset exceeds its fair value.
The evaluation of impairment involves comparing the current fair
value of each of the Companys reporting units to their
recorded value, including goodwill. Components of the
Companys home nursing operating segment are generally
represented by individual subsidiaries or joint ventures with
individual licenses to conduct specific operations within
geographic markets as limited by the terms of each license.
Components of the Companys facility-based services are
represented by individual operating entities. Management
aggregates the components of these two segments into two
reporting units for purposes of evaluating impairment.
The Company performs its annual impairment review as of
September 30th,
by estimating the fair value of its identified reporting units
using the discounted cash flow method and the market multiple
analysis method. These valuations require management to make
estimates and assumptions regarding industry economic factors
and the profitability of future business strategies. Management
considers historical experience and all available information at
the time the fair values of its reporting units are estimated.
For each of the reporting units, the estimated fair value is
determined based on a formula that considers 75% of the
estimated value based on a multiple of earnings before interest,
taxes, depreciation and amortization plus 25% of the estimated
value using recent sales of comparable facilities. A change in
the weight assigned to each methodology would not have changed
the conclusion that no impairment charge is necessary during the
year ending December 31, 2008. The Company has not
recognized goodwill impairment charges in 2008, 2007 or 2006.
Included in intangible assets, net are definite-lived assets
subject to amortization such as non-compete agreements.
Amortization of definite-lived intangible assets is calculated
on a straight-line basis over the estimated useful lives of the
related assets.
The Company also has indefinite-lived assets that are not
subject to amortization expense such as trade names and
certificates of need. The Company has concluded that trade names
and certificates of need have indefinite lives, as management
has determined that there are no legal, regulatory, contractual,
economic or other factors that would limit the useful life of
these intangible assets and the Company intends to renew and
operate the licenses and use these trade names indefinitely. The
Company performs an annual impairment test on the trade names
using the relief-from royalty method. Under this method, the
fair value of the intangible asset is determined by calculating
the present value of the after-tax cost savings associated with
owning the trade names and therefore not having to pay royalties
for its use for the remainder of its estimated useful lives. The
certificates of need are tested annually for impairment using
the cost approach. Under this method assumptions are made about
the cost to replace the certificates of need.
F-11
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Due
to/from Governmental Entities
The amounts recorded in due to/from governmental entities
on the Companys consolidated balance sheet relate to
settled and open cost reports that are subject to the completion
of audits and the issuance of final assessments. Final
reimbursement is determined based on submission of annual cost
reports and audits by the fiscal intermediary. Adjustments are
accrued on an estimated basis in the period the related services
were rendered and further adjusted as final settlements are
determined. These adjustments are accounted for as changes in
estimates. There have been no significant changes in estimates
during the years ended December 31, 2008 and 2007.
Property,
Building and Equipment
Property, building and equipment are stated at cost.
Depreciation is computed using the straight-line method over the
estimated useful lives of the individual assets. Estimated
useful lives for buildings is 39 years and ranges from 3 to
10 years for transportation equipment and furniture and
other equipment. The useful life for leasehold improvements is
the lesser of the lease term or the expected life of the
leasehold improvement. Routine repairs and maintenance are
expensed when incurred.
In accordance with Statement of Financial Accounting Standards
No. 144, Accounting for the impairment or Disposal
of Long-Lived Assets, property, plant and equipment is
reviewed whenever events or changes in circumstances occur that
indicate possible impairment. There were no impairments
recognized during the periods ended December 31, 2008, 2007
or 2006.
The following table describes the components of property,
building and equipment:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Land
|
|
$
|
342
|
|
|
$
|
135
|
|
Building and improvements
|
|
|
3,719
|
|
|
|
3,079
|
|
Transportation equipment
|
|
|
5,496
|
|
|
|
3,434
|
|
Furniture and other equipment
|
|
|
17,695
|
|
|
|
13,661
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,252
|
|
|
|
20,309
|
|
Less accumulated depreciation and amortization
|
|
|
10,904
|
|
|
|
7,786
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
16,348
|
|
|
$
|
12,523
|
|
|
|
|
|
|
|
|
|
|
Depreciation expense for the years ended December 31, 2008,
2007 and 2006 was $3.7 million, $3.0 million and
$2.4 million, respectively.
Minority
Interest
The interest held by third parties in subsidiaries owned or
controlled by the Company is reported on the consolidated
balance sheets as minority interest. Minority interest reported
in the consolidated statements of income reflects the respective
interests in the income or loss before income taxes of the
subsidiaries attributable to the other parties, the effect of
which is removed from the Companys consolidated results of
operations.
Minority
Interest Subject to Put Agreements
One of the Companys joint venture agreements allows the
minority interest holders to put their minority interest to the
Company. The put option allows the minority interest holder to
exchange their minority interest for cash based on the joint
ventures earnings before interest, taxes, depreciation and
amortization (EBITDA)
F-12
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
for the prior fiscal year and the Companys stock price.
The put options have been presented in the historical financial
statements in accordance with Accounting Series Release
(ASR) No 268 and EITF Topic D-98, which generally
require a public companys stock subject to redemption
requirements that are outside the control of the issuer to be
excluded from the caption stockholders equity
and presented separately in the issuers balance sheet.
Under EITF Topic D-98, once it becomes probable that the
minority interest would be redeemable, the minority interest
should be adjusted to its current redemption amount, marked to
market.
The Company recorded mark to market benefits of $193,000 and
$124,000 for the years ended December 31, 2007 and 2006,
respectively and a mark to market expense of $58,000 for the
year ended December 31, 2008.
During the first quarter of 2008, certain minority interest
holders redeemed their interest in the joint venture, resulting
in a cash payment of approximately $89,000. In connection with
the partial redemption of certain minority interests, the
Company decreased minority interests by approximately $84,000
and increased retained earnings by the same amount, representing
the fair value at December 31, 2007 of the shares converted
during the first quarter of 2008. Simultaneously, the Company
recorded goodwill of $89,000 to represent the value of the
minority interests redeemed.
There were no redemptions in the year ended December 31,
2007.
In connection with the partial redemption of certain minority
interest in the year ended December 31, 2006, the Company
decreased minority interest by approximately $1,039,000 and
increased retained earnings by the same amount. Simultaneously,
The Company recorded goodwill of $979,000 to represent the value
of the minority interest redeemed.
Included in minority interests subject to exchange contracts at
December 31, 2008 and 2007 is $95,000 and $121,000,
respectively, related to these redeemable minority interests. As
of December 31, 2008, one minority interest holder had not
converted his interest to cash.
Stock-Based
Employee Compensation
The Company adopted Statement of Financial Accounting Standards
No. 123(R) (revised 2004), Share-Based Payment, a
revision of SFAS No. 123, Accounting for
Stock-Based Compensation
(SFAS No. 123(R)), on January 1,
2006 using the modified prospective method. This method required
compensation cost to be recognized beginning with the effective
date (a) based on the requirements of
SFAS No. 123(R) for all share-based payments granted
after the effective date and (b) based on the requirements
of SFAS No. 123 for all awards granted to employees
prior to the effective date of SFAS No. 123(R) that
remain unvested on the effective date.
The Company grants restricted stock or restricted stock units to
employees and members of its Board of Directors as a form of
compensation. The expense for such awards is based on the grant
date fair value of the award and is recognized on a
straight-line basis over the requisite service period. See
Note 7 for further discussion.
Earnings
Per Share
Basic per share information is computed by dividing the item by
the weighted-average number of shares outstanding during the
period, under the treasury stock method. Diluted per share
information is computed by dividing the item by the
weighted-average number of shares outstanding plus dilutive
potential shares.
F-13
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table sets forth shares used in the computation of
basic and diluted per share information for the years ended
December 31, 2008, 2007 and 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Weighted average number of shares outstanding for basic per
share calculation
|
|
|
17,855,634
|
|
|
|
17,760,432
|
|
|
|
17,090,583
|
|
Effect of dilutive potential shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
|
5,705
|
|
|
|
6,461
|
|
|
|
2,399
|
|
Restricted stock
|
|
|
37,748
|
|
|
|
60,551
|
|
|
|
11,678
|
|
Adjusted weighted average shares for diluted per share
calculation
|
|
|
17,899,087
|
|
|
|
17,827,444
|
|
|
|
17,104,660
|
|
Adoption
of New Accounting Standards
In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements (SFAS 157),
which defines fair value, establishes a framework for measuring
fair value in US GAAP and expands disclosures about fair value
measurements. SFAS 157 does not require any new fair value
measurements but rather eliminates inconsistencies in guidance
found in various prior accounting pronouncements. In February
2008, the FASB issued FASB Staff Position
No. 157-2,
which deferred the effective date for all nonfinancial assets
and nonfinancial liabilities, except those that are recognized
or disclosed at fair value in the financial statements on a
recurring basis, until fiscal years beginning after
November 15, 2008, and interim periods within those fiscal
years. These nonfinancial items include assets and liabilities
such as reporting units measured at fair value in goodwill
impairment tests and nonfinancial assets acquired and
liabilities assumed in a business combination. The Company
adopted SFAS 157 for financial assets and liabilities
recognized at fair value on recurring bases effective
January 1, 2008. The partial adoption of SFAS 157 for
financial assets and liabilities did not have a material effect
on the Companys consolidated financial position, results
of operations or cash flows.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option for Financial Assets and Financial Liabilities
(SFAS 159). Under SFAS 159, companies
may elect to measure certain financial instruments and certain
other items at fair value. The standard requires that unrealized
gains and losses on items for which the fair value option has
been elected be reported in operations. SFAS 159 was
effective for the Company beginning in the first quarter of
2008. The Company has not elected to fair value any eligible
items throughout 2008. Therefore, the adoption of SFAS 159
did not affect the Companys consolidated financial
position, results of operations or cash flows.
Recently
Issued Accounting Pronouncements
In December 2007, the Financial Accounting Standards Board
(FASB) issued Statement of Financial Accounting
Standards No. 141 (Revised 2007), Business Combinations
(SFAS 141R). SFAS 141R changes the
accounting treatment and disclosure for certain specific items
in a business combination. Under SFAS 141R, an acquiring
entity will be required to recognize all the assets acquired and
liabilities assumed in a transaction at the acquisition-date
fair value with limited exceptions. This includes the fair
values of the non-controlling interest acquired. Under current
guidance, the non-controlling interest (minority owner) is
recorded at the minority owners historical balance. This
also includes contingent payments on acquisitions. Contingent
payments under FAS 141 are recorded when settled, however
under SFAS 141R contingent payments will be recorded at the
acquisition-date fair value. The change in the fair value of the
contingent payment and the settlement amount will be recognized
through the statement of income. Other changes include the
treatment of acquisition-related costs, which, with the
exception of debt or equity issuance costs, are to be recognized
as an expense in the period that the costs are incurred and the
services are received. Currently, these costs are included as
part of the purchase price and allocated to the assets and
liabilities acquired. Further, any
F-14
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
adjustments during the measurement period to the provisional
amounts recognized as part of the purchase price allocation are
treated retrospectively as of the acquisition date.
SFAS 141R applies prospectively to business combinations
for which the acquisition date is on or after the beginning of
the first annual reporting period beginning on or after
December 15, 2008. Early adoption is prohibited. The
Company expects SFAS 141R will have an effect on accounting
for business combinations as well as an effect on the
Companys consolidated balance sheet. The effect however,
is dependent upon acquisitions subsequent to adoption.
In December 2007, the FASB issued SFAS No. 160,
Non-controlling Interests in Consolidated Financial
Statements an Amendment of ARB No. 51
(SFAS 160). SFAS 160 establishes new
accounting and reporting standards for the non-controlling
interest, currently known as minority interest. Non-controlling
ownership interest in consolidated subsidiaries will be
presented in the consolidated balance sheet within
stockholders equity as a separate component from the
parents equity. Consolidated net income will include
earnings attributable to both the parent and the non-controlling
interest. Earnings per share, which is not effected by
SFAS 160, will continue to be based on earnings
attributable only to the parent company. SFAS 160 also
provides guidance on accounting for changes in the parents
ownership interest in a subsidiary, including transactions where
control is retained and where control is relinquished.
SFAS 160 requires additional disclosure information related
to amounts attributable to the parent for income from continuing
operations, discontinued operations and extraordinary items and
reconciliations of the parent and non-controlling
interests equity in subsidiaries. SFAS 160 is
effective for fiscal years beginning on or after
December 15, 2008. The Company will adopt SFAS 160
prospectively during the first quarter of 2009. While the
adoption is prospective, the disclosure requirements will be
applied retrospectively for periods presented in the
Companys filings subsequent to adoption.
|
|
3.
|
Acquisitions
and Divestitures
|
The following acquisitions were completed pursuant to the
Companys strategy of becoming the leading provider of
post-acute health care services in the United States. The
purchase price of each acquisition was determined based on the
Companys analysis of comparable acquisitions and target
markets potential cash flows. Goodwill generated from the
acquisitions was recognized based on the expected contributions
of each acquisition to the overall corporate strategy.
2008
Acquisitions
Home-Based
During the year ended December 31, 2008, the Company
acquired the existing operations of 11 entities operating a
total of 43 agencies and a majority ownership in 12 entities
operating a total of 17 agencies. The total purchase price for
the acquisitions was $63.7 million, including
$2.0 million of acquisition-related costs. Goodwill of
$47.2 million and other intangibles of $14.9 million
were assigned to the home-based services segment related to the
acquisitions. Goodwill of $23.5 million is not deductible
for income tax purposes. The estimated purchase price allocation
is preliminary and subject to revision upon settlement of the
working capital purchased as part of the acquisitions and
finalization of the valuation on deferred taxes acquired.
In October 2008, the Company purchased a majority ownership in
an entity with three agencies in exchange for a minority
ownership interest in two of the Companys entities.
Minority interest of $1.9 million was recorded in the
Companys consolidated balance sheet as of
December 31, 2008 related to the minority ownership
transferred as consideration. The Company recognized a gain of
$624,000 on the transaction. Goodwill of $2.4 million and
other intangibles of $485,000 were assigned to the home-based
services segment related to the acquisition.
One of the Companys acquisitions contains contingent
consideration to the seller that may be settled in the
Companys stock one year after the acquisition date. The
amount of stock that will be issued is contingent
F-15
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
upon certain financial measurements of the acquired Company. As
of December 31, 2008, no liability is recorded as the
amount of the stock payment is not determinable beyond a
reasonable doubt.
Facility-Based
The Company also acquired an additional ownership interest in
one of its majority-owned hospitals for $1.0 million, paid
by issuing 51,736 shares of its common stock. Goodwill of
$1.0 million related to this acquisition, which is
nondeductible for income tax purposes, was assigned to the
facility-based services segment.
In conjunction with certain minority interest holders redeeming
their interest in one of the Companys joint ventures,
$89,000 of goodwill, which is not deductible for income tax
purposes, was recognized in the facility-based services segment.
The acquisitions during the year individually were immaterial to
our financial statement; however, when aggregated, total
acquisitions were material. The following table contains
unaudited pro forma consolidated income statement information
assuming the acquisitions closed January 1, 2007 for 2008
acquisitions.
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
Net service revenue
|
|
$
|
438,510
|
|
|
$
|
373,965
|
|
Operating income
|
|
|
27,119
|
|
|
|
36,175
|
|
Net income
|
|
|
27,992
|
|
|
|
18,009
|
|
Basic and diluted earnings per share
|
|
$
|
1.56
|
|
|
$
|
1.01
|
|
To provide financial information that is more representative of
the combined results of the Company as if the acquisitions had
occurred January 1, 2007, the pro forma disclosure in the
table above includes adjustments for depreciation expense,
amortization of intangible assets and income tax expense. This
pro forma information is presented for illustrative purposes
only and may not be indicative of the results of operations that
would have actually occurred. In addition, future results may
vary significantly from the results reflected in the pro forma
information.
There were no divestitures during the year ended
December 31, 2008.
2007
Acquisitions
During the year ended December 31, 2007, the Company
acquired the existing operations of 11 locations and a majority
ownership interest in the existing operations of 12 locations
for $26.0 million in cash, and $2.4 million in
acquisition costs. Goodwill of $21.9 million and other
intangibles of $5.8 million were assigned to the home-based
services segment.
2007
Divestitures
During the year ended December 31, 2007, the Company sold
its critical access hospital for $180,000 and recognized a gain
of $31,000, net of tax of $20,000. There was no goodwill related
to this hospital. Additionally, the Company closed a home health
pharmacy location in the year ended December 31, 2007. The
assets related to the home health pharmacy are classified as
assets held for sale on the balance sheet. The Company retired
goodwill of $48,000 related to the termination of its private
duty business.
2006
Acquisitions
During the year ended December 31, 2006, the Company
acquired the existing operations of seven entities, including
assets of $2.2 million, primarily patient accounts
receivable, the minority interest in one of
F-16
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
its joint ventures and a license which was being leased for
$22.1 million in cash and $1.4 million in acquisition
costs. Goodwill of $13.7 million and other intangibles of
$8.1 million were assigned to the home based services
segment.
In conjunction with certain minority interest holders redeeming
their interests in St. Landry, $979,000 of goodwill, which is
deductible for income tax purposes, was recognized in the
facility based services segment.
2006
Divestitures
During the year ended December 31, 2006, the Company sold
one of its long-term acute care hospitals for $1.2 million
and recognized a gain of $958,000 on the sale of this hospital.
In conjunction with this transaction, the Company allocated and
retired $155,000 of goodwill related to this hospital. The
Company also sold a clinic for promissory notes totaling
$946,000 and recognized a loss on the sale of $28,000. Goodwill
of $891,000 was retired in conjunction with the sale of the
clinic. Additionally, the Company closed one location of another
clinic and terminated virtually all of its private duty
business. Finally, the Company sold one of its home health
agencies for $240,000 and retired goodwill of $50,000. The
Company recognized a gain of $98,000 on the sale of this agency.
The Company has identified one long-term acute care hospital and
one pharmacy operation as held for sale as of December 31,
2006. Goodwill of $402,000 and other assets related to these
operations are classified as assets held for sale on the balance
sheet.
The following table summarizes the operating results of the
divestitures described above which have been presented as loss
from discontinued operations in the accompanying consolidated
statements of income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
Net service revenue
|
|
$
|
51
|
|
|
$
|
2,979
|
|
|
$
|
5,261
|
|
Costs, expenses and minority interest
|
|
|
689
|
|
|
|
4,885
|
|
|
|
7,622
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations before income taxes
|
|
|
(638
|
)
|
|
|
(1,906
|
)
|
|
|
(2,361
|
)
|
Income tax benefit
|
|
|
110
|
|
|
|
239
|
|
|
|
897
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
$
|
(528
|
)
|
|
$
|
(1,667
|
)
|
|
$
|
(1,464
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The 2007 and 2006 acquisitions are considered to be immaterial
individually and in the aggregate. Accordingly, no supplemental
pro forma information is presented.
F-17
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
4. Goodwill
and Other Intangibles, Net
The following table summarizes the changes in goodwill by
segment:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Home-based services segment:
|
|
|
|
|
|
|
|
|
Balances at beginning of period
|
|
$
|
57,885
|
|
|
$
|
35,740
|
|
Goodwill acquired during the period from acquisitions
|
|
|
49,223
|
|
|
|
22,192
|
|
Goodwill retired during the period
|
|
|
|
|
|
|
(47
|
)
|
|
|
|
|
|
|
|
|
|
Home-based services balance at end of period
|
|
|
107,108
|
|
|
|
57,885
|
|
|
|
|
|
|
|
|
|
|
Facility-based services segment:
|
|
|
|
|
|
|
|
|
Balance at beginning of period
|
|
$
|
4,342
|
|
|
|
3,941
|
|
Goodwill classified as held for sale during the period
|
|
|
|
|
|
|
401
|
|
Goodwill acquired during the period from redemption of minority
interest
|
|
|
1,122
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Facility-based services balance at end of period
|
|
|
5,464
|
|
|
|
4,342
|
|
|
|
|
|
|
|
|
|
|
Consolidated Balance at end of period
|
|
$
|
112,572
|
|
|
$
|
62,227
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes the changes in other intangibles,
net during 2008, which all related to the home-based services
segment. (Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade
|
|
|
Certificates of
|
|
|
Other
|
|
|
|
|
|
|
Names
|
|
|
Need
|
|
|
Intangibles
|
|
|
Total
|
|
|
Balance at December 31, 2007
|
|
$
|
12,873
|
|
|
$
|
1,041
|
|
|
$
|
141
|
|
|
$
|
14,055
|
|
Additions
|
|
|
14,360
|
|
|
|
843
|
|
|
|
874
|
|
|
|
16,077
|
|
2007 Acquisition Adjustments
|
|
|
|
|
|
|
117
|
|
|
|
|
|
|
|
117
|
|
Amortization
|
|
|
|
|
|
|
|
|
|
|
(274
|
)
|
|
|
(274
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
$
|
27,233
|
|
|
$
|
2,001
|
|
|
$
|
741
|
|
|
$
|
29,975
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Approximately $15.4 million of the increase in other
intangibles, net, relates to acquisitions completed during the
year ended December 31, 2008. The remaining $600,000 of the
increase relates to non-compete agreements entered into during
the period ending December 31, 2008.
The Company accounts for income taxes using the liability
method. Under the liability method, deferred taxes are
determined based on differences between the financial reporting
and tax bases of assets and liabilities and are measured using
the enacted tax laws that will be in effect when the differences
are expected to reverse. Management provides a valuation
allowance for any net deferred tax assets when it is more likely
than not that a portion of such net deferred tax assets will not
be recovered.
F-18
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Significant components of the Companys deferred tax assets
and liabilities as of December 31, 2008 and 2007 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Allowance for uncollectible accounts
|
|
$
|
3,503
|
|
|
$
|
3,392
|
|
Accrued employee benefits
|
|
|
1,679
|
|
|
|
1,005
|
|
Stock compensation
|
|
|
742
|
|
|
|
495
|
|
Net operating loss carry forward
|
|
|
644
|
|
|
|
505
|
|
Valuation allowance
|
|
|
(689
|
)
|
|
|
(505
|
)
|
Accrued self-insurance
|
|
|
796
|
|
|
|
508
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
6,675
|
|
|
|
5,400
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Amortization of intangible assets
|
|
|
(4,733
|
)
|
|
|
(2,166
|
)
|
Tax in excess of book depreciation
|
|
|
(1,683
|
)
|
|
|
(1,563
|
)
|
Prepaid expenses
|
|
|
(364
|
)
|
|
|
(1,095
|
)
|
Non-accrual experience accounting method
|
|
|
(654
|
)
|
|
|
(862
|
)
|
Conversion from cash basis accounting
|
|
|
|
|
|
|
(11
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities
|
|
|
(7,434
|
)
|
|
|
(5,697
|
)
|
Net deferred tax liability
|
|
$
|
(759
|
)
|
|
$
|
(297
|
)
|
|
|
|
|
|
|
|
|
|
Based on the Companys historical pattern of taxable
income, the Company believes it will produce sufficient income
in the future to realize its deferred income tax assets. A
valuation allowance is established for any portion of a deferred
income tax asset if the Company believes it is more likely than
not that the Company will not be able to realize the benefits or
portions of a deferred income tax asset. Management established
a valuation allowance primarily related to the tax net operating
losses and deferred tax assets on the Companys home health
pharmacy included in discontinued operations.
The components of the Companys income tax expense from
continuing operations, less minority interest, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
15,858
|
|
|
$
|
10,542
|
|
|
$
|
10,139
|
|
State
|
|
|
2,408
|
|
|
|
1,476
|
|
|
|
1,931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,266
|
|
|
|
12,018
|
|
|
|
12,070
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
401
|
|
|
|
111
|
|
|
|
(1,053
|
)
|
State
|
|
|
61
|
|
|
|
18
|
|
|
|
(200
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
462
|
|
|
|
129
|
|
|
|
(1,253
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
18,728
|
|
|
$
|
12,147
|
|
|
$
|
10,817
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-19
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
A reconciliation of the differences between income taxes from
continuing operations, less minority interest, computed at the
federal statutory rate and provisions for income taxes for each
period is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Income taxes computed at federal statutory tax rate
|
|
$
|
17,190
|
|
|
$
|
11,680
|
|
|
$
|
11,283
|
|
State income taxes, net of federal benefit
|
|
|
1,730
|
|
|
|
1,001
|
|
|
|
967
|
|
Gulf Opportunity Act tax credit
|
|
|
(518
|
)
|
|
|
(662
|
)
|
|
|
(1,027
|
)
|
Nondeductible expenses
|
|
|
326
|
|
|
|
128
|
|
|
|
54
|
|
Tax exempt proceeds from life insurance
|
|
|
|
|
|
|
|
|
|
|
(380
|
)
|
Tax exempt interest income
|
|
|
|
|
|
|
|
|
|
|
(80
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
18,728
|
|
|
$
|
12,147
|
|
|
$
|
10,817
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In July 2006, the FASB issued FASB Interpretation No. 48,
Accounting for Uncertainty in Income Taxes an
Interpretation of FASB Statement No. 109
(FIN 48). FIN 48 prescribes a recognition
threshold and measurement attribute for financial statement
recognition and measurement of a tax position taken or expected
to be taken in a tax return. FIN 48 was effective for
fiscal years beginning after December 15, 2006. The Company
adopted the provisions of FIN 48 effective January 1,
2007. The adoption did not have a material effect on the
consolidated financial position or results of operations of the
Company. At the date of adoption, the Company had no
unrecognized tax benefits. The Company recognizes interest and
penalties related to uncertain tax positions, if applicable, in
interest expense and general and administrative expenses,
respectively. During the years ended December 31, 2008,
2007 and 2006, the Company did not recognize any interest or
penalties in its consolidated financial statements, nor has it
recorded an accrued liability of interest or penalty payments
related to uncertain tax positions.
The Company is subject to both federal and state income tax for
jurisdictions within which it operates. Within these
jurisdictions, the Company is open to examination for tax years
ended after December 31, 2003.
Long-Term
Debt
Long-term debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Notes payable:
|
|
|
|
|
|
|
|
|
Due in monthly installments of $28,056 through February 2015 at
LIBOR plus 1.90% (3.8% at December 31, 2008) plus a
balloon payment of $2.7 million
|
|
|
4,769
|
|
|
|
|
|
Due in monthly installments of $12,500 through November 2009 at
5.78%
|
|
|
122
|
|
|
|
260
|
|
Due in yearly installments of $50,000 through August 2010 at
6.25%
|
|
|
100
|
|
|
|
150
|
|
Due in monthly installments of $20,565 through October 2015 at
LIBOR plus 2.25% (6.71% at December 31, 2007)
|
|
|
|
|
|
|
2,870
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,991
|
|
|
|
3,280
|
|
Less current portion of long-term debt
|
|
|
508
|
|
|
|
433
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4,483
|
|
|
$
|
2,847
|
|
|
|
|
|
|
|
|
|
|
In February 2008, the Company entered into a loan agreement with
Capital One, National Association (Capital One) for
a term note in the amount of $5.1 million for the purchase
of a 1999 Cessna 560 aircraft.
F-20
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The aircraft is collateral for the term note, which is payable
in 83 monthly installments of principal plus interest
commencing on March 6, 2008 followed by one balloon
installment on February 6, 2015 of $2.7 million. The
term note bears interest at the LIBOR Rate (adjusted monthly)
plus the Applicable Margin of 1.9%.
On February 28, 2008, the Company paid its prior promissory
note with Bancorp Equipment Finance, Inc. in full. The note was
collateralized by the Companys previous aircraft, which
was sold in February 2008 for $3.1 million. The sale
resulted in a gain of $315,000.
In August 2005, the Company entered into a promissory note with
the seller of
A-1 Nursing
Registry, Inc.
(A-1)
in conjunction with the purchase of the assets of
A-1. The
principal amount of the note is $250,000 and it bears interest
at 6.25%. As of December 31, 2008 the principal balance on
the note was $100,000.
Certain of the Companys loan agreements contain
restrictive covenants, including limitations on indebtedness and
the maintenance of certain financial ratios. The Company was in
compliance with all covenants at December 31, 2008 and 2007.
The scheduled principal payments on long-term debt are as
follows for each of the next five years following
December 31, 2008 (in thousands):
|
|
|
|
|
2009
|
|
$
|
508
|
|
2010
|
|
|
387
|
|
2011
|
|
|
337
|
|
2012
|
|
|
337
|
|
2013
|
|
|
337
|
|
Thereafter
|
|
|
3,085
|
|
|
|
|
|
|
|
|
$
|
4,991
|
|
|
|
|
|
|
Credit
Facility
On February 20, 2008, the Company entered into a new credit
facility agreement with Capital One (New Credit
Facility), which was amended on March 6, 2008 to
include an additional lender, First Tennessee Bank, N.A., to
increase the line of credit from $25.0 million to
$37.5 million and to amend the Eurodollar Margin for each
Eurodollar Loan (as those terms are defined in the New Credit
Facility) issued under the New Credit Facility. The Credit
Agreement was amended and restated on June 12, 2008 to add
Branch Banking and Trust Company as a Lender and to
increase the maximum aggregate principal amount of the line of
credit from $37.5 million to $75.0 million. The New
Credit Facility is unsecured, has a term of two years and a
letter of credit sublimit of $2.5 million. The annual
facility fee is 0.125% of the total availability. The interest
rate for borrowings under the New Credit Agreement is a function
of the prime rate (Base Rate) or the Eurodollar rate
(Eurodollar), as elected by the Company, plus the applicable
margin based on the Leverage Ratio (as defined in the New Credit
Facility). The Company paid $211,000 of credit fees on the
credit facility during the year ended December 31, 2008. No
amounts were outstanding on the facility as of December 31,
2008.
Issuance
of Common Stock
As discussed in Footnote 3, the Company issued
51,736 shares of common stock to purchase an additional
ownership percentage in one of its majority-owned hospitals. The
stock was valued as of May 14, 2008, the effective date of
the acquisition.
F-21
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Equity
Based Awards
On January 20, 2005, the board of directors and
stockholders of the Company approved the 2005 Long Term
Incentive Plan (the Incentive Plan). The Incentive
Plan, which is administered by the Compensation Committee of the
Companys Board of Directors, provides for
1,000,000 shares of common stock that may be issued or
transferred pursuant to awards made under the plan. A variety of
discretionary awards for employees, officers, directors and
consultants are authorized under the Incentive Plan, including
restricted stock and incentive or non-qualified statutory stock
options. All awards must be evidenced by a written award
certificate which will include the provisions specified by the
Compensation Committee of the Board of Directors. The Incentive
Plan provides that shares of common stock subject to awards
granted become available again for issuance if such awards are
canceled or forfeited.
Restricted Stock is an award of common stock that is subject to
restrictions and to the risk of forfeiture and such other terms
and conditions as defined by the Incentive Plan.
The Compensation Committee will determine the exercise price for
non-statutory stock options. The exercise price for any option
cannot be less than the fair market value of our common stock as
of the date of grant.
In the event of a change of control as defined in the Incentive
Plan, all restricted periods and restrictions imposed on
non-performance based restricted stock awards will lapse and
outstanding options will become immediately exercisable in full.
Also on January 20, 2005, the 2005 Director
Compensation Plan was adopted by the Board of Directors. The
shares issued under our 2005 Director Compensation Plan are
issued from the 1,000,000 shares reserved for issuance
under the Companys Incentive Plan.
Share
Based Compensation
Stock
Options
The following table represents stock options activity for the
year ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted Average
|
|
|
|
|
|
|
Number of
|
|
|
Average Exercise
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
Shares
|
|
|
Price
|
|
|
Contractual Term
|
|
|
Intrinsic Value
|
|
|
Options outstanding at January 1, 2008
|
|
|
19,000
|
|
|
|
17.20
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options forfeited or expired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding at December 31, 2008
|
|
|
19,000
|
|
|
|
17.20
|
|
|
|
7.0 years
|
|
|
$
|
357,275
|
|
Options exercisable at December 31, 2008
|
|
|
19,000
|
|
|
|
17.20
|
|
|
|
7.0 years
|
|
|
$
|
357,275
|
|
All options are fully vested and exercisable at
December 31, 2008. No options were exercised in the year
ended December 31, 2008. There were no options granted
during 2008 or 2007. No compensation expense related to stock
option grants was recorded in the years ended December 31,
2008 or 2007. The total intrinsic value of options exercised
during the years ended December 31, 2007 and 2006 was
$14,120 and $29,800, respectively. The Company has recorded
$134,000 in compensation expense related to stock option grants
in the year ended December 31, 2006.
F-22
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Non-vested
Stock
The Company issues stock-based compensation to employees in the
form of restricted stock, which is an award of common stock
subject to certain restrictions. The awards, which the Company
calls nonvested shares, generally vest over a five year period,
conditioned on continued employment for the full incentive
period. Compensation expense for the restricted stock is
recognized for the awards that are expected to vest. The expense
is based on the fair value of the awards on the date of grant
recognized on a straight-line basis over the requisite service
period, which generally relates to the vesting period.
During 2008, 2007 and 2006, respectively, 149,095, 181,071 and
86,114 non-vested shares were granted to employees pursuant to
the 2005 Long-Term Incentive Plan. These shares vest over a five
year period.
The Company also issues restricted stock to its non-employee
members of the Companys Board of Directors. During 2008,
2007 and 2006, respectively, 16,100, 16,100 and 3,500 non-vested
shares of stock were granted to our independent directors under
the 2005 Director Compensation Plan. New non-employee
directors receive an initial grant of non-vested shares in which
one third of these shares vest immediately and the remaining
vest over the two year period following the grant date.
Additionally, the 2005 Director Compensation Plan provides
for annual grants of non-vested shares to non-employee directors
in which the full amount of shares vests at the one year
anniversary of the grant date.
The fair value of non-vested shares is determined based on the
closing trading price of the Companys shares on the grant
date. The weighted average grant date fair values of non-vested
shares granted during the years ended December 31, 2008,
2007 and 2006 were $18.67, $27.83 and $18.66, respectively.
The following table represents the non-vested stock activity for
the year ended December 31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
Number of
|
|
|
Average Grant
|
|
|
|
Shares
|
|
|
Date Fair Value
|
|
|
Non-vested shares outstanding at January 1, 2008
|
|
|
218,332
|
|
|
|
24.08
|
|
Granted
|
|
|
165,195
|
|
|
|
18.67
|
|
Vested
|
|
|
(53,026
|
)
|
|
|
25.49
|
|
Forfeited
|
|
|
(24,095
|
)
|
|
|
21.40
|
|
Non-vested shares outstanding at December 31, 2008
|
|
|
306,406
|
|
|
|
22.45
|
|
As of December 31, 2008, there was $5.4 million of
total unrecognized compensation cost related to non-vested
shares granted. That cost is expected to be recognized over the
weighted average period of 1.7 years. The total fair value
of shares vested in the years ended December 31, 2008, 2007
and 2006 were $1.3 million, $468,361 and $141,294,
respectively. The Company records compensation expense related
to non-vested share awards at the grant date for shares that are
awarded fully vested and over the vesting term on a straight
line basis for shares that vest over time. The Company has
recorded $1.9 million, $1.2 million and $449,000 in
compensation expense related to non-vested stock grants in the
years ended December 31, 2008, 2007 and 2006 respectively.
Employee
Stock Purchase Plan
In 2006, the Company adopted the Employee Stock Purchase Plan
allowing eligible employees to purchase the Companys
common stock at 95% of the market price on the last day of each
calendar quarter. There were 250,000 shares reserved for
the plan. During 2007 and 2006, the Company issued
16,893 shares and 7,096 shares, respectively. The
Company issued 22,988 shares of common stock under the plan
at a weighted average per share price of $21.39 during the year
ended December 31, 2008. At December 31, 2008 there
were 203,023 shares available for future issuance.
F-23
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Treasury
Stock
In conjunction with the vesting of the non-vested shares of
stock, recipients incur withholding tax liabilities. The Company
allows the holders to turn in shares of common stock to satisfy
those tax obligations. The Company redeemed 7,202 and
370 shares of common stock related to these tax obligations
at December 31, 2008 and 2007, respectively. There were no
shares redeemed during the year ended December 31, 2006.
Public
Offering
On July 19, 2006, the Company closed its follow-on public
offering of 4,000,000 shares of common stock at a price of
$19.25 per share. Of the 4,000,000 shares of common stock
offered, 1,000,000 shares were offered by the Company, with
the remaining 3,000,000 shares of common stock sold by the
selling stockholders identified in the prospectus supplement.
The underwriters exercised an over-allotment of an additional
600,000 shares, 150,000 of which were sold by the Company.
The additional net cash provided to the Company from this
offering after deducting expenses and underwriting discounts and
commissions amounted to approximately $20.7 million.
|
|
8.
|
Related
Party Transactions
|
Employee
Receivables
As a result of Hurricanes Katrina and Rita, the Company
established a loan fund to allow affected employees to borrow up
to six months of their salary to aid in their recovery from the
hurricanes. The loan agreements bear interest of 3.5%. The
employees began payment on the loans one year after the date of
the loan agreement through payroll deductions. As of
December 31, 2008, 2007 and 2006, these loans totaled
$174,000, $245,000 and $363,000, respectively and are included
in other assets on the balance sheet.
The Company also leases property from certain joint venture
partners at rates that reflect market rates.
In certain instances, state laws may prohibit the sale of a home
nursing agency or hospitals may be reluctant to sell their home
health agencies. In these instances, the Company, through its
wholly owned subsidiaries, enters into lease agreement for a
Medicare and Medicaid license, as well as the associated
provider number to provide home health or hospice services. As
of December 31, 2008, the Company had four license lease
arrangements to operate five home nursing agencies and three
hospice agencies.
Two of the leases were entered into in 2007 and expire in 2017.
Expense related to these leases was $260,000 in 2008 and
$173,000 in 2007. Payments due under these leases are $260,000
in 2009.
Two of the leases were entered into in 2005 and expire in 2010.
Expense related to these leases was $186,000 in 2008, $226,000
in 2007 and $215,000 in 2006. The lease payments associated with
these leases are based on a percentage of net quarterly profits;
therefore, the future payments will vary with the future profits.
The Company leases office space and equipment at its various
locations. Many of the leases contain renewal options with
varying terms and conditions. Management expects that in the
normal course of business, expiring leases will be renewed or,
upon making a decision to relocate, replaced by leases for new
locations. Operating lease terms range from three to ten years.
Rent expense includes insurance, maintenance, and other costs as
required by the lease. Total rental expense was approximately
$10.6 million in 2008, $8.1 million in
F-24
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
2007 and $7.6 million in 2006. Future minimum rental
commitments under non-cancelable operating leases are as follows
(in thousands):
|
|
|
|
|
2009
|
|
$
|
7,699
|
|
2010
|
|
|
4,364
|
|
2011
|
|
|
2,811
|
|
2012
|
|
|
1,928
|
|
2013
|
|
|
1,450
|
|
Thereafter
|
|
|
797
|
|
|
|
|
|
|
|
|
$
|
19,049
|
|
|
|
|
|
|
As of December 31, 2008, future minimum payments by year
and in the aggregate, under non-cancelable capital leases with
initial terms of one year or more, consisted of the following
(in thousands):
|
|
|
|
|
2009
|
|
$
|
75
|
|
2010
|
|
|
28
|
|
2011
|
|
|
22
|
|
2012
|
|
|
|
|
2013
|
|
|
|
|
Thereafter
|
|
|
|
|
|
|
|
|
|
Total minimum lease payments
|
|
|
125
|
|
Current portion of capital lease obligations
|
|
|
75
|
|
|
|
|
|
|
Capital lease obligations, long-term
|
|
$
|
50
|
|
|
|
|
|
|
The cost of assets held under capital leases was $531,000 and
$456,000 at December 31, 2008 and 2007, respectively. The
related accumulated amortization was $456,000 and $456,000 at
December 31, 2008 and 2007, respectively.
|
|
10.
|
Employee
Benefit Plan
|
Defined
Contribution Plan
The Company sponsors a 401(k) plan to all eligible full-time
employees. The plan allows participants to contribute up to 15%
of their compensation and allows discretionary Company
contributions as determined by the Companys Board of
Directors. Effective January 1, 2006, the Company
implemented a discretionary match of up to two percent of
participating employee contributions. The employer contribution
will vest 20% after two years and 20% each additional year until
it is fully vested in year six. At December 31, 2008 and
December 31, 2007, $100,000 and $215,000, respectively,
related to this match is included in salaries, wages and
benefits payable. Contribution expense to the Company was
$1.4 million, $1.1 million and $700,000 in 2008, 2007
and 2006.
|
|
11.
|
Commitments
and Contingencies
|
Contingencies
The Company is involved in various legal proceedings arising in
the ordinary course of business. Although the results of
litigation cannot be predicted with certainty, management
believes the outcome of pending litigation will not have a
material adverse effect, after considering the effect of the
Companys insurance coverage, on the Companys
consolidated financial statements.
F-25
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Compliance
The laws and regulations governing the Companys
operations, along with the terms of participation in various
government programs, regulate how the Company does business, the
services offered and interactions with patients and the public.
These laws and regulations and their interpretations are subject
to frequent change. Changes in existing laws or regulations, or
their interpretations, or the enactment of new laws or
regulations could materially and adversely affect the
Companys operations and financial condition.
The Company is subject to various routine and non-routine
governmental reviews, audits and investigations. In recent
years, federal and state civil and criminal enforcement agencies
have heightened and coordinated their oversight efforts related
to the health care industry, including with respect to referral
practices, cost reporting, billing practices, joint ventures and
other financial relationships among health care providers.
Violation of the laws governing the Companys operations,
or changes in the interpretation of those laws, could result in
the imposition of fines, civil or criminal penalties, the
termination of the Companys rights to participate in
federal and state-sponsored programs and the suspension or
revocation of the Companys licenses.
If the Companys long-term acute care hospitals fail to
meet or maintain the standards for Medicare certification as
long-term acute care hospitals, such as average minimum length
of patient stay, they will receive payments under the
prospective payment system applicable to general acute care
hospitals rather than payment under the system applicable to
long-term acute care hospitals. Payments at rates applicable to
general acute care hospitals would likely result in the Company
receiving less Medicare reimbursement than currently received
for patient services. Moreover, all but one of the
Companys long-term acute care hospitals are subject to
additional Medicare criteria because they operate as separate
hospitals located in space leased from and located in, a general
acute care hospital, known as a host hospital. This is known as
a hospital within a hospital model. These additional
criteria include requirements concerning financial and
operational separateness from the host hospital.
The Company anticipates there may be changes to the standard
episode-of-care payment from Medicare in the future. Due to the
uncertainty of the revised payment amount, the Company cannot
estimate the impact that changes in the payment rate, if any,
will have on its future financial statements.
The Company believes that it is in material compliance with all
applicable laws and regulations and is not aware of any pending
or threatened investigations involving allegations of potential
wrongdoing. While no such regulatory inquiries have been made,
compliance with such laws and regulations can be subject to
future government review and interpretation as well as
significant regulatory action, including fines, penalties and
exclusion from the Medicare program.
The Companys segments consist of (a) home-based
services and (b) facility-based services. Home-based
services include home nursing services and hospice services.
Facility-based services include long-term acute care services
and outpatient rehabilitation services. The accounting policies
of the segments are the same as those described in the summary
of significant accounting policies.
F-26
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2008
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
Net service revenue
|
|
$
|
326,041
|
|
|
$
|
57,255
|
|
|
$
|
383,296
|
|
Cost of service revenue
|
|
|
154,376
|
|
|
|
32,473
|
|
|
|
186,849
|
|
Provision for bad debts
|
|
|
10,208
|
|
|
|
1,563
|
|
|
|
11,771
|
|
General and administrative expenses
|
|
|
109,917
|
|
|
|
14,473
|
|
|
|
124,390
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
51,540
|
|
|
|
8,746
|
|
|
|
60,286
|
|
Interest expense
|
|
|
(377
|
)
|
|
|
(92
|
)
|
|
|
(469
|
)
|
Non operating income, including gain on sale of assets
|
|
|
1,246
|
|
|
|
194
|
|
|
|
1,440
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
minority interest
|
|
|
52,409
|
|
|
|
8,848
|
|
|
|
61,257
|
|
Minority interest
|
|
|
10,219
|
|
|
|
1,580
|
|
|
|
11,799
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
|
|
|
42,190
|
|
|
|
7,268
|
|
|
|
49,458
|
|
Total assets
|
|
$
|
220,822
|
|
|
$
|
22,578
|
|
|
$
|
243,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
Net service revenue
|
|
$
|
244,107
|
|
|
$
|
53,924
|
|
|
$
|
298,031
|
|
Cost of service revenue
|
|
|
116,962
|
|
|
|
33,797
|
|
|
|
150,759
|
|
Provision for bad debt
|
|
|
9,426
|
|
|
|
2,822
|
|
|
|
12,248
|
|
General and administrative expenses
|
|
|
80,595
|
|
|
|
15,770
|
|
|
|
96,365
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
37,124
|
|
|
|
1,535
|
|
|
|
38,659
|
|
Interest expense
|
|
|
(250
|
)
|
|
|
(126
|
)
|
|
|
(376
|
)
|
Non operating income, including gain on sale of assets
|
|
|
746
|
|
|
|
327
|
|
|
|
1,073
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
minority interest
|
|
|
37,620
|
|
|
|
1,736
|
|
|
|
39,356
|
|
Minority interest
|
|
|
5,177
|
|
|
|
807
|
|
|
|
5,984
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
|
|
|
32,443
|
|
|
|
929
|
|
|
|
33,372
|
|
Total assets
|
|
|
151,540
|
|
|
|
23,445
|
|
|
|
174,985
|
|
F-27
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
Net service revenue
|
|
$
|
164,701
|
|
|
$
|
53,834
|
|
|
$
|
218,535
|
|
Cost of service revenue
|
|
|
78,089
|
|
|
|
32,705
|
|
|
|
110,794
|
|
Provision for bad debt
|
|
|
3,051
|
|
|
|
1,054
|
|
|
|
4,105
|
|
General and administrative expenses
|
|
|
53,630
|
|
|
|
14,681
|
|
|
|
68,311
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
29,931
|
|
|
|
5,394
|
|
|
|
35,325
|
|
Interest expense
|
|
|
(210
|
)
|
|
|
(115
|
)
|
|
|
(325
|
)
|
Non operating income, including gain on sale of assets
|
|
|
1,404
|
|
|
|
629
|
|
|
|
2,033
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
minority interest
|
|
|
31,125
|
|
|
|
5,908
|
|
|
|
37,033
|
|
Minority interest
|
|
|
3,075
|
|
|
|
1,720
|
|
|
|
4,795
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
|
|
|
28,050
|
|
|
|
4,188
|
|
|
|
32,238
|
|
Total assets
|
|
|
117,585
|
|
|
|
35,109
|
|
|
|
152,694
|
|
|
|
13.
|
Fair
Value of Financial Instruments
|
The carrying amounts of the Companys cash, receivables,
accounts payable and accrued liabilities approximate their fair
values because of their short maturity. The carrying value of
the Companys long-term debt equals its fair value based on
a variable interest rate.
|
|
14.
|
Allowance
for Uncollectible Accounts
|
The following table summarizes the activity and ending balances
in the allowance for uncollectible accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning
|
|
|
|
|
|
|
|
|
End of
|
|
|
|
of Year
|
|
|
Additions and
|
|
|
|
|
|
Year
|
|
|
|
Balance
|
|
|
Expenses
|
|
|
Deductions
|
|
|
Balance
|
|
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
Year ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
$
|
8,953
|
|
|
$
|
12,463
|
|
|
$
|
11,440
|
|
|
$
|
9,976
|
|
2007
|
|
|
5,769
|
|
|
|
13,817
|
|
|
|
10,633
|
|
|
|
8,953
|
|
2006
|
|
|
2,544
|
|
|
|
4,778
|
|
|
|
1,553
|
|
|
|
5,769
|
|
|
|
15.
|
Concentration
of Risk
|
The Companys Louisiana facilities accounted for
approximately 41.9%, 50.9%, and 64.1% of net service revenue
during the years ended December 31, 2008, 2007 and 2006,
respectively. Any material change in the current economic or
competitive conditions in Louisiana could have a
disproportionate effect on the Companys overall business
results.
F-28
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
16.
|
Unaudited
Summarized Quarterly Financial Information
|
The following table presents the Companys unaudited
quarterly results of operations (amounts in thousands, except
share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
Second Quarter
|
|
|
Third Quarter
|
|
|
Fourth Quarter
|
|
|
|
2008
|
|
|
2008
|
|
|
2008
|
|
|
2008
|
|
|
Net service revenue
|
|
$
|
83,473
|
|
|
$
|
90,115
|
|
|
$
|
98,166
|
|
|
$
|
111,542
|
|
Gross margin
|
|
|
42,201
|
|
|
|
45,180
|
|
|
|
50,813
|
|
|
|
58,253
|
|
Net income
|
|
|
5,338
|
|
|
|
6,334
|
|
|
|
8,032
|
|
|
|
10,498
|
|
Net income available to common stockholders
|
|
|
5,439
|
|
|
|
6,298
|
|
|
|
8,003
|
|
|
|
10,493
|
|
Basic and Diluted earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.30
|
|
|
$
|
0.35
|
|
|
$
|
0.45
|
|
|
$
|
0.58
|
|
Net income available to common shareholders
|
|
$
|
0.31
|
|
|
$
|
0.35
|
|
|
$
|
0.45
|
|
|
$
|
0.58
|
|
Weighted average shares outstanding Basic
|
|
|
17,800,066
|
|
|
|
17,849,820
|
|
|
|
17,881,228
|
|
|
|
17,891,426
|
|
Diluted
|
|
|
17,813,967
|
|
|
|
17,883,964
|
|
|
|
17,976,305
|
|
|
|
17,993,815
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
Second Quarter
|
|
|
Third Quarter
|
|
|
Fourth Quarter
|
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
Net service revenue
|
|
$
|
68,727
|
|
|
$
|
70,564
|
|
|
$
|
77,495
|
|
|
$
|
81,245
|
|
Gross margin
|
|
|
34,567
|
|
|
|
34,937
|
|
|
|
37,970
|
|
|
|
39,798
|
|
Net income
|
|
|
5,786
|
|
|
|
5,038
|
|
|
|
6,025
|
|
|
|
2,740
|
|
Net income available to common stockholders
|
|
|
5,820
|
|
|
|
5,160
|
|
|
|
6,082
|
|
|
|
2,720
|
|
Basic and Diluted earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.33
|
|
|
$
|
0.28
|
|
|
$
|
0.34
|
|
|
$
|
0.15
|
|
Net income available to common shareholders
|
|
$
|
0.33
|
|
|
$
|
0.29
|
|
|
$
|
0.34
|
|
|
$
|
0.15
|
|
Weighted average shares outstanding Basic
|
|
|
17,748,369
|
|
|
|
17,754,632
|
|
|
|
17,766,612
|
|
|
|
17,773,616
|
|
Diluted
|
|
|
17,807,338
|
|
|
|
17,798,952
|
|
|
|
17,794,072
|
|
|
|
17,808,795
|
|
Because of the method used to calculate per share amounts, the
quarterly per share amounts may not necessarily total to the per
share amounts for the entire year.
F-29
SIGNATURES
Pursuant to the requirements of Section 13 or 15
(d) of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
LHC GROUP, INC.
Keith G. Myers
President and Chief Executive Officer
Date March 16, 2009
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Keith G. Myers and Peter
J. Roman and either of them (with full power in each to act
alone) as true and lawful attorneys-in-fact with full power of
substitution, for him and in his name, place and stead, in any
and all capacities, to sign any and all amendments to this
Annual Report on
Form 10-K
and to file the same, with all exhibits thereto and other
documents in connection therewith, with the Securities and
Exchange Commission, hereby ratifying and confirming all that
said attorneys-in-fact, or their substitute or substitutes, may
lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed by the following persons on
behalf of the registrant and in the capacities and on the dates
indicated:
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Keith
G. Myers
Keith
G. Myers
|
|
Chief Executive Officer and Chairman of the Board of Directors
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Peter
J. Roman
Peter
J. Roman
|
|
Senior Vice President, Chief Financial Officer
|
|
March 16, 2009
|
|
|
|
|
|
/s/ John
L. Indest
John
L. Indest
|
|
President, Chief Operating Officer Secretary and Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Dan
S. Wilford
Dan
S. Wilford
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Ronald
T. Nixon
Ronald
T. Nixon
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Ted
W. Hoyt
Ted
W. Hoyt
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ George
A. Lewis
George
A. Lewis
|
|
Director
|
|
March 16, 2009
|
71
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ John
B. Breaux
John
B. Breaux
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ Monica
F. Azare
Monica
F. Azare
|
|
Director
|
|
March 16, 2009
|
|
|
|
|
|
/s/ W.J.
Billy Tauzin
W.J.
Billy Tauzin
|
|
Director
|
|
March 16, 2009
|
72
EXHIBIT INDEX
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibits
|
|
|
3
|
.1
|
|
Certificate of Incorporation of LHC Group, Inc. (previously
filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
3
|
.2
|
|
Amended and Restated Bylaws of LHC Group, Inc., as amended
December 3, 2008 (previously filed as Exhibit 3.2 to the
Form 10-Q on May 9, 2008).
|
|
3
|
.3
|
|
Certificate of Designations (previously filed as Exhibit B
to Exhibit 4.1 to the
Form 8-A12B
on March 11, 2008).
|
|
4
|
.1
|
|
Specimen Stock Certificate of LHCs Common Stock, par value
$0.01 per share (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
4
|
.2
|
|
Reference is made to Exhibits 3.1 and 3.2 (previously filed
as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005 and May 9, 2005, respectively).
|
|
4
|
.3
|
|
Stockholder Protection Rights Agreement, Dated March 10,
2008 by and between LHC Group, Inc. and Computershare
Trust Company, N.A., as rights agent (previously filed as
Exhibit 4.1 to the
Form 8-A12B
on March 11, 2008).
|
|
10
|
.1
|
|
LHC 2003 Key Employee Equity Participation Plan (previously
filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on November 26, 2004).
|
|
10
|
.2
|
|
LHC Group, Inc. 2005 Long-Term Incentive Plan (previously filed
as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.3
|
|
Form of Award under LHC Group, Inc. 2005 Director
Compensation Plan. (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.4
|
|
Form of Indemnity Agreement between LHC Group and directors and
certain officers (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.5
|
|
LHC Group, Inc. 2005 Director Compensation Plan (previously
filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.6
|
|
Amendment to LHC Group, Inc. 2005 Director Compensation
Plan (previously filed as Exhibit 99.1 to the
Form 8-K
on June 12, 2006).
|
|
10
|
.7
|
|
LHC Group, Inc. 2006 Employee Stock Purchase Plan (previously
filed as Exhibit 99.2 to the
Form 8-K
on June 12, 2006).
|
|
10
|
.8
|
|
Severance and Consulting Agreement by and between LHC Group,
Inc. and Barry E. Stewart, dated August 15, 2007
(previously filed as Exhibit 10.1 to the
Form 8-K
on August 15, 2007).
|
|
10
|
.9
|
|
Employment Agreement by and between LHC Group, Inc. and Don
Stelly, dated October 22, 2007 (previously filed as
Exhibit 10.1 to the
Form 8-K
on October 30, 2007).
|
|
10
|
.10
|
|
Employment Agreement between LHC Group, Inc. and Keith G. Myers
dated January 1, 2008 (previously filed as
Exhibit 10.1 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.11
|
|
Employment Agreement between LHC Group, Inc. and John L. Indest
dated January 1, 2008 (previously filed as
Exhibit 10.2 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.12
|
|
Employment Agreement by and between LHC Group, Inc. and Peter
Roman, dated January 1, 2008 (previously filed as
Exhibit 10.3 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.13
|
|
Employment Agreement between LHC Group, Inc. and Daryl Doise
dated January 1, 2008 (previously filed as
Exhibit 10.4 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.14
|
|
Loan Agreement by and between LHC Group, Inc., Palmetto Express,
L.L.C. and Capital One, National Association dated
February 6, 2008 (previously filed as Exhibit 10.1 to
the
Form 8-K
on February 13, 2008).
|
|
10
|
.15
|
|
Amended and Restated Credit Agreement by and among LHC Group,
Inc., Capital One, National Association, First Tennessee Bank,
N.A. and Brand Banking and Trust Company, dated
June 12, 2008 (previously filed as Exhibit 10.1 to the
Form 8-K
on June 17, 2008).
|
|
21
|
.1
|
|
Subsidiaries of the Registrant.
|
|
23
|
.1
|
|
Consent of Ernst & Young LLP.
|
|
23
|
.2
|
|
Consent of KPMG LLP.
|
73
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibits
|
|
|
31
|
.1
|
|
Certification of Keith G. Myers, Chief Executive Officer
pursuant to
Rule 13a-
14(a)/15d-14(a), as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
31
|
.2
|
|
Certification of Peter J. Roman, Chief Financial Officer
pursuant to
Rule 13a-
14(a)/15d-14(a), as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
32
|
.1*
|
|
Certification of the Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
* |
|
This exhibit is furnished to the SEC as an accompanying document
and is not deemed to be filed for purposes of
Section 18 of the Securities Exchange Act of 1934 or
otherwise subject to the liabilities of that Section, and the
document will not be deemed incorporated by reference into any
filing under the Securities Act of 1933. |
74